<SEC-DOCUMENT>0001193125-24-158758.txt : 20240611
<SEC-HEADER>0001193125-24-158758.hdr.sgml : 20240611
<ACCEPTANCE-DATETIME>20240611085031
ACCESSION NUMBER:		0001193125-24-158758
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20240607
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240611
DATE AS OF CHANGE:		20240611

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BLUE RIDGE BANKSHARES, INC.
		CENTRAL INDEX KEY:			0000842717
		STANDARD INDUSTRIAL CLASSIFICATION:	STATE COMMERCIAL BANKS [6022]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				541838100
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39165
		FILM NUMBER:		241034662

	BUSINESS ADDRESS:	
		STREET 1:		1801 BAYBERRY COURT
		STREET 2:		SUITE 101
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23226
		BUSINESS PHONE:		540-743-6521

	MAIL ADDRESS:	
		STREET 1:		1801 BAYBERRY COURT
		STREET 2:		SUITE 101
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23226

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BLUE RIDGE BANKSHARES INC
		DATE OF NAME CHANGE:	19881115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d828101d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:brbs="http://www.mybrb.bank/20240607" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-363">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-06-07_to_2024-06-07">0000842717</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="brbs-20240607.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-06-07_to_2024-06-07"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000842717</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-06-07</xbrli:startDate> <xbrli:endDate>2024-06-07</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-374">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt:datemonthdayyearen" id="ixv-375">June&#160;7, 2024</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-376">BLUE RIDGE BANKSHARES, INC.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:stateprovnameen" id="ixv-377">Virginia</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-378">001-39165</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-379">54-1838100</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-380">1801 Bayberry Court</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-381">Suite 101</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-382">Richmond</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:stateprovnameen" id="ixv-383">Virginia</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-384">23226</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-385">(540)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-386">743-6521</ix:nonNumeric></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:boolballotbox" id="ixv-387">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:boolballotbox" id="ixv-388">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:boolballotbox" id="ixv-389">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:boolballotbox" id="ixv-390">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title&#160;of&#160;each&#160;class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name&#160;of&#160;each&#160;exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which&#160;registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-391">Common stock, no par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-392">BRBS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:exchnameen" id="ixv-393">NYSE American LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#8201;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:boolballotbox" id="ixv-394">&#9746;</ix:nonNumeric>&#8195;&#8195;&#8195;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2024-06-07_to_2024-06-07" format="ixt-sec:boolballotbox" id="ixv-395">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Securities Purchase Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As previously disclosed, on April&#160;3, 2024, Blue Ridge Bankshares, Inc. (the &#8220;Company&#8221;), entered into an Amended and Restated Securities Purchase Agreement with Kenneth R. Lehman, Castle Creek Capital Partners VIII, LP, other investors and certain directors and executive officers of the Company (collectively, the &#8220;Purchasers&#8221;) and issued and sold to the Purchasers, in the aggregate, (i) 3.4&#160;million shares of the Company&#8217;s common stock, no par value (the &#8220;Common Stock&#8221;), at a purchase price of $2.50 per share, (ii) 11,418 shares of the Company&#8217;s Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, par value $50.00 per share (the &#8220;Series B Preferred Stock&#8221;), at a purchase price of $10,000.00 per share, (iii) 2,732 shares of the Company&#8217;s Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series C, par value $50.00 per share (the &#8220;Series C Preferred Stock&#8221; and together with the Series B Preferred Stock, the &#8220;Preferred Stock&#8221;), at a purchase price of $10,000.00 per share, and (iv)&#160;warrants to purchase 5,942 shares of Series B Preferred Stock and 1,441 shares of Series C Preferred Stock at an exercise price of $10,000.00 per share, for gross proceeds to the Company of $150,000,000 (the &#8220;April Issuance&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is also party to two Stock Purchase Agreements, dated March&#160;17, 2015 and December&#160;31, 2014 (the &#8220;2014/2015 Agreements&#8221;), respectively, by and among the Company and the purchasers identified therein, including Richard T. Spurzem, a shareholder of the Company (&#8220;Mr.&#160;Spurzem&#8221;). Pursuant to the 2014/2015 Agreements, Mr.&#160;Spurzem has <span style="white-space:nowrap">gross-up</span> rights with respect to certain issuances of equity or equity-linked securities by the Company, including the April Issuance. The purchase price payable by Mr.&#160;Spurzem upon exercise of his <span style="white-space:nowrap">gross-up</span> rights to maintain his proportionate Common Stock interest in the Company pursuant to the 2014/2015 Agreements is net of any underwriting discounts or sales commissions. By notice to the Company, Mr.&#160;Spurzem properly exercised his <span style="white-space:nowrap">gross-up</span> rights under the 2014/2015 Agreements with respect to the April Issuance to purchase 290,000 shares of Common Stock (the &#8220;Common Shares&#8221;) at a purchase price of $2.39 per Common Share, 1,140 shares of Series B Preferred Stock (the &#8220;Preferred Shares&#8221;), at a purchase price of $9,566.13 per Preferred Share, and a warrant to purchase 607 shares of Series B Preferred Stock at an exercise price of $10,000.00 per share (the &#8220;Warrant&#8221; and the shares of Preferred Stock (and after conversion, the shares of Common Stock) issuable upon exercise of or otherwise pursuant to the Warrant collectively are referred to as the &#8220;Warrant Shares&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;7, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) with Mr.&#160;Spurzem to purchase the Common Shares, the Preferred Shares and the Warrant for gross proceeds to the Company of approximately $11.6&#160;million (the &#8220;Private Placement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The closing of the Private Placement is anticipated to occur on June&#160;12, 2024, or the first business day after the satisfaction or waiver of the conditions to closing set forth in the Securities Purchase Agreement. The conditions to closing consist of standard closing conditions, including authorization from the NYSE American to list the Common Shares for trading on such exchange. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will use the net proceeds from the Private Placement for general corporate purposes and to reposition business lines, support organic growth and enhance capital levels of Blue Ridge Bank, National Association, the Company&#8217;s wholly-owned banking subsidiary. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Piper Sandler&#160;&amp; Co. (the &#8220;Placement Agent&#8221;) is serving as placement agent with respect to the Private Placement. The Company will pay a fee to the Placement Agent in connection with the Private Placement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder Approvals </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Conversion of the Preferred Shares and Series B Preferred Stock underlying the Warrant is contingent upon stockholder approval of (i)&#160;an amendment to the Company&#8217;s articles of incorporation to increase the number of authorized shares of Common Stock to at least 150,000,000 shares (the &#8220;Articles Amendment Approval&#8221;) and (ii)&#160;the issuance of the Underlying Preferred Shares (defined below) and the Warrant Shares pursuant to applicable listing standards of the NYSE American (the &#8220;Issuance Approval&#8221; and together with the Articles Amendment Approval, the &#8220;Stockholder Approvals&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once issued, the Preferred Shares will be convertible into shares of Common Stock (the &#8220;Underlying Preferred Shares&#8221;) at the initial conversion rate of 4,000 shares of Common Stock per Preferred Share, which conversion rate is based on an initial conversion price of $2.50 per share of Common Stock and is subject to certain adjustments (the &#8220;Conversion Rate&#8221;). Similarly, the shares of Series B Preferred Stock issuable upon exercise of the Warrant are convertible into shares of Common Stock at the same Conversion Rate (the &#8220;Warrant Shares&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After receiving each respective Stockholder Approval, in the time and manner required by the NYSE American, the Company will prepare and file with the NYSE American a supplemental listing application covering all of the Underlying Preferred Shares and the Warrant Shares and will use its commercially reasonable efforts to cause all of the Underlying Preferred Shares and the Warrant Shares to be approved for listing on the NYSE American as promptly as possible. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the Company has obtained the Issuance Approval but the Company&#8217;s shareholders have not approved the Articles Amendment Approval, the Company will effect a &#8220;Partial Conversion&#8221; of the Series B Preferred Stock, whereby outstanding shares of Series B Preferred Stock will automatically convert into shares of Common Stock, but only to the extent of the total number of shares of Common Stock available for issuance by the Company pursuant to its then effective articles of incorporation (taking into consideration any shares previously reserved for issuance), allocated pro rata among the holders of the Series B Preferred Stock and the Series C Preferred Stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Indemnification </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations, the Company will indemnify Mr.&#160;Spurzem and certain of his related parties against losses in connection with breaches of the Securities Purchase Agreement and the other documents contemplated therein by the Company or in connection with the transactions contemplated by the Securities Purchase Agreement. Subject to certain limitations, Mr.&#160;Spurzem will indemnify the Company and its affiliates and certain related persons against losses in connection with breaches of the Securities Purchase Agreement and the other documents contemplated therein by Mr.&#160;Spurzem. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Warrant </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the closing of the Private Placement, the Company will issue a Warrant to Mr.&#160;Spurzem, which will be exercisable at any time after issuance, and from time to time, in whole or in part into shares of Series B Preferred Stock until the fifth anniversary of the closing date of the Private Placement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that all (but not less than all) outstanding shares of Series B Preferred Stock are converted into shares of Common Stock pursuant to the provisions of the Company&#8217;s Articles of Incorporation as then in effect, then from and after the date on which such outstanding shares of Series B Preferred Stock have been so converted, the Warrant shall be exercisable for such number of shares of Common Stock into which the shares of Series B Preferred Stock subject to the Warrant would have been converted had the shares of Series B Preferred Stock subject to the Warrant been outstanding on the date of such conversion as provided in the Company&#8217;s Articles of Incorporation as then in effect. After such conversion, the exercise price per share of Common Stock subject to the Warrant shall equal the exercise price in effect as of immediately prior to such conversion divided by the number of shares of Common Stock into which one share of Series B Preferred Stock previously subject to the Warrant would have been converted on such date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Spurzem or his permitted, registered assigns may exercise such Warrant by paying the exercise price in immediately available funds to the Company or, in certain circumstances, through a &#8220;cashless exercise&#8221; whereby the holder of the Warrant forfeits shares subject to the Warrant in lieu of paying the exercise price. The Warrant contains certain anti-dilution price protection. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Registration Rights Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Closing of the Private Placement, the Company and Mr.&#160;Spurzem will enter into a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;). Pursuant to the Registration Rights Agreement, the Company will register for resale the Common Shares, the Warrant Shares (if Common Stock) and the Underlying Preferred Shares (collectively, the &#8220;Registrable Securities&#8221;). The Company has agreed to file a registration statement registering the Registrable Securities for resale by Mr.&#160;Spurzem by the earliest of (i) 30 days after the Stockholder Approvals, (ii)&#160;thirty days after the Partial Conversion and (iii)&#160;October&#160;15, 2025. The Company will use its commercially reasonable efforts to cause such registration statement to be declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;) and to keep such registration statement effective until the earlier of (i)&#160;such time as all of the Registrable Securities covered by such registration statement have been publicly sold by the holders thereof and (ii)&#160;the date on which all Common Shares, Warrant Shares and Underlying Preferred Shares cease to be Registrable Securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company fails to file the registration statement or have it declared effective by certain deadlines, if the registration statement ceases to remain effective, subject to specified grace periods, or if the Company fails to satisfy the current public information requirement of Rule 144(c)(1) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), then the Company will pay monthly liquidated damages to the holder of Registrable Securities in an amount of one percent (1.0%) of the aggregate purchase price paid by Mr.&#160;Spurzem pursuant to the Securities Purchase Agreement for any unregistered Registrable Securities then held by such Holder, subject to certain caps and limitations. The Company will pay all fees and expenses incident to the Company&#8217;s performance of its obligations under the Registration Rights Agreement, excluding (with certain exceptions) any underwriting discounts, selling commissions, fees of underwriters, selling brokers, dealer managers or similar securities industry </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
professionals and all legal fees and expenses of legal counsel for any holder of Registrable Securities. The Company and Mr.&#160;Spurzem agreed to provide each other with certain indemnification and contribution rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing descriptions of the Securities Purchase Agreement, the Warrant and the Registration Rights Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the form of Securities Purchase Agreement, the form of Warrant and the form of Registration Rights Agreement, copies of which are filed as, or contained in, the exhibits hereto, and incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The representations, warranties and covenants of the Company set forth in the Securities Purchase Agreement have been made only for purposes of, and were and are solely for the benefit of the parties to, the Securities Purchase Agreement, may be subject to limitations agreed upon by the contracting parties and standards of materiality applicable to the contracting parties that differ from those applicable to investors. Accordingly, the representations and warranties may not describe the actual state of affairs at the date they were made or at any other time, and investors should not rely on them as statements of fact. In addition, such representations and warranties, unless otherwise specified therein, were made only as of the date of the Securities Purchase Agreement, and information concerning the subject matter of the representations and warranties may change after the date of the Securities Purchase Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s public disclosures. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;3.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information contained in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is hereby incorporated by reference into this Item 3.02. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based in part upon the representations of Mr.&#160;Spurzem in the Securities Purchase Agreement, the Private Placement is exempt from registration under Section&#160;4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated under the Securities Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Additional Information </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain investments discussed above involve the sale of securities in a private transaction that will not be registered under the Securities Act and will be subject to the resale restrictions under the Securities Act. Such securities may not be offered or sold absent registration or an applicable exemption from registration. This Current Report on Form <span style="white-space:nowrap">8-K</span> does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Forward Looking Statements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> contains forward-looking statements, including statements regarding the Company&#8217;s plans for raising capital, the expected use of proceeds from the Private Placement, the filing of a registration statement to register the resale of the Common Shares, the Underlying Preferred Shares and the Warrant Shares, and the Company&#8217;s business strategies, plans and prospects. All statements, other than statements of historical facts, contained in this Current Report on Form <span style="white-space:nowrap">8-K</span> are forward-looking statements. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
are typically identified with words such as &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;aim,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; or words or phrases of similar meaning. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements. The forward-looking statements are based on management&#8217;s current expectations, estimates and projections and are not guarantees of future performance. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company cautions that the forward-looking statements are based largely on its expectations and are subject to a number of known and unknown risks and uncertainties that are subject to change based on factors which are, in many instances, beyond the Company&#8217;s control. The forward-looking statements contained in this Current Report on Form <span style="white-space:nowrap">8-K</span> are subject to risks and uncertainties, including those described in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the period ended December&#160;31, 2023 and from time to time other filings with the SEC, which are available on the SEC&#8217;s website (http://www.sec.gov). Stockholders of the Company are cautioned not to place undue reliance on the Company&#8217;s forward-looking statements, which speak only as of the date such statements are made. The Company does not undertake any obligation to publicly update any forward-looking statements to reflect events, circumstances or new information after the date of this filing or to reflect the occurrence of unanticipated events. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8195;No.&#8195;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d828101dex101.htm">Form of Securities Purchase Agreement, dated June&#160;7, 2024, by and between Blue Ridge Bankshares, Inc. and Richard T. Spurzem. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">BLUE RIDGE BANKSHARES, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;11, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Judy C. Gavant</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Judy C. Gavant</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President and</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</p></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d828101dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Securities Purchase Agreement (this &#147;<I>Agreement</I>&#148;) is dated as of June&nbsp;7, 2024, by and between Blue Ridge Bankshares,
Inc., a Virginia corporation (the &#147;<I>Company</I>&#148;), and the purchaser identified on the signature page hereto (including his successors and assigns, the &#147;<I>Purchaser</I>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RECITALS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A. Pursuant to that
certain Amended and Restated Securities Purchase Agreement, dated April&nbsp;3, 2024, by and among the Company and the purchasers identified on the signature pages thereto (the &#147;<I>SPA</I>&#148;), the Company issued and sold (i)&nbsp;shares of
the Company&#146;s common stock, no par value per share (the &#147;<I>Common Stock</I>&#148;), (ii) shares of either the Company&#146;s Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, par value $50.00 per share (the
&#147;<I>Series B</I>&#148;), or Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series C, par value $50.00 per share (the &#147;<I>Series C</I>,&#148; and together with the Series B, the &#147;<I>Preferred Stock</I>&#148;), and
(iii)&nbsp;warrants to purchase shares of either Series B or Series C depending on what type of Preferred Stock such Purchaser purchased pursuant to clause (ii)&nbsp;above; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">B. Pursuant to Section&nbsp;4.13 and Section&nbsp;6.4 of (i)&nbsp;that certain Stock Purchase Agreement, dated March&nbsp;17, 2015, by and
among the Company and the purchasers, including Purchaser, identified on the signature pages thereto and (ii)&nbsp;that certain Stock Purchase Agreement, dated December&nbsp;31, 2014, by and among the Company and the purchasers, including Purchaser,
identified on the signature pages thereto (together, the &#147;<I>2014/2015 Agreements</I>&#148;), the Company provided a written offer by letter, dated April&nbsp;25, 2024, to Purchaser to acquire shares of Common Stock, shares of Series B and/or
shares of Series C and a corresponding warrant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">C. Purchaser properly exercised his rights under Section&nbsp;4.13 of the 2014/2015
Agreements with respect to 290,000 shares of Common Stock (the &#147;<I>Common Shares</I>&#148;), 1,140 shares of Series B (the &#147;<I>Preferred Shares</I>&#148;) and a warrant exercisable for 607 shares of Series B in substantially the form
attached hereto as <U>Exhibit A</U> (the &#147;<I>Warrant</I>&#148; and the shares of Preferred Stock (and after Conversion, the shares of Common Stock) issuable upon exercise of or otherwise pursuant to the Warrant collectively are referred to
herein as the &#147;<I>Warrant Shares</I>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">D. The Company and the Purchaser are executing and delivering this Agreement in
reliance upon the exemption from securities registration afforded by Section&nbsp;4(a)(2) of the Securities Act of 1933, as amended (the &#147;<I>Securities Act</I>&#148;), and Rule 506(b) of Regulation D (&#147;<I>Regulation D</I>&#148;) as
promulgated by the United States Securities and Exchange Commission (the &#147;<I>Commission</I>&#148;) under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">E. The
Preferred Stock Articles of Amendment previously have been made a part of the Company&#146;s Articles of Incorporation by filing the Preferred Stock Articles of Amendment with the Virginia State Corporation Commission (the &#147;<I>VSCC</I>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">F. The Common Shares, Preferred Shares, the Underlying Preferred Shares and the Warrant Shares collectively are referred to herein as the
&#147;<I>Shares</I>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">G. The Shares and the Warrant collectively are referred to herein as the &#147;<I>Securities</I>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">H. The Company has engaged Piper Sandler&nbsp;&amp; Co. as its exclusive placement agent (the &#147;<I>Placement Agent</I>&#148;) for the
offering of the Shares and Warrant on a &#147;best efforts&#148; basis. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">I. At Closing, the parties hereto shall execute and deliver a Registration Rights Agreement,
substantially in the form attached hereto as <U>Exhibit B</U> (the &#147;<I>Registration Rights Agreement</I>&#148;), pursuant to which, among other things, the Company will agree to provide certain registration rights with respect to the
Registrable Securities under the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE I. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DEFINITIONS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall have the meanings indicated in this <U>Section</U><U></U><U>&nbsp;1.1</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Affiliate</I>&#148; means, with respect to any Person, any other Person that, directly or indirectly through one or more
intermediaries, Controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act. With respect to the Purchaser, any investment fund or managed account that is
managed on a discretionary basis by the same investment manager as the Purchaser will be deemed to be an Affiliate of the Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Agreement</I>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Articles Amendment</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Bank</I>&#148; means Blue Ridge Bank, National Association, a national banking association and wholly-owned subsidiary of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Bank Reports</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(o)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>BHC Act</I>&#148; means the Bank Holding Company Act of 1956, as amended, and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Board of Directors</I>&#148; means the board of directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Business Day</I>&#148; means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any
day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>CIBC Act</I>&#148; means the Change in Bank Control Act of 1978, as amended, and the rules and regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Closing</I>&#148; means the closing of the purchase and sale of the Common Shares, Preferred Shares and the Warrant pursuant to
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Closing Date</I>&#148; means the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties thereto, and all of the conditions set forth in <U>Sections 2.1</U>, <U>2.2</U>, <U>5.1</U> and <U>5.2</U> hereof are satisfied or waived, as the case may be, or such other date as the parties may agree. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Commission</I>&#148; has the meaning set forth in the Recitals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Common Shares</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Common Stock</I>&#148; has the meaning set forth in the Recitals, and also includes any other class of securities into which the
Common Stock may hereafter be reclassified or changed into. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Common Stock Equivalents</I>&#148; means any securities of the
Company or any Subsidiary which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or
exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock or other securities that entitle the holder to receive, directly or indirectly, Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Common Stock Purchase Price</I>&#148; means $2.39 per share of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Company</I>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Company Counsel</I>&#148; means Williams Mullen, with offices located at 200 South 10th Street, Suite 1600, Richmond, Virginia 23219.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Company Deliverables</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Company Indemnified Party</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.8(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Company&#146;s Knowledge</I>&#148; means with respect to any statement made to the Company&#146;s Knowledge, that the statement is
based upon the actual knowledge of the executive officers of the Company having responsibility for the matter or matters that are the subject of the statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Control</I>&#148; (including the terms &#147;controlling&#148;, &#147;controlled by&#148; or &#147;under common control with&#148;)
means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of Voting Securities, by contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Conversion</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Covered Person</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(cc)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Current Report</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Disclosure Materials</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(h)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Disclosure Schedules</I>&#148; has the meaning set forth in Section&nbsp;3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Disqualification Events</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(cc)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>DTC</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Effective Date</I>&#148; means the date on which the initial Registration Statement required by Section&nbsp;2(a) of the Registration
Rights Agreement is first declared effective by the Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Environmental Laws</I>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.1(ee)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Evaluation Date</I>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.1(u)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Exchange Act</I>&#148; means the Securities Exchange Act of 1934, as amended, or
any successor statute, and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Federal Reserve</I>&#148; means the Board of
Governors of the Federal Reserve System. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>GAAP</I>&#148; means U.S. generally accepted accounting principles, as applied by the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Indemnified Person</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.8(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Indemnifying Person</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.8(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Intellectual Property Rights</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(q)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Irrevocable Transfer Agent Instructions</I>&#148; means, with respect to the Company, the Irrevocable Transfer Agent Instructions, in
the form of <U>Exhibit E</U>, executed by the Company and delivered to and acknowledged in writing by the Transfer Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Issuance Approval</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(c).</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Legend Removal Date</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Lien</I>&#148; means any lien, charge, claim, encumbrance, security interest, right of first refusal, preemptive right or other
restrictions of any kind. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Losses</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.8(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Material Adverse Effect</I>&#148; means a material adverse effect on the results of operations, assets, business or financial
condition of the Company and the Subsidiaries, taken as a whole, except that any of the following, either alone or in combination, shall not be deemed a Material Adverse Effect: (i)&nbsp;effects resulting from changes or circumstances affecting
general political, economic or market conditions in the United States or which are generally applicable to the industry in which the Company operates, (ii)&nbsp;effects resulting from changes or circumstances affecting generally the industries or
markets in which the Company operates, (iii)&nbsp;effects resulting from acts of war, sabotage or terrorism, military actions or the escalation thereof, natural disasters, or any epidemic, pandemic, outbreak of disease or other public health event,
(iv)&nbsp;effects of any changes in applicable laws or accounting rules or principles, including changes in GAAP, (v)&nbsp;a decline in the trading price of the Common Stock or the Company&#146;s failure, in and of itself, to meet earnings
projections or internal financial forecasts, but not, in either case, including any underlying causes thereof; (vi)&nbsp;effects resulting from or relating to the announcement or disclosure of the sale of the Securities or other transactions
contemplated by this Agreement, or (vii)&nbsp;the taking of any action in accordance with this Agreement (except, with respect to clauses (i), (ii), (iii), or (iv), to the extent that such changes, circumstances or effects have a disproportionate
effect on the Company compared to other participants in the industries or markets in which the Company operates). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Material
Contract</I>&#148; means any contract of the Company that has been filed or was required to have been filed as an exhibit to the SEC Reports pursuant to Item 601(b)(4) or Item 601(b)(10) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Material Permits</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(n)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Materially Burdensome Regulatory Condition</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.13</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>New York Courts</I>&#148; means the state and federal courts sitting in the City of
New York, Borough of Manhattan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Nonvoting Securities</I>&#148; shall have the meaning ascribed to such term in 12 C.F.R. &#167;
225.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>OFAC</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(ll)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Original Agreement</I>&#148; means that certain Securities Purchase Agreement, dated as of December&nbsp;21, 2023, by and among the
Company and the purchasers signatory thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Outside Date</I>&#148; means December&nbsp;6, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Person</I>&#148; means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint
stock company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Placement Agent</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Preferred Shares</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Preferred Stock</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Preferred Stock Articles of Amendment</I>&#148; has the meaning ascribed to such term in the SPA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Preferred Stock Purchase Price</I>&#148; means $9,566.13 per share of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Principal Trading Market</I>&#148; means the Trading Market on which the Common Stock is primarily listed on and quoted for trading,
which, as of the date of this Agreement and the Closing Date, shall be the NYSE American. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Proceeding</I>&#148; means an action,
claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition) before or by any federal, state, county, local or foreign court, arbitrator, governmental or administrative
agency, regulatory authority, stock market, stock exchange or trading facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Purchaser</I>&#148; has the meaning set forth in
the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Purchaser Deliverables</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Purchaser Indemnified Party</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.8(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>&#147;Registrable Securities</I>&#148; has the meaning ascribed to such term in the Registration Rights Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>&#147;Registration Rights Agreement</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Registration Statement</I>&#148; means a registration statement meeting the requirements set forth in the Registration Rights
Agreement and covering the resale by the Purchaser of the Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Regulation D</I>&#148; has the meaning set
forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Regulatory Approvals</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.13</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Required Approvals</I>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.1(e)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Rule 144</I>&#148; means Rule 144 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>SEC Report</I>s&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(h)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Secretary&#146;s Certificate</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)(vii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Securities Act</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Series B</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Series C</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Shares</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Short Sales</I>&#148; include, without limitation, (i)&nbsp;all &#147;short sales&#148; as defined in Rule 200 promulgated under
Regulation SHO under the Exchange Act, whether or not against the box, and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, short sales, swaps, &#147;put equivalent positions&#148; (as defined in Rule <FONT
STYLE="white-space:nowrap">16a-1(h)</FONT> under the Exchange Act) and similar arrangements (including on a total return basis), and (ii)&nbsp;sales and other transactions through <FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker dealers or
foreign regulated brokers (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Solicitor</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(cc)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Stockholder Approvals</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Subscription Amount</I>&#148; means, with respect to the Purchaser, the aggregate amount to be paid for the Common Shares, the
Preferred Shares and the related Warrant purchased hereunder as indicated on the Purchaser&#146;s signature page to this Agreement next to the heading &#147;Aggregate Purchase Price (Subscription Amount)&#148; in United States dollars and in
immediately available funds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Subsidiary</I>&#148; means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>,
and shall, where applicable, include any subsidiary of the Company formed or acquired after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Threshold
Amount</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.8(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Trading Affiliate</I>&#148; has the
meaning set forth in <U>Section</U><U></U><U>&nbsp;3.2(h)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Trading Day</I>&#148; means (i)&nbsp;a day on which the Common
Stock is listed or quoted and traded on its Principal Trading Market (other than the OTC Bulletin Board), or (ii)&nbsp;if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Stock is
traded in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, as reported by the OTC Bulletin Board, or (iii)&nbsp;if the Common Stock is not quoted on any Trading Market, a day on which the
Common Stock is quoted in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market as reported in the &#147;pink sheets&#148; by Pink Sheets LLC (or any similar organization or agency succeeding to
its functions of reporting prices); <I>provided</I>, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii)&nbsp;hereof, then Trading Day shall mean a Business Day. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Trading Market</I>&#148; means whichever of the New York Stock Exchange, the NYSE
American, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Transaction Documents</I>&#148; means this Agreement, the schedules and exhibits attached hereto, the Warrant, the Registration
Rights Agreement, the Irrevocable Transfer Agent Instructions and any other documents or agreements explicitly contemplated hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Transfer Agent</I>&#148; means Computershare, the current transfer agent of the Company, with a mailing address of 250 Royall Street,
Canton, Massachusetts 02021, or any successor transfer agent for the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Underlying Preferred Shares</I>&#148; means the
shares of Common Stock issued upon conversion of the Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Voting Securities</I>&#148; shall have the meaning
ascribed to such term in 12 C.F.R. &#167; 225.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>VSCC</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Warrant</I>&#148; has the meaning set forth in the Recitals to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Warrant Shares</I>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE II. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PURCHASE AND SALE
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Closing</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<U>Amount</U>. Subject to the terms and conditions set forth in this Agreement, at the Closing, the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, (i)&nbsp;at the Common Stock Purchase Price such
number of shares of Common Stock set forth on the Purchaser&#146;s signature page hereto, and (ii)&nbsp;at the Preferred Stock Purchase Price such number of shares of Preferred Stock set forth on the Purchaser&#146;s signature page hereto. In
addition, the Purchaser shall receive a Warrant to purchase a number of shares of Preferred Stock (with such shares of Preferred Stock being either Series B or Series C depending on which series of Preferred Stock the Purchaser purchases pursuant to
clause (ii)&nbsp;of the preceding sentence) equal to fifty percent (50%) of the sum of (x)&nbsp;the number of Common Shares purchased by the Purchaser divided by 4,000 and (y)&nbsp;the number of Preferred Shares purchased by the Purchaser, rounded
up to the nearest whole share. The Warrant shall have an exercise price equal to $10,000.00 per Warrant Share, which price is subject to adjustment in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Closing</U>. The Closing of the purchase and sale of the Common Shares, Preferred Shares and Warrant shall take place on the Closing
Date remotely by facsimile transmission or other electronic means. Subject to the satisfaction or waiver of the conditions set forth in this Agreement, the closing of the purchase and sale of the Common Shares, Preferred Shares and Warrant shall
occur at 3:00 p.m., New York City time, on June&nbsp;12, 2024, <I>provided</I> that if such conditions have not been so satisfied or waived on such date, the Closing shall occur on the first Business Day after the satisfaction or waiver (by the
party entitled to grant such waiver) of the conditions to the Closing set forth in this Agreement (other than those conditions that by their nature are to be satisfied at the Closing, but subject to fulfillment or waiver of those conditions). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Form of Payment</U>. Except as may otherwise be agreed to between the Company and the
Purchaser, on or prior to the Business Day immediately prior to the Closing Date, the Purchaser shall wire to the Company its Subscription Amount, in United States dollars and in immediately available funds, in accordance with the Company&#146;s
written wire transfer instructions. On the Closing Date, (a)&nbsp;the Company shall irrevocably instruct the Transfer Agent to deliver to the Purchaser <FONT STYLE="white-space:nowrap">non-certificated</FONT> shares of Common Stock, free and clear
of all restrictive and other legends (except as expressly provided in <U>Section</U><U></U><U>&nbsp;4.1(b)</U> hereof), evidencing the number of Common Shares the Purchaser is purchasing as is set forth on the Purchaser&#146;s signature page to this
Agreement, within three (3)&nbsp;Trading Days after the Closing, (b)&nbsp;the Company shall irrevocably instruct the Transfer Agent to deliver to the Purchaser <FONT STYLE="white-space:nowrap">non-certificated</FONT> shares of Preferred Stock, free
and clear of all restrictive and other legends (except as expressly provided in <U>Section</U><U></U><U>&nbsp;4.1(b)</U> hereof), evidencing the number of Preferred Shares the Purchaser is purchasing as is set forth on the Purchaser&#146;s signature
page to this Agreement, within three (3)&nbsp;Trading Days after the Closing, and (c)&nbsp;the Company shall deliver to the Purchaser the Warrant, free and clear of all restrictive and other legends (except as expressly provided in
<U>Section</U><U></U><U>&nbsp;4.1(b)</U> hereof), that the Purchaser is purchasing as is set forth on the Purchaser&#146;s signature page to this Agreement next to the heading &#147;Underlying Preferred Shares Subject to Warrant&#148;, within three
(3)&nbsp;Trading Days after the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Closing Deliveries</U>. (a) On or prior to the Closing, the Company shall issue, deliver
or cause to be delivered to the Purchaser the following (the &#147;<I>Company Deliverables</I>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) this Agreement, duly executed
by the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) facsimile copies or other evidence reasonably satisfactory to the Purchaser of
<FONT STYLE="white-space:nowrap">(x)&nbsp;non-certificated</FONT> shares of Common Stock, free and clear of all restrictive and other legends (except as provided in <U>Section</U><U></U><U>&nbsp;4.1(b)</U> hereof), evidencing the Common Shares
subscribed for by the Purchaser hereunder, registered in the name of the Purchaser as set forth on the Stock Certificate Questionnaire included as <U>Exhibit <FONT STYLE="white-space:nowrap">C-2</FONT></U> hereto, and
<FONT STYLE="white-space:nowrap">(y)&nbsp;non-certificated</FONT> shares of Preferred Stock, free and clear of all restrictive and other legends (except as provided in <U>Section</U><U></U><U>&nbsp;4.1(b)</U> hereof), evidencing the Preferred Shares
subscribed for by the Purchaser hereunder, registered in the name of the Purchaser; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) facsimile copy of the Warrant, executed by the
Company and registered in the name of the Purchaser as set forth on the Stock Certificate Questionnaire included as <U>Exhibit <FONT STYLE="white-space:nowrap">C-2</FONT></U> hereto, pursuant to which the Purchaser shall have the right to acquire
such number of Warrant Shares determined in accordance with <U>Section</U><U></U><U>&nbsp;2.1(a)</U>, on the terms set forth therein, with the original Warrant delivered within three (3)&nbsp;Trading Days of Closing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) a legal opinion of Company Counsel, dated as of the Closing Date and substantially in the form attached hereto as <U>Exhibit D</U>,
executed by such counsel and addressed to the Purchaser and the Placement Agent; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) the Registration Rights Agreement, duly executed by
the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) duly executed Irrevocable Transfer Agent Instructions instructing the Transfer Agent to deliver, on an expedited
basis, evidence of shares in uncertificated book-entry form evidencing the Common Shares and the Preferred Shares acquired by the Purchaser as set forth on the Purchaser&#146;s signature page hereto, registered in the name of the Purchaser; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) a certificate of the Secretary of the Company (the &#147;<I>Secretary&#146;s Certificate</I>&#148;), dated as of the Closing Date,
(a)&nbsp;certifying the resolutions adopted by the Board of Directors of the Company or a duly authorized committee thereof approving the transactions contemplated by this Agreement and the other Transaction Documents and the issuance of the
Securities, (b)&nbsp;certifying the current versions of the certificate or articles of incorporation, as amended (including the Preferred Stock Articles of Amendment), and bylaws of the Company and (c)&nbsp;certifying as to the signatures and
authority of persons signing the Transaction Documents and related documents on behalf of the Company, in the form attached hereto as <U>Exhibit F</U>; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) the Compliance Certificate referred to in <U>Section</U><U></U><U>&nbsp;5.1(k)</U>;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) a certificate evidencing the existence and good standing of the Company issued by the Clerk of the VSCC, as of a date within three
(3)&nbsp;Business Days of the Closing Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) a certificate evidencing the Company&#146;s qualification as a foreign corporation and
good standing issued by the Secretary of State (or comparable office) of each jurisdiction in which the Company is qualified to do business as a foreign corporation, as of a date within three (3)&nbsp;Business Days of the Closing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) [reserved]; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) a
certified copy of the certificate or articles of incorporation, as certified by the Clerk of the VSCC, as of a date within three (3)&nbsp;Business Days of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) On or prior to the Closing, the Purchaser shall deliver or cause to be delivered to the Company the following (the &#147;<I>Purchaser
Deliverables</I>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) this Agreement, duly executed by such Purchaser; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) its Subscription Amount, in United States dollars and in immediately available funds, in the amount set forth below the Purchaser&#146;s
name on the applicable signature page hereto under the heading &#147;Aggregate Purchase Price (Subscription Amount)&#148;, by wire transfer in accordance with the Company&#146;s written instructions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the Registration Rights Agreement, duly executed by the Purchaser; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) a fully completed and duly executed Selling Stockholder Questionnaire in the form attached as Annex B to the Registration Rights
Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) a fully completed and duly executed Accredited Investor Questionnaire, satisfactory to the Company, and Stock
Certificate Questionnaire in the forms attached hereto as <U>Exhibits <FONT STYLE="white-space:nowrap">C-1</FONT></U> and <U><FONT STYLE="white-space:nowrap">C-2</FONT></U>, respectively. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE III. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND
WARRANTIES </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Representations and Warranties of the Company</U>. Except (i)&nbsp;as set forth in the schedules delivered herewith
(the &#147;<I>Disclosure Schedules</I>&#148;), which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation made herein to the extent of the disclosure contained in the corresponding section of the Disclosure
Schedules, or (ii)&nbsp;disclosed in the SEC Reports, the Company hereby represents and warrants as of the date hereof and the Closing Date (except for the representations and warranties that speak as of a specific date, which shall be made as of
such date), to the Purchaser and to the Placement Agent: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Subsidiaries</U>. The Company has no direct or indirect Subsidiaries other
than those listed in <U>Schedule 3.1(a)</U> hereto. Except as disclosed in <U>Schedule 3.1(a)</U> hereto, the Company owns, directly or indirectly, all of the capital stock or comparable equity interests of each Subsidiary free and clear of any and
all Liens, and all the issued and outstanding shares of capital stock or comparable equity interest of each Subsidiary are validly issued and are fully paid, <FONT STYLE="white-space:nowrap">non-assessable</FONT> and free of preemptive and similar
rights to subscribe for or purchase securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Organization and Qualification</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company and each of its Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite corporate power and authority to own or lease and use its properties and assets and to carry on its business as currently conducted. Neither
the Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. The Company and each of its Subsidiaries is duly
qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to
be so qualified or in good standing, as the case may be, would not have or reasonably be expected to result in a Material Adverse Effect, and no Proceeding has been instituted, is pending, or, to the Company&#146;s Knowledge, has been threatened in
writing in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company is duly registered as a bank holding company under the BHC Act. The Bank is a national banking association chartered under
the laws of the United States and a direct, wholly-owned subsidiary of the Company. The deposit accounts of the Bank are insured up to applicable limits by the Federal Deposit Insurance Corporation, and all premiums and assessments required to be
paid in connection therewith have been paid when due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Authorization; Enforcement; Validity</U>. The Company has the requisite
corporate power and authority to enter into the Transaction Documents and to issue the Preferred Stock and, subject to obtaining the Stockholder Approvals, to consummate the transactions contemplated by each of the Transaction Documents to which it
is a party and otherwise to carry out its obligations hereunder and thereunder. The Company&#146;s execution and delivery of each of the Transaction Documents to which it is a party and the consummation by it of the transactions contemplated hereby
and thereby (including, but not limited to, the issuance, sale and delivery of the Common Shares and Preferred Shares, the sale and delivery of the Warrant, the reservation for issuance and the subsequent issuance of the Warrant Shares upon exercise
of the Warrant and the reservation for issuance and the subsequent issuance of the Underlying Preferred Shares upon conversion (the &#147;<I>Conversion</I>&#148;) of Preferred Stock into Common Stock) have been duly authorized by all necessary
corporate action on the part of the Company, and no further corporate action is required by the Company, its Board of Directors or its stockholders in connection therewith, other than in connection with the Required Approvals and the receipt of
requisite approvals by the Company&#146;s stockholders of (i)&nbsp;an amendment to the Company&#146;s articles of incorporation to increase the number of authorized shares of Common Stock to at least 150,000,000 shares or such other amount as the
Board of Directors determines in its reasonable judgment is necessary to effectuate the transactions contemplated by the Transaction Documents (the &#147;<I>Articles Amendment</I>&#148;) and (ii)&nbsp;the issuance of the Securities pursuant to the
Transaction Documents pursuant to applicable listing standards of the NYSE American (the &#147;<I>Issuance Approval</I>&#148; and, the requisite stockholder approvals of the proposals described in clauses (i)&nbsp;and (ii), the &#147;<I>Stockholder
Approvals</I>&#148;). Each of the Transaction Documents to which it is a party has been (or upon delivery will have been) duly executed by the Company and is, or when delivered in accordance with the terms hereof, will constitute the legal, valid
and binding obligation of the Company enforceable against the Company in accordance with its terms, except (A)&nbsp;as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally the enforcement of, creditors&#146; rights and remedies or by other equitable principles of general application, (B)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (C)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>No Conflicts</U>. The execution, delivery and performance by the Company of the
Transaction Documents to which it is a party and the consummation by the Company of the transactions contemplated hereby or thereby (including, without limitation, the issuance of the Common Shares, Preferred Shares and Warrant and the reservation
for issuance and issuance of the Underlying Preferred Shares and the Warrant Shares) do not and will not (i)&nbsp;subject to the Stockholder Approvals, conflict with or violate any provisions of the Company&#146;s or any Subsidiary&#146;s
certificate or articles of incorporation, bylaws or otherwise result in a violation of the organizational documents of the Company, (ii)&nbsp;conflict with, or constitute a default (or an event that with notice or lapse of time or both would result
in a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time
or both) of, any Material Contract, or (iii)&nbsp;subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations and the rules and regulations, assuming the correctness of the representations and warranties made by the Purchaser herein, of any
self-regulatory organization to which the Company or its securities are subject, including all applicable Trading Markets), or by which any property or asset of the Company or a Subsidiary is bound or affected, except in the case of clauses
(ii)&nbsp;and (iii) such as would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Filings, Consents and Approvals</U>. Except as set forth on <U>Schedule 3.1(e)</U>, neither the Company nor any of its Subsidiaries is
required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents (including the issuance of the Securities), other than (i)&nbsp;the filing with the Commission of a proxy statement (including any amendments or supplements thereto) and
other proxy solicitation materials of the Company relating to the Stockholder Approvals and such other filings and reports as required pursuant to the applicable requirements of the Exchange Act, (ii)&nbsp;the filing of any requisite notices and/or
application(s) to the Principal Trading Market for the issuance and sale of the Securities and the listing of the Common Shares, the Underlying Preferred Shares and the Warrant Shares (if Common Stock) for trading or quotation, as the case may be,
thereon in the time and manner required thereby; (iii)&nbsp;the filing of an articles of amendment to the Company&#146;s articles of incorporation with, and the issuance of a certificate of amendment by, the VSCC to effect the Articles Amendment,
(iv) [reserved], (v) the filing required in accordance with <U>Section</U><U></U><U>&nbsp;4.5</U> of this Agreement, (vi)&nbsp;filings required by applicable state securities laws, (vii) [reserved], (viii) the filing with the Commission of one or
more Registration Statements in accordance with the requirements of the Registration Rights Agreement, and (ix)&nbsp;those that have been made or obtained prior to the date of this Agreement (collectively, the &#147;<I>Required Approvals</I>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Issuance of the Securities</U>. Subject to <U>Schedule 3.1(f)</U>, the Common Shares and Preferred Shares have been duly
authorized and when issued and paid for in accordance with the terms of the Transaction Documents, will be duly and validly issued, fully paid and nonassessable and free and clear of all Liens, other than restrictions on transfer provided for in the
Transaction Documents or imposed by applicable securities laws, and shall not be subject to preemptive or similar rights. Subject to the Stockholder Approvals and <U>Schedule 3.1(f)</U>, the Warrant has been duly authorized and, when issued and paid
for in accordance with the terms of the Transaction Documents, will be duly and validly issued, free and clear of all Liens, other than restrictions on transfer provided for in the Transaction Documents or imposed by applicable securities laws, and
shall not be subject to preemptive or similar rights of stockholders. Subject to the Stockholder Approvals and <U>Schedule 3.1(f)</U>, the Warrant Shares issuable upon exercise of the Warrant have been duly authorized and, when issued and paid for
in accordance with the terms of the Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens, other than restrictions on transfer provided for in the Transaction Documents or imposed by
applicable securities laws, and shall not be subject to preemptive or similar rights of stockholders. Subject to the Stockholder Approvals and <U>Schedule 3.1(f)</U>, the Underlying </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Preferred Shares issuable upon Conversion of the Preferred Stock have been duly authorized and, when issued and paid for in accordance with the terms of the Transaction Documents, will be duly
and validly issued, fully paid and nonassessable, free and clear of all Liens, other than restrictions on transfer provided for in the Transaction Documents or imposed by applicable securities laws, and shall not be subject to preemptive or similar
rights of stockholders. Assuming the accuracy of the representations and warranties of the Purchaser in this Agreement, the Securities will be issued in compliance with all applicable federal and state securities laws. As of the Closing Date, the
Company shall have reserved from its duly authorized capital stock the number of shares of Preferred Stock issuable upon exercise of the Warrant (without taking into account any limitations on the exercise of the Warrant set forth in the Warrant).
The Company shall, so long as the Warrant is outstanding, take all action necessary to reserve and keep available out of its authorized and unissued capital stock, solely for the purpose of effecting the exercise of the Warrant, the number of shares
of Preferred Stock issuable upon exercise of the Warrant (without taking into account any limitations on the exercise of the Warrant set forth in the Warrant). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Capitalization</U>. As of the date hereof, the number of shares and type of all authorized, issued and outstanding capital stock,
options and other securities of the Company (whether or not presently convertible into or exercisable or exchangeable for shares of capital stock of the Company) is set forth in Schedule 3.1(g) hereto. The Company has not issued any capital stock
since the date of its most recently filed SEC Report other than to reflect stock option and warrant exercises that do not, individually or in the aggregate, have a material effect on the issued and outstanding capital stock, options and other
securities. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;3.1(f)</U>, no Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction
Documents that have not been effectively waived as of the Closing Date. Except as set forth on <U>Schedule</U><U></U><U>&nbsp;3.1(g)</U> or a result of the purchase and sale of the Shares and Warrant, there are no outstanding options, warrants,
scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any
shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. Except as set forth on
<U>Schedule 3.1(f)</U>, the issuance and sale of the Common Shares, Preferred Shares and Warrant will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Purchaser) and will not result in a
right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital stock of the Company are validly issued, fully paid and nonassessable, have
been issued in compliance with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. There are no
stockholders agreements, voting agreements or other similar agreements with respect to the Company&#146;s capital stock to which the Company is a party or, to the Company&#146;s Knowledge, between or among any of the Company&#146;s stockholders.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>SEC Reports; Disclosure Materials</U>. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it under the Exchange Act, including pursuant to Section&nbsp;13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, as and if amended, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#147;<I>SEC Reports</I>&#148;, and the SEC Reports, together with the
Disclosure Schedules, being collectively referred to as the &#147;<I>Disclosure Materials</I>&#148;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such
extension, except where the failure to file on a timely basis would not have or reasonably be expected to result in a Material Adverse Effect (including, for this purpose only, any failure to qualify to register the Common Shares and Underlying
Preferred Shares for resale on Form <FONT STYLE="white-space:nowrap">S-3</FONT> or which would prevent the Purchaser from using Rule&nbsp;144 to resell any Securities). As of their respective filing dates, or to the extent corrected by a subsequent
restatement, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of
the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. Each of the Material Contracts to which the Company or any Subsidiary is a party or to which the property or assets of the Company or
any of its Subsidiaries are subject has been filed as an exhibit to the SEC Reports. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Financial Statements</U>. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing (or to the extent
corrected by a subsequent restatement). Such financial statements have been prepared in accordance with GAAP applied on a consistent basis during the periods involved, except as may be otherwise specified in such financial statements or the notes
thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries taken as a whole as of and for
the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Material Changes</U>. Since the date of the latest audited financial statements included within the SEC Reports, except as specifically
disclosed in a subsequent SEC Report filed prior to the date hereof, (i)&nbsp;there have been no events, occurrences or developments that have had or would reasonably be expected to have, either individually or in the aggregate, a Material Adverse
Effect, (ii)&nbsp;the Company has not incurred any material liabilities (contingent or otherwise) other than (A)&nbsp;trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and
(B)&nbsp;liabilities not required to be reflected in the Company&#146;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii)&nbsp;the Company has not altered materially its method of accounting or the manner
in which it keeps its accounting books and records, (iv)&nbsp;the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock (other than in connection with repurchases of unvested stock issued to employees of the Company), and (v)&nbsp;except pursuant to the SPA, the Company has not issued any equity securities to any officer, director or
Affiliate, except Common Stock issued in the ordinary course as dividends on outstanding preferred stock or issued pursuant to existing Company equity compensation plans or stock purchase plans or executive and director compensation arrangements
disclosed in the SEC Reports. Except for the issuance of the Shares and Warrant contemplated by this Agreement, no event, liability or development has occurred or exists with respect to the Company or its Subsidiaries or their respective business,
properties, operations or financial condition, that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made that has not been publicly disclosed at least one (1)&nbsp;Trading Day
prior to the date that this representation is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Litigation</U>. There is no Proceeding pending or, to the Company&#146;s
Knowledge, threatened, against the Company, any Subsidiary or any of their respective properties or, to the Company&#146;s Knowledge, against any officer, director or employee of the Company or any Subsidiary acting in his or her capacity as such
which (i)&nbsp;adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii)&nbsp;except as specifically disclosed in the SEC Reports, would, if there were an unfavorable
decision, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor to the Company&#146;s Knowledge any director or officer thereof, is or has been the
subject of any Proceeding involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the Company&#146;s Knowledge there is not pending or contemplated, any
investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the
Company or any of its Subsidiaries under the Exchange Act or the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Employment Matters</U>. No material labor dispute exists or, to the Company&#146;s
Knowledge, is imminent with respect to any of the employees of the Company which would have or reasonably be expected to result in a Material Adverse Effect. None of the Company&#146;s or any Subsidiary&#146;s employees is a member of a union that
relates to such employee&#146;s relationship with the Company, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and each Subsidiary believes that its relationship with its employees
is good. No executive officer of the Company (as defined in Rule 501(f) of the Securities Act) has notified the Company or any such Subsidiary that such officer intends to leave the Company or any such Subsidiary or otherwise terminate such
officer&#146;s employment with the Company or any such Subsidiary. To the Company&#146;s Knowledge, no executive officer, is, or is now expected to be, in violation of any term of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement or <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, or any other contract or agreement or any restrictive covenant in favor of a third party, and to the Company&#146;s Knowledge, the
continued employment of each such executive officer does not subject the Company or any Subsidiary to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance would not, individually or in the aggregate, have or reasonably be
expected to result in a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Compliance</U>. Subject to <U>Section</U><U></U><U>&nbsp;6.3</U> and except as
disclosed in <U>Schedule 3.1(m)</U>, neither the Company nor any of its Subsidiaries (i)&nbsp;is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a
default by the Company or any of its Subsidiaries under), nor has the Company or any of its Subsidiaries received written notice of a claim that it is in default under or that it is in violation of, any Material Contract (whether or not such default
or violation has been waived), (ii) is in violation of any order of any court, arbitrator or governmental body having jurisdiction over the Company or its properties or assets, or (iii)&nbsp;is in violation of, or in receipt of written notice that
it is in violation of, any statute, rule or regulation of any governmental authority applicable to the Company, except in each case as would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Regulatory Permits</U>. The Company and each of its Subsidiaries possess all certificates, authorizations and permits
issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct its respective business as currently conducted and as described in the SEC Reports, except where the failure to possess such permits, individually
or in the aggregate, has not and would not have or reasonably be expected to result in a Material Adverse Effect (&#147;<I>Material Permits</I>&#148;), and neither the Company nor any of its Subsidiaries has received any notice of Proceedings
relating to the revocation or modification of any such Material Permits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <U>Bank Regulatory Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company and each of its Subsidiaries have filed all reports, forms, correspondence, registrations and statements, together with any
amendments required to be made with respect thereto (the &#147;<I>Bank Reports</I>&#148;), that they were required to file in the two years preceding the date hereof with the Federal Reserve, the Office of the Comptroller of the Currency, the Bureau
of Financial Institutions of the VSCC and any other federal, state or foreign governmental or regulatory agency or authority having jurisdiction over the Company or any of its Subsidiaries, including any Bank Report required to be filed pursuant to
the laws of the United States or any state or the rules or regulations of any such governmental authority, and have paid all fees and assessments due and payable in connection therewith, except where the failure to file such Bank Report or to pay
such fees and assessments, would not reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Disclosure Materials describe all regulatory enforcement actions to which the
Company or any of its Subsidiaries is subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Except in connection with the bank examination process conducted by bank regulatory
authorities having jurisdiction over the Company or any of its Subsidiaries, (A)&nbsp;there is no pending Proceeding before, or, to the Company&#146;s Knowledge, examination or investigation by, any governmental authority into the business or
operations of the Company or any of its Subsidiaries since January&nbsp;1, 2020, except where such proceedings or investigations would not reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect,
(B)&nbsp;there is no unresolved violation, criticism or exception by any governmental authority with respect to any Bank Report or statement relating to any examination or inspection of the Company or any of its Subsidiaries which would reasonably
be expected to have, either individually or in the aggregate, a Material Adverse Effect and (C)&nbsp;there are no unresolved inquiries by, or disagreements or disputes with, any governmental authority with respect to the business, operations,
policies or procedures of the Company or any of its Subsidiaries since January&nbsp;1, 2020 which, in the case of any of (A), (B), or (C),would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Neither the Company nor any of its Subsidiaries is subject to any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cease-and-desist</FONT></FONT> or other order or enforcement action issued by, or is a party to any written agreement or consent agreement with, or is subject to any order or
directive by, or has been ordered to pay any civil money penalty by, any bank regulatory authorities having jurisdiction over the Company or any of its Subsidiaries that would give rise to a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <U>Title to Assets</U>. The Company and its Subsidiaries have good and marketable title in fee simple to all real property owned by them.
The Company and its Subsidiaries have good and marketable title to all tangible personal property owned by them that is material to the business of the Company and its Subsidiaries, taken as whole, in each case free and clear of all Liens except
such as do not materially affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company and any of its Subsidiaries. Any real property and facilities held under lease by the Company
and any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its
Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) <U>Patents and Trademarks</U>. To the Company&#146;s Knowledge, the Company and the Subsidiaries own, possess, license
or have other rights to use, all patents, patent applications, trade and service marks, trade and service mark applications and registrations, trade names, trade secrets, inventions, copyrights, licenses, technology,
<FONT STYLE="white-space:nowrap">know-how</FONT> and other intellectual property rights and similar rights described in the SEC Reports as necessary or material for use in connection with their respective businesses and which the failure to so have
would have or reasonably be expected to result in a Material Adverse Effect (collectively, the &#147; <I>Intellectual Property Rights</I>&#148;). Neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of the
Intellectual Property Rights used by the Company or any Subsidiary violates or infringes upon the rights of any Person. There is no pending or, to the Company&#146;s Knowledge, threatened action, suit, proceeding or claim by any Person that the
Company&#146;s business as now conducted infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of another. To the Company&#146;s Knowledge, there is no existing infringement by another Person of
any of the Intellectual Property Rights that would have or would reasonably be expected to have a Material Adverse Effect. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of
all of their Intellectual Property Rights, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) <U>Insurance</U>. The Company and each of the Subsidiaries are insured by insurers of
recognized financial responsibility against such losses and risks and in such amounts as the Company believes to be prudent and customary in the businesses and locations in which the Company and the Subsidiaries are engaged, including, but not
limited to, directors and officers insurance coverage. Neither the Company nor any of its Subsidiaries has received any notice of cancellation of any such insurance, nor, to the Company&#146;s Knowledge, will it or any Subsidiary be unable to renew
their respective existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) <U>Transactions With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the
Company and, to the Company&#146;s Knowledge, none of the employees of the Company is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors or loans made in compliance
with Federal Reserve Regulation O in the ordinary course of the Bank&#146;s business), that would be required to be disclosed pursuant to Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) <U>Internal Accounting Controls</U>. The Company maintains a system of internal accounting controls sufficient to provide reasonable
assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to
maintain asset and liability accountability, (iii)&nbsp;access to assets or incurrence of liabilities is permitted only in accordance with management&#146;s general or specific authorization, and (iv)&nbsp;the recorded accountability for assets and
liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any differences. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) <U>Sarbanes-Oxley; Disclosure Controls</U>. The Company is in compliance in all material respects with all of the provisions of the
Sarbanes-Oxley Act of 2002 which are applicable to it as of the Closing Date. The Company has established disclosure controls and procedures (as such term is defined in Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT
STYLE="white-space:nowrap">15d-15(e)</FONT> under the Exchange Act) for the Company and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the
Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#146;s rules and forms. The Company&#146;s certifying officers have evaluated the effectiveness of the Company&#146;s disclosure
controls and procedures as of the end of the period covered by the Company&#146;s most recently filed periodic report under the Exchange Act (such date, the &#147;<I>Evaluation Date</I>&#148;). The Company presented in its most recently filed
periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no
changes in the Company&#146;s internal control over financial reporting (as such term is defined in the Exchange Act) that has materially affected, or is reasonably likely to materially affect, the Company&#146;s internal control over financial
reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) <U>Certain Fees</U>. No person or entity will have, as a result of the transactions contemplated by this Agreement, any
valid right, interest or claim against or upon the Company or a Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company, other than the Placement
Agent with respect to the offer and sale of the Common Shares, Preferred Shares and Warrant (which placement agent fees are being paid by the Company). The Purchaser shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this paragraph (v)&nbsp;that may be due in connection with the transactions contemplated by the Transaction Documents. The Company shall indemnify, pay, and hold the Purchaser
harmless against, any liability, loss or expense (including, without limitation, attorneys&#146; fees and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses) arising in connection with any such
right, interest or claim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) <U>Private Placement</U>. Assuming the accuracy of the Purchaser&#146;s representations
and warranties set forth in <U>Section</U><U></U><U>&nbsp;3.2</U> of this Agreement and the accuracy of the information disclosed in the Accredited Investor Questionnaires provided by the Purchaser, no registration under the Securities Act is
required for the offer and sale of the Securities by the Company to the Purchaser under the Transaction Documents. Subject to the Required Approvals and the Stockholder Approvals, the issuance and sale of the Securities hereunder does not contravene
the rules and regulations of the Trading Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) <U>Investment Company</U> The Company is not, and immediately after receipt of
payment for the Common Shares, Preferred Shares and Warrant, will not be an &#147;investment company&#148; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not
become subject to the Investment Company Act of 1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) <U>Registration Rights</U>. Other than the Purchaser or as set
forth in <U>Schedule 3.1(y)</U> hereto, no Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company other than those securities which are currently registered on an effective
registration statement on file with the Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) <U>Listing and Maintenance Requirements</U>. The Company&#146;s Common Stock is
registered pursuant to Section&nbsp;12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to terminate the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the
Commission is contemplating terminating such registration. The Company has not, in the twelve (12)&nbsp;months preceding the date hereof, received written notice from any Trading Market on which the Common Stock is listed or quoted to the effect
that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is in compliance with all listing and maintenance requirements of the Principal Trading Market on the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) <U>Application of Takeover Protections; Rights Agreements</U>. The Company and the Board of Directors have taken all necessary action, if
any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar <FONT STYLE="white-space:nowrap">anti-takeover</FONT> provision under the
Company&#146;s charter documents or the laws of its state of incorporation that is or could reasonably be expected to become applicable to the Purchaser as a result of the Purchaser and the Company fulfilling their obligations or exercising their
rights under the Transaction Documents, including, without limitation, the Company&#146;s issuance of the Securities hereunder. Without limiting the foregoing, there will be no limitations upon voting the Shares by the Purchaser imposed by
applicable state laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) <U>No Integrated Offering</U>. Assuming the accuracy of the Purchaser&#146;s representations and warranties
set forth in <U>Section</U><U></U><U>&nbsp;3.2</U>, none of the Company, its Subsidiaries nor, to the Company&#146;s Knowledge, any of its Affiliates or any Person acting on its behalf has, directly or indirectly, at any time within the past six
(6)&nbsp;months, made any offers or sales of any Company security or solicited any offers to buy any security under circumstances that would (i)&nbsp;eliminate the availability of the exemption from registration under Regulation D under the
Securities Act in connection with the offer and sale by the Company of the Securities as contemplated hereby or (ii)&nbsp;cause the offering of the Securities pursuant to the Transaction Documents to be integrated with any offerings by the Company
prior to the SPA for purposes of any applicable law, regulation or stockholder approval provisions, including, without limitation, under the rules and regulations of any Trading Market on which any of the securities of the Company are listed or
designated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) <U>No &#147;Bad Actor&#148; Disqualification</U>. The Company has exercised reasonable care, in accordance with
Commission rules and guidance, and has conducted a factual inquiry including the procurement of relevant questionnaires from each Covered Person or other means, the nature and scope of which reflect reasonable care under the relevant facts and
circumstances, to determine whether any Covered Person is subject to any of the &#147;bad actor&#148; disqualifications described in Rule 506(d)(1)(i) to (viii)&nbsp;under the Securities Act (&#147;<I>Disqualification Events</I>&#148;). To the
Company&#146;s Knowledge, after conducting such sufficiently </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
diligent factual inquiries, no Covered Person is subject to a Disqualification Event, except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under the Securities Act. The Company
has complied, to the extent applicable, with any disclosure obligations under Rule 506(e) under the Securities Act. &#147;<I>Covered Persons</I>&#148; are those persons specified in Rule 506(d)(1) under the Securities Act, including the Company; any
predecessor or affiliate of the Company; any director, executive officer, other officer participating in the offering, general partner or managing member of the Company; any beneficial owner of 20% or more of the Company&#146;s outstanding voting
equity securities, calculated on the basis of voting power; any promoter (as defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of the sale of the Common Shares, the Preferred Shares or the Warrant;
and any person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of the Securities (a &#147;<I>Solicitor</I>&#148;), any general partner or managing member of any
Solicitor, and any director, executive officer or other officer participating in the offering of any Solicitor or general partner or managing member of any Solicitor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) <U>Tax Matters</U>. The Company and each of its Subsidiaries (i)&nbsp;has accurately and timely prepared and filed all foreign, federal
and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to
be due on such returns, reports and declarations, except those being contested in good faith, with respect to which adequate reserves have been set aside on the books of the Company and (iii)&nbsp;has set aside on its books provisions reasonably
adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply, except, in the case of clauses (i)&nbsp;and (ii) above, where the failure to so pay or file any such tax, assessment,
charge or return would not have or reasonably be expected to result in a Material Adverse Effect. There are no unpaid taxes in any material amount claimed to be due by the Company or any of its Subsidiaries by the taxing authority of any
jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) <U>Environmental Matters</U>. To the Company&#146;s Knowledge, neither the Company nor any of its Subsidiaries
(i)&nbsp;is in violation of any statute, rule, regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the
protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, &#147;<I>Environmental Laws</I>&#148;), (ii) owns or operates any real property contaminated with any substance that is in violation of
any Environmental Laws, (iii)&nbsp;is liable for any <FONT STYLE="white-space:nowrap">off-site</FONT> disposal or contamination pursuant to any Environmental Laws, or (iv)&nbsp;is subject to any claim relating to any Environmental Laws; which
violation, contamination, liability or claim has had or would have, individually or in the aggregate, a Material Adverse Effect; and there is no pending investigation or, to the Company&#146;s Knowledge, investigation threatened in writing that
might lead to such a claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff) <U>No General Solicitation</U>. Neither the Company nor, to the Company&#146;s Knowledge, any person
acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg) <U>Foreign Corrupt Practices</U>. Neither the Company, nor to the Company&#146;s Knowledge, any agent or other person acting on behalf of
the Company, has: (i)&nbsp;directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii)&nbsp;made any unlawful payment to foreign or
domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)&nbsp;failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of
which the Company is aware) which is in violation of law or (iv)&nbsp;violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hh) <U>Off Balance Sheet Arrangements</U>. There is no transaction, arrangement, or other relationship between the Company (or any
Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Acknowledgment Regarding Purchaser&#146;s Purchase of Securities</U>.&nbsp;The
Company acknowledges and agrees that the Purchaser is acting solely in the capacity of an arm&#146;s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby.&nbsp;The Company further
acknowledges that the Purchaser is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by the Purchaser
or any of his respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchaser&#146;s purchase of the Securities.&nbsp;The Company further represents to
the Purchaser that the Company&#146;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jj) <U>Regulation M Compliance</U>.&nbsp;The Company has not, and to the Company&#146;s Knowledge no one acting on its behalf has,
(i)&nbsp;taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii)&nbsp;sold, bid for,
purchased, or paid any compensation for soliciting purchases of, any of the securities of the Company or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other
than, in the case of clauses (ii)&nbsp;and (iii), compensation paid to the Placement Agent in connection with the placement of the Shares and Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kk) <U>PFIC</U>. Neither the Company nor any Subsidiary is or intends to become a &#147;passive foreign investment company&#148; within the
meaning of Section&nbsp;1297 of the U.S. Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ll) <U>OFAC</U>. Neither the Company nor any
Subsidiary nor, to the Company&#146;s Knowledge, any director, officer, agent, employee, Affiliate or Person acting on behalf of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&#147;<I>OFAC</I>&#148;); and the Company will not directly or indirectly use the proceeds of the sale of the Securities, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint
venture partner or other Person or entity, towards any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to any U.S.
sanctions administered by OFAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(mm) <U>Shell Company</U>. The Company is not, and was not in the past, an &#147;ineligible issuer&#148;
(as defined in Rule 405 promulgated under the Securities Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(nn) <U>No Additional Agreements</U>. The Company does not have any
agreement or understanding with the Purchaser with respect to the transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Representations and Warranties of the Purchaser</U>. The Purchaser hereby represents and warrants as of the date hereof and as of the
Closing Date to the Company and the Placement Agent as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Organization; Authority</U>. If such Purchaser is an entity,
(i)&nbsp;it is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite corporate, limited liability company or partnership power and authority to enter into and to consummate
the transactions contemplated by the applicable Transaction Documents and otherwise to carry out its obligations hereunder and thereunder, and (ii)&nbsp;the execution and delivery of this Agreement by such Purchaser and performance by such Purchaser
of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate or, if such Purchaser is not a corporation, such partnership, limited liability company or other
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable like action, on the part of such Purchaser. If such Purchaser is not an entity, such Purchaser has all requisite capacity to enter into and consummate the transactions contemplated
hereby, and no further consent or authorization is required by the Purchaser in connection with the execution, delivery and performance by the Purchaser of the transactions contemplated by the applicable Transaction Documents to which it is a party
and this Agreement. Each Transaction Document to which it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of the
Purchaser, enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the
enforcement of, creditors&#146; rights and remedies or by other equitable principles of general application. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Conflicts;
Consents</U>. The execution, delivery and performance by the Purchaser of this Agreement and the Registration Rights Agreement and the consummation by the Purchaser of the transactions contemplated hereby and thereby will not (i)&nbsp;result in a
violation of the organizational documents of the Purchaser (if the Purchaser is an entity), (ii) subject to the Regulatory Approvals, conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Purchaser is a party, or (iii)&nbsp;result in a violation of any law, rule, regulation,
order, judgment or decree (including federal and state securities laws) applicable to the Purchaser, except in the case of clauses (ii)&nbsp;and (iii) above, for such conflicts, defaults, rights or violations which would not, individually or in the
aggregate, reasonably be expected to have a material adverse effect on the ability of the Purchaser to perform its obligations hereunder. The Purchaser is not required to obtain any consent, waiver, authorization or order of, give any notice to, or
make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Purchaser of the Transaction Documents and the
transactions contemplated thereby (including the purchase of the Securities), other than the Regulatory Approvals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Investment
Intent</U>. The Purchaser understands that the Securities are &#147;restricted securities&#148; and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Common Shares, Preferred Shares and
Warrant, and, upon Conversion of Preferred Stock into Common Stock, will acquire the Underlying Preferred Shares issuable upon conversion thereof, and, upon exercise of the Warrant, will acquire the Warrant Shares issuable upon exercise thereof, in
each case as principal for its own account and not with a view to, or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities laws, <I>provided, however</I>, that by
making the representations herein, the Purchaser does not agree to hold any of the Securities for any minimum period of time and reserves the right, subject to the provisions of this Agreement and the Registration Rights Agreement, at all times to
sell or otherwise dispose of all or any part of such Securities pursuant to an effective registration statement under the Securities Act or under an exemption from such registration and in compliance with applicable federal and state securities
laws. The Purchaser is acquiring the Securities hereunder in the ordinary course of its business. The Purchaser does not presently have any agreement, plan or understanding, directly or indirectly, with any Person to distribute or effect any
distribution of any of the Securities (or any securities which are derivatives thereof) to or through any person or entity; the Purchaser is not a registered broker-dealer under Section&nbsp;15 of the Exchange Act or an entity engaged in a business
that would require it to be so registered as a broker-dealer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Purchaser Status</U>. At the time the Purchaser was offered the
Shares and Warrant, it was, and at the date hereof it is, and on each date on which it exercises the Warrant it will be, an &#147;accredited investor&#148; as defined in Rule 501(a) under the Securities Act. The Purchaser has provided the
information in the Accredited Investor Questionnaire attached hereto as <U>Exhibit <FONT STYLE="white-space:nowrap">C-1</FONT></U>, and the information contained therein is complete and accurate as of the date thereof, as of the date hereof, and as
of the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>General Solicitation</U>. The Purchaser is not purchasing the Securities as a result
of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general advertisement or form
of general solicitation (within the meaning of Regulation D and interpreted by the Commission). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Experience of the Purchaser</U>.
The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the
Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Access to Information</U>. The Purchaser acknowledges that it has had the opportunity to review the Disclosure Materials and has been
afforded (i)&nbsp;the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of
investing in the Securities; (ii)&nbsp;access to information about the Company and the Subsidiaries and their respective financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate
its investment; and (iii)&nbsp;the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the
investment. Neither such inquiries nor any other investigation conducted by or on behalf of the Purchaser or its representatives or counsel shall modify, amend or affect the Purchaser&#146;s right to rely on the truth, accuracy and completeness of
the Disclosure Materials and the Company&#146;s representations and warranties contained in the Transaction Documents. The Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed decision with
respect to its acquisition of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Certain Trading Activities</U>. Other than with respect to the transactions
contemplated herein, since the time that the Purchaser was first contacted by the Company, the Placement Agent or any other Person regarding the transactions contemplated hereby or by the Original Agreement, neither the Purchaser nor any Affiliate
of the Purchaser which (x)&nbsp;had knowledge of the transactions contemplated hereby or thereby, (y)&nbsp;has or shares discretion relating to the Purchaser&#146;s investments or trading or information concerning the Purchaser&#146;s investments,
including in respect of the Securities, and (z)&nbsp;is subject to the Purchaser&#146;s review or input concerning such Affiliate&#146;s investments or trading (collectively, &#147;<I>Trading Affiliate</I>s&#148;) has directly or indirectly, nor has
any Person acting on behalf of or pursuant to any understanding with the Purchaser or Trading Affiliate, effected or agreed to effect any purchases or sales of the securities of the Company (including, without limitation, any Short Sales involving
the Company&#146;s securities). Notwithstanding the foregoing, if the Purchaser and/or Trading Affiliate is, individually or collectively, a multi-managed investment bank or vehicle whereby separate portfolio managers manage separate portions of the
Purchaser&#146;s or Trading Affiliate&#146;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of the Purchaser&#146;s or Trading Affiliate&#146;s assets,
the representation set forth above shall apply only with respect to the portion of assets managed by the portfolio manager that have knowledge about the financing transaction contemplated by this Agreement or by the Original Agreement. Other than to
other Persons party to this Agreement, the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction) and in connection with the transaction
contemplated under the Original Agreement. Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability
of, or securing of, available shares to borrow in order to effect short sales or similar transactions in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Brokers and
Finders</U>. Other than the Placement Agent with respect to the Company, no Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim against or upon the Company or the Purchaser for any
commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Independent Investment Decision</U>. The Purchaser has independently evaluated the
merits of its decision to purchase Securities pursuant to the Transaction Documents. The Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Purchaser in connection with the
purchase of the Securities constitutes legal, tax or investment advice. The Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the
Securities. The Purchaser understands that the Placement Agent has acted solely as the agent of the Company in this placement of the Shares and Warrant and the Purchaser has not relied on the business or legal advice of the Placement Agent or any of
its agents, counsel or Affiliates in making its investment decision hereunder, and confirms that none of such Persons has made any representations or warranties to the Purchaser in connection with the transactions contemplated by the Transaction
Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Reliance on Exemptions</U>. The Purchaser understands that the Securities being offered and sold to it in reliance on
specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and the Purchaser&#146;s compliance with, the representations,
warranties, agreements, acknowledgements and understandings of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>No Governmental Review</U>. The Purchaser understands that no United States federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Regulation M</U>. The Purchaser is aware that the anti-manipulation rules of Regulation M under the Exchange Act may
apply to sales of Common Stock and other activities with respect to the Common Stock by the Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Residency</U>. The
Purchaser&#146;s residence (if an individual) or offices in which its investment decision with respect to the Securities was made (if an entity) are located at the address immediately below the Purchaser&#146;s name on its signature page hereto.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and the Purchaser acknowledge and agree that no party to this Agreement has made or makes any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in this <U>Article III</U> and the Transaction Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OTHER AGREEMENTS OF THE PARTIES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Transfer Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Compliance with Laws</U>. Notwithstanding any other provision of this <U>Article IV</U>, the Purchaser covenants that the Securities
may be disposed of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act, and in compliance with any applicable state and federal securities laws. In connection with any transfer of the Securities other than (i)&nbsp;pursuant to an effective registration statement, (ii)&nbsp;to the
Company, (iii)&nbsp;pursuant to Rule 144 (<I>provided</I> that the Purchaser provides the Company with reasonable assurances (in the form of seller and, if applicable, broker representation letters) that the securities may be sold pursuant to such
rule) or (iv)&nbsp;in connection with a bona fide pledge as contemplated in <U>Section</U><U></U><U>&nbsp;4.1(b)</U>, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and
reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As
a condition of any transfer in accordance with the preceding sentence, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights Agreement and shall have the rights of the Purchaser under this
Agreement and the Registration Rights Agreement with respect to such transferred Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Legends</U>. Certificates evidencing
the Securities shall bear any legend as required by the &#147;blue sky&#148; laws of any state and a restrictive legend in substantially the following form (or, with respect to Shares held in uncertificated form, the Transfer Agent will record such
a legend on the share register), until such time as they are not required under <U>Section</U><U></U><U>&nbsp;4.1(c)</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">[NEITHER THESE
SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED] [NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON CONVERSION OF THESE SECURITIES HAVE BEEN REGISTERED] [THESE SECURITIES HAVE NOT BEEN
REGISTERED] UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I)&nbsp;IN THE ABSENCE OF (A)&nbsp;AN
EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B)&nbsp;AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II)&nbsp;UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT. NOTWITHSTANDING THE FOREGOING, THE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company acknowledges and agrees that the Purchaser may from time to time pledge, and/or grant a security interest in, some or all of the
legended Securities in connection with applicable securities laws, pursuant to a bona fide margin agreement or loan from a depository institution in compliance with a bona fide margin or bank loan. Such a pledge would not be subject to approval or
consent of the Company and no </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
legal opinion of legal counsel to the pledgee, secured party or pledgor shall be required in connection with the pledge, but such legal opinion shall be required in connection with a subsequent
transfer or foreclosure following default by the Purchaser transferee of the pledge. No notice shall be required of such pledge, but Purchaser&#146;s transferee shall promptly notify the Company of any such subsequent transfer or foreclosure. The
Purchaser acknowledges that the Company shall not be responsible for any pledges relating to, or the grant of any security interest in, any of the Securities or for any agreement, understanding or arrangement between the Purchaser and its pledgee or
secured party. At the Purchaser&#146;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) of the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of Selling Stockholders thereunder. The
Purchaser acknowledges and agrees that, except as otherwise provided in <U>Section</U><U></U><U>&nbsp;4.1(c)</U>, any Securities subject to a pledge or security interest as contemplated by this <U>Section</U><U></U><U>&nbsp;4.1(b)</U> shall continue
to bear the legend set forth in this <U>Section</U><U></U><U>&nbsp;4.1(b)</U> and be subject to the restrictions on transfer set forth in <U>Section</U><U></U><U>&nbsp;4.1(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Removal of Legends</U>. The legend set forth in <U>Section</U><U></U><U>&nbsp;4.1(b)</U> above shall be removed and the Company shall
issue a certificate without such legend or any other legend to the holder of the applicable Securities upon which it is stamped or issue to such holder by electronic delivery at the applicable balance account at the Depository Trust Company
(&#147;<I>DTC</I>&#148;) or the Transfer Agent, if (i)&nbsp;such Securities are registered for resale under the Securities Act (provided that, if the Purchaser is selling pursuant to the effective registration statement registering the Securities
for resale, the Purchaser agrees to only sell such Securities during such time that such registration statement is effective and not withdrawn or suspended, and only as permitted by such registration statement), (ii) such Securities are sold or
transferred pursuant to Rule 144 (if the transferor is not an Affiliate of the Company), or (iii)&nbsp;such Securities are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public
information required under Rule 144 as to such securities and without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions. Following the earlier of (i)&nbsp;the Effective Date or
(ii)&nbsp;Rule 144 becoming available for the resale of Securities, without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such securities and without volume or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions, the Company shall cause Company Counsel to issue to the Transfer Agent the legal opinion referred to in the Irrevocable Transfer Agent
Instructions. Any fees (with respect to the Transfer Agent, Company Counsel or otherwise) associated with the issuance of such opinion or the removal of such legend shall be borne by the Company. Following the Effective Date, or at such earlier time
as a legend is no longer required for certain Securities pursuant to the foregoing, the Company will no later than three (3)&nbsp;Trading Days following the delivery by the Purchaser to the Transfer Agent (with notice to the Company) of a legended
certificate or instrument representing Common Shares (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer) (such third (3<SUP
STYLE="font-size:75%; vertical-align:top">rd</SUP>) Trading Day, the &#147;<I>Legend Removal Date</I>&#148;), deliver or cause to be delivered to the Purchaser a certificate or instrument (as the case may be) representing such Securities that is
free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this <U>Section</U><U></U><U>&nbsp;4.1(c)</U>.
Certificates for Common Shares subject to legend removal hereunder may be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&#146;s broker with DTC as directed by the Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Irrevocable Transfer Agent Instructions</U>. The Company shall issue irrevocable instructions to its transfer agent, and any subsequent
transfer agent, in the form of <U>Exhibit E</U> attached hereto (the &#147;<I>Irrevocable Transfer Agent Instructions</I>&#148;). The Company represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions referred
to in this <U>Section</U><U></U><U>&nbsp;4.1(d)</U> (or instructions that are consistent therewith) will be given by the Company to its transfer agent in connection with this Agreement, and that the Securities shall otherwise be freely transferable
on the books and records of the Company as and to the extent provided in this Agreement and the other Transaction Documents and applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Acknowledgement</U>. The Purchaser hereunder acknowledges its primary
responsibilities under the Securities Act and accordingly will not sell or otherwise transfer the Securities or any interest therein without complying with the requirements of the Securities Act. While the Registration Statement remains effective,
the Purchaser hereunder may sell the Registrable Securities in accordance with the plan of distribution contained in the Registration Statement and if it does so it will comply therewith and with the related prospectus delivery requirements unless
an exemption therefrom is available. The Purchaser agrees that if it is notified by the Company in writing at any time that the Registration Statement registering the resale of the Registrable Securities is not effective or that the prospectus
included in such Registration Statement no longer complies with the requirements of Section&nbsp;10 of the Securities Act, the Purchaser will refrain from selling such Registrable Securities until such time as the Purchaser is notified by the
Company that such Registration Statement is effective or such prospectus is compliant with Section&nbsp;10 of the Securities Act, unless the Purchaser is able to, and does, sell such Registrable Securities pursuant to an available exemption from the
registration requirements of Section&nbsp;5 of the Securities Act. Both the Company and its Transfer Agent, and their respective directors, officers, employees and agents, may rely on this Section&nbsp;4.1(e) and the Purchaser hereunder will
indemnify and hold harmless each of such persons from any breaches or violations of this Section&nbsp;4.1(e). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Reservation of
Common Stock; Conversion of Preferred Stock; No Dilutive Actions</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall take all action necessary to at all times
have authorized, and reserved for the purpose of issuance from and after the Closing Date, an aggregate number of shares of Common Stock sufficient for issuance upon Conversion (subject to the Stockholder Approvals) of all outstanding shares of
Preferred Stock into Common Stock and exercise of the Warrant issued at the Closing (prior to receiving the Stockholder Approvals only, taking into account any limitations on exercise of the Warrant set forth in the Warrant). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that the Company has obtained the Issuance Approval but the Company&#146;s stockholders have not approved the Articles
Amendment, pursuant to Article <FONT STYLE="white-space:nowrap">II-A,</FONT> Section&nbsp;5 of the Preferred Stock Articles of Amendment with respect to the Series B, the Company will effect a &#147;Partial Conversion&#148; (as defined in the
Preferred Stock Articles of Amendment) of the Series B. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Furnishing of Information</U>. In order to enable the Purchaser to sell
the Securities under Rule 144, for a period of twelve (12)&nbsp;months from the Closing, the Company shall use its commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period)
all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. During such twelve (12)&nbsp;month period, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare and furnish
to the Purchaser and make publicly available in accordance with Rule 144(c) such information as is required for the Purchaser to sell the Securities under Rule 144. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Integration</U>. The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company
shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section&nbsp;2 of the Securities Act) that will be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities to the Purchaser, or that will be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would
require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>Securities Laws Disclosure; Publicity</U>. On or before 9:00 A.M., New York City time, on the second (2<SUP
STYLE="font-size:75%; vertical-align:top">nd</SUP>) Trading Day immediately following the execution of this Agreement, the Company will file a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (the &#147;<I>Current Report</I>&#148;)
with the Commission describing the terms of the Transaction Documents (and including all required exhibits to the Current Report). Notwithstanding the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
foregoing, the Company shall not publicly disclose the name of the Purchaser or an Affiliate of the Purchaser, or include the name of the Purchaser or an Affiliate of the Purchaser in any press
release or filing with the Commission (other than the Registration Statement) or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (i)&nbsp;as required by federal securities law in connection with
(A)&nbsp;any registration statement contemplated by the Registration Rights Agreement and (B)&nbsp;the Current Report and (ii)&nbsp;to the extent such disclosure is required by law, request of the Staff of the Commission or Trading Market
regulations, in which case the Company shall provide the Purchaser with prior written notice of such disclosure permitted under this subclause (ii). From and after the issuance of the Current Report, the Purchaser shall not be in possession of any
material, <FONT STYLE="white-space:nowrap">non-public</FONT> information received from the Company, any Subsidiary or any of their respective officers, directors, employees or agents, that is not disclosed in the Current Report unless the Purchaser
shall have executed a written agreement regarding the confidentiality and use of such information. The Purchaser covenants that until such time as the transactions contemplated by this Agreement are required to be publicly disclosed by the Company
as described in this <U>Section</U><U></U><U>&nbsp;4.5</U>, the Purchaser will maintain the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <U><FONT STYLE="white-space:nowrap">Non-Public</FONT> Information</U>. Except with respect to the material terms and conditions of the
transactions contemplated by the Transaction Documents, including this Agreement, or as expressly required by any applicable securities law, the Company covenants and agrees that neither it, nor any other Person acting on its behalf, will provide
the Purchaser or its agents or counsel with any information regarding the Company that the Company believes constitutes material <FONT STYLE="white-space:nowrap">non-public</FONT> information without the express written consent of the Purchaser,
unless prior thereto the Purchaser shall have executed a written agreement regarding the confidentiality and use of such information. The Company understands and confirms that the Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Shares
and Warrant hereunder for general corporate purposes and to reposition business lines, support organic growth and enhance capital levels of the Bank and shall not use such proceeds for: (a)&nbsp;the satisfaction of any portion of the Company&#146;s
debt (other than payment of trade payables in the ordinary course of the Company&#146;s business and prior practices), (b)&nbsp;the redemption of any Common Stock or Common Stock Equivalents or (c)&nbsp;the settlement of any outstanding litigation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <U>Indemnification</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the provisions of this <U>Section</U><U></U><U>&nbsp;4.8</U>, the Company will indemnify and hold harmless the Purchaser and
its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who
controls the Purchaser (within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a
functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#147;<I>Purchaser Indemnified Party</I>&#148;) against, and reimburse any of the Purchaser
Indemnified Parties for, any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#146; fees and costs of
investigation (collectively, &#147;<I>Losses</I>&#148;) that any such Purchaser Indemnified Party may suffer or incur as a result of (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the Company in this
Agreement or in the other Transaction Documents or (b)&nbsp;any action instituted against the Purchaser in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of the Purchaser, with
respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a breach of any of the representations, warranties, covenants or agreements made by the Purchaser in the Transaction Documents or any
agreements or understandings the Purchaser may have with any such stockholder or any violations by the Purchaser of state or federal securities laws or any conduct by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Purchaser which constitutes fraud, gross negligence, willful misconduct or malfeasance). Notwithstanding anything to the contrary contained herein, as to the Purchaser, the Company shall not be
required to indemnify, defend, hold harmless or reimburse the Purchaser or its respective Purchaser Indemnified Parties pursuant to this <U>Section</U><U></U><U>&nbsp;4.8</U> (i) unless and until the aggregate amount of such Purchaser Indemnified
Parties&#146; Losses incurred with respect to all claims pursuant to this <U>Section</U><U></U><U>&nbsp;4.8</U> exceeds $100,000 (the &#147;<I>Threshold Amount</I>&#148;), in which event the Company shall be responsible for the total amount of such
Losses (without regard to the Threshold Amount) for which such Purchaser Indemnified Parties are finally determined to be otherwise entitled to indemnification under this <U>Section</U><U></U><U>&nbsp;4.8</U> and (ii)&nbsp;for Losses in a cumulative
aggregate amount exceeding the Subscription Amount paid by the Purchaser to the Company pursuant to <U>Section</U><U></U><U>&nbsp;2.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to the provisions of this <U>Section</U><U></U><U>&nbsp;4.8</U>, the Purchaser will indemnify and hold harmless the Company and
its Affiliates and their respective directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any
other title) (each, a &#147;<I>Company Indemnified Party</I>&#148;) against, and reimburse any of the Company Indemnified Parties for, any and all Losses that any Company Indemnified Party may suffer or incur as a result of (a)&nbsp;any breach of
any of the representations, warranties, covenants or agreements made by the Purchaser in this Agreement or in the other Transaction Documents or (b)&nbsp;any breach or failure by the Purchaser to perform any of its covenants or agreements contained
in this Agreement. Notwithstanding anything to the contrary contained herein, the Purchaser shall not be required to indemnify, defend, hold harmless or reimburse the Company or its respective Company Indemnified Parties pursuant to this
<U>Section</U><U></U><U>&nbsp;4.8</U> (i) unless and until the aggregate amount of such Company Indemnified Parties&#146; Losses incurred with respect to all claims pursuant to this <U>Section</U><U></U><U>&nbsp;4.8</U> exceeds the Threshold Amount,
in which event the Purchaser shall be responsible for the total amount of such Losses (without regard to the Threshold Amount) for which the Company Indemnified Parties are finally determined to be otherwise entitled to indemnification under this
<U>Section</U><U></U><U>&nbsp;4.8</U> and (ii)&nbsp;for Losses in a cumulative aggregate amount exceeding the Subscription Amount paid by the Purchaser to the Company pursuant to <U>Section</U><U></U><U>&nbsp;2.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after receipt by any Person (the &#147;<I>Indemnified Person</I>&#148;) of notice of any demand, claim or circumstances which
would or might give rise to a claim or the commencement of any action, proceeding or investigation in respect of which indemnity may be sought pursuant to this <U>Section</U><U></U><U>&nbsp;4.8</U>, such Indemnified Person shall promptly notify the
Person liable for such indemnification (the &#147;<I>Indemnifying Person</I>&#148;) in writing and the Indemnifying Person shall assume the defense thereof, including the employment of counsel reasonably satisfactory to such Indemnified Person, and
shall assume the payment of all fees and expenses; provided, however, that the failure of any Indemnified Person so to notify the Indemnifying Person shall not relieve the Indemnifying Person of its obligations hereunder except to the extent that
the Indemnifying Person is actually and materially prejudiced by such failure to notify. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Person unless: (i)&nbsp;the Indemnifying Person and the Indemnified Person shall have mutually agreed to the retention of such counsel; (ii)&nbsp;the Indemnifying Person shall have failed promptly to assume the defense of such
proceeding and to employ counsel reasonably satisfactory to such Indemnified Person in such proceeding; or (iii)&nbsp;in the reasonable judgment of counsel to such Indemnified Person, representation of both parties by the same counsel would be
inappropriate due to actual or potential differing interests between them; provided, however, that the Indemnifying Person shall not be required to pay for more than two separate counsel for all Indemnified Persons. The Indemnifying Person shall not
be liable for any settlement of any proceeding effected without its written consent, which consent shall not be unreasonably withheld, delayed or conditioned. Without the prior written consent of the Indemnified Person, which consent shall not be
unreasonably withheld, delayed or conditioned, the Indemnifying Person shall not effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnity could have been
sought hereunder by such Indemnified Person, unless such settlement includes an unconditional release of such Indemnified Person from all liability arising out of such proceeding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each party hereto acknowledges and agrees that following the Closing, the
indemnification provisions hereunder shall be the sole and exclusive monetary remedies of the parties hereto for (i)&nbsp;any breach of any of the representations, warranties, covenants or agreements contained in this Agreement, and (ii)&nbsp;any
claim, suit, action, proceeding or any other matter of whatsoever kind or nature arising out of, resulting from or related to the Transaction Documents or the transactions contemplated herein or therein; provided, that nothing herein shall limit in
any way any such parties&#146; remedies in respect of fraud, criminal activity or willful misconduct by the other party in connection with the transactions contemplated hereby. No party to this Agreement (or any of its Affiliates) shall, in any
event, be liable or otherwise responsible to any other party (or any of its Affiliates) for any consequential or punitive damages of such other party (or any of its Affiliates) arising out of or relating to this Agreement or the performance or
breach hereof. No investigation of the Company by the Purchaser, or of the Purchaser by the Company, whether prior to or after the date of this Agreement, shall limit any Indemnified Person&#146;s exercise of any right hereunder or be deemed to be a
waiver of any such right. The parties agree that any indemnification payment made pursuant to this Agreement shall be treated as an adjustment to the Purchase Price for tax purposes, unless otherwise required by law. Such payment shall not result in
an adjustment to the value of the original investment reported by the Company under GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.9 <U>Principal Trading Market Listing</U>.
The Company shall promptly use its reasonable best efforts to prepare and file with such Principal Trading Market a supplemental listing application covering all of the Common Shares and shall use its reasonable best efforts to take all steps
necessary to cause all of the Common Shares to be approved for listing on the Principal Trading Market prior to the Closing. Notwithstanding any other provision in this Agreement to the contrary, the Company shall not issue at the Closing such
number of shares that would be equal to or greater than 20% of the Company&#146;s outstanding Common Stock. After receiving each respective Stockholder Approval, in the time and manner required by the Principal Trading Market, the Company shall
prepare and file with the Principal Trading Market a supplemental listing application covering all of the Underlying Preferred Shares and the Warrant Shares (if Common Stock) to the extent practicable, and shall use its commercially reasonable
efforts to take all steps necessary to cause all of the Underlying Preferred Shares and the Warrant Shares (if Common Stock) to be approved for listing on the Principal Trading Market as promptly as possible thereafter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.10 <U>Form</U><U></U><U>&nbsp;D; Blue Sky</U>. The Company has timely filed a Form&nbsp;D with respect to the Securities as required under
Regulation&nbsp;D. The Company, on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for or to qualify the Securities for sale to the Purchasers under applicable
securities or &#147;Blue Sky&#148; laws of the states of the United States (or to obtain an exemption from such qualification) and shall provide evidence of such actions promptly upon the written request of the Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.11 <U>Conduct of Business Pending Closing</U>. From the date hereof until the earlier of the Closing Date or the termination of this
Agreement in accordance with its terms, except as contemplated by this Agreement, the Company will, and will cause its Subsidiaries to, operate their business in the ordinary course consistent with past practice, preserve intact the current business
organization of the Company, use commercially reasonable efforts to retain the services of their officers, employees, consultants and agents, preserve its rights and permits issued by governmental authorities, preserve the current relationships of
the Company and its Subsidiaries with material customers and other Persons with whom the Company and its Subsidiaries have and intend to maintain significant relations and maintain all of its operating assets in their current condition (normal wear
and tear excepted), and not take any action that would reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.12 <U>No Shop</U>.
From the date hereof until the earlier of the Closing Date or the termination of this Agreement in accordance with its terms, the Company shall not, and the Company shall not permit any of its Affiliates, directors, officers or employees to, and the
Company shall use commercially reasonable efforts to cause its other representatives or agents (together with directors, officers, and employees, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<I>Representatives</I>&#148;) not to, directly or indirectly, (i)&nbsp;discuss, encourage, negotiate, undertake, initiate, authorize, recommend, propose or enter into, whether as the
proposed surviving, merged, acquiring or acquired corporation or otherwise, any transaction involving a merger, consolidation, business combination, recapitalization, purchase or disposition of any material amount of the assets of the Company or any
material amount of the capital stock or other ownership interests of the Company (other than in connection with the transactions contemplated hereby) (an &#147;<I>Acquisition Transaction</I>&#148;), (ii) facilitate, encourage, solicit or initiate
discussions, negotiations or submissions of proposals or offers in respect of an Acquisition Transaction, (iii)&nbsp;furnish or cause to be furnished, to any Person, any information concerning the business, operations, properties or assets of the
Company in connection with an Acquisition Transaction, or (iv)&nbsp;otherwise cooperate in any way with, or assist or participate in, facilitate or encourage, any effort or attempt by any other Person to do or seek any of the foregoing.
Notwithstanding the foregoing, in the event that the Company receives an unsolicited bona fide written offer, proposal or inquiry relating to, or any third-party indication of interest in, an Acquisition Transaction that did not result from or arise
in connection with a breach of this <U>Section</U><U></U><U>&nbsp;4.12</U>, the Company may, and may permit its Affiliates and its Affiliates&#146; Representatives to, furnish or cause to be furnished any information concerning the business,
operations, properties or assets of the Company and participate in discussions in connection therewith, if the Board of Directors of concludes in good faith (after consulting with its outside counsel, and with respect to financial matters, its
financial advisors) that the failure to take such actions would be reasonably likely be a violation of its fiduciary duties under applicable law. The Company shall notify the Purchaser orally and in writing promptly (but in no event later than one
(1)&nbsp;Business Day) after receipt by the Company or any of the Representatives thereof of any proposal or offer from any Person other than the Purchaser to effect an Acquisition Transaction or any request for
<FONT STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or for access to the properties, books or records of the Company by any Person other than the Purchaser in connection with an Acquisition Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.13 <U>Regulatory Matters</U>. The Purchaser shall prepare and file all necessary documentation to effect all applications, notices,
petitions and filings to obtain as promptly as practicable all permits, consents, orders, approvals, waivers, <FONT STYLE="white-space:nowrap">non-objections</FONT> and authorizations of the Federal Reserve, the Bureau of Financial Institutions of
the VSCC or other governmental authority which are necessary or advisable to consummate the transactions contemplated by the Transaction Documents and to perform the covenants contemplated by the Transaction Documents (the &#147;<I>Regulatory
Approvals&#148;</I>). The Purchaser shall use its reasonable best efforts to promptly obtain such Regulatory Approvals, and the Company will cooperate as may reasonably be requested by the Purchaser to help the Purchaser obtain or submit, as
promptly as practicable, any documentation or written materials requested by or submitted to any governmental authority in connection with the Regulatory Approvals. The parties hereto will consult with each other with respect to the obtaining of
such Regulatory Approvals, promptly furnish each other with copies of written communications received by them, or delivered by them to, any governmental authority in respect of the transactions contemplated hereby and keep the other apprised of the
status of matters relating to completion of the transactions contemplated herein; provided, however, that the Purchaser shall not be obligated hereunder to share any portion of an application or communication for which the Purchaser has requested
confidential treatment or any regulatory correspondence containing confidential information. Notwithstanding the foregoing, nothing contained herein shall be deemed to require the Purchaser to take any action, or commit to take any action, or agree
to any condition, commitment or restriction, in connection with obtaining the Regulatory Approvals, which the Purchaser determines, in its reasonable good faith judgement, would be materially financially burdensome on the Company&#146;s business
following the Closing or would reduce the economic benefits of the transactions contemplated by this Agreement to the Purchaser to such a degree that the Purchaser would not have entered into this Agreement had such condition or restriction been
known to it at the date hereof (a &#147;<I>Materially Burdensome Regulatory Condition</I>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.14 <U>Short Sales and Confidentiality After the Date Hereof</U>. The Purchaser shall not,
and shall cause its Trading Affiliates not to, engage, directly or indirectly, in any transactions in the Company&#146;s securities (including, without limitation, any Short Sales involving the Company&#146;s securities) during the period from the
date hereof until the earlier of such time as (i)&nbsp;the transactions contemplated by this Agreement are first publicly announced as required by and described in <U>Section</U><U></U><U>&nbsp;4.5</U> or (ii)&nbsp;this Agreement is terminated in
full pursuant to <U>Section</U><U></U><U>&nbsp;6.19</U>. The Purchaser covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company as described in <U>Section</U><U></U><U>&nbsp;4.5</U>, the
Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Transaction Documents and Disclosure Schedules. Notwithstanding the foregoing, the Purchaser makes no representation,
warranty or covenant hereby that it will not engage in Short Sales in the securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced as described in
<U>Section</U><U></U><U>&nbsp;4.5</U>; <I>provided, however</I>, the Purchaser agrees that he will not enter into any Net Short Sales (as hereinafter defined) from the period commencing on the Closing Date and ending on the earliest of (x)&nbsp;the
Effective Date of the initial Registration Statement, (y)&nbsp;the twenty-four (24)&nbsp;month anniversary of the Closing Date or (z)&nbsp;the date that the Purchaser no longer holds any Securities. For purposes of this
<U>Section</U><U></U><U>&nbsp;4.14</U>, a &#147;<I>Net Short Sale</I>&#148; by the Purchaser shall mean a sale of Common Stock by the Purchaser that is marked as a short sale and that is made at a time when there is no equivalent offsetting long
position in Common Stock held by the Purchaser. For purposes of determining whether there is an equivalent offsetting position in Common Stock held by the Purchaser, Underlying Preferred Shares that have not yet been issued pursuant to the
Conversion of Preferred Shares shall be deemed to be held long by the Purchaser, and the amount of shares of Common Stock held in a long position shall be all shares of Common Stock and all Underlying Preferred Shares into which the Purchaser&#146;s
Preferred Shares are convertible, plus any shares of Common Stock Equivalents otherwise then held by the Purchaser. Notwithstanding the foregoing, in the event that the Purchaser is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser&#146;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of the Purchaser&#146;s assets, the
representation set forth above shall apply only with respect to the portion of assets managed by the portfolio manager that have knowledge about the financing transaction contemplated by this Agreement. Moreover, notwithstanding the foregoing, in
the event that the Purchaser has sold Securities pursuant to Rule 144 prior to the Effective Date of the initial Registration Statement and the Company has failed to deliver certificates without legends prior to the settlement date for such sale
(assuming that such certificates meet the requirements set forth in <U>Section</U><U></U><U>&nbsp;4.1(c)</U> for the removal of legends), the provisions of this <U>Section</U><U></U><U>&nbsp;4.14</U> shall not prohibit the Purchaser from entering
into Net Short Sales for the purpose of delivering shares of Common Stock in settlement of such sale. The Purchaser understands and acknowledges that the Commission currently takes the position that covering a short position established prior to
effectiveness of a resale registration statement with shares included in such registration statement would be a violation of Section&nbsp;5 of the Securities Act, as set forth in Item 65, Section&nbsp;5 under Section A, of the Manual of Publicly
Available Telephone Interpretations, dated July 1997, compiled by the Office of Chief Counsel, Division of Corporation Finance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.15
<U>Reserved</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.16 <U>Reserved</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.17 <U>Required Regulatory Capital</U>. In the event that either of the Company or the Bank does not have regulatory capital in an amount
equal or greater to, (a)&nbsp;if neither the Company nor the Bank is subject to a regulatory capital requirement pursuant to an enforcement action issued by a bank regulatory authority, the amount necessary for the Company (if applicable) or the
Bank to be deemed to be &#147;well capitalized,&#148; as such term is defined in the applicable state and federal rules and regulations, or, (b)&nbsp;if either the Company or the Bank is subject to a regulatory capital requirement pursuant to an
enforcement action issued by a bank regulatory authority, the amount necessary for the Company and/or the Bank to be in compliance with any capital requirements imposed by any bank regulatory authority, as applicable, pursuant to such enforcement
action (including, without limitation, the existing consent order between the Office of the Comptroller of the Currency (the &#147;<I>OCC</I>&#148;) and the Bank and the individual minimum capital ratios (&#147;<I>IMCR</I>&#148;) contained therein)
(the greater of the amount in either (a)&nbsp;or (b), the &#147;<I>Required Regulatory Capital</I>&#148;), the Company agrees to use </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commercially reasonable efforts to ensure that each of the Company and the Bank is in compliance with the Required Regulatory Capital as soon as practicable, either promptly through commencing a
capital raise or other means that are reasonably anticipated to restore compliance with Required Regulatory Capital. Required Regulatory Capital shall be measured as of any fiscal quarter end beginning on the quarter in which the Closing Date
occurs, and the requirements of this Section&nbsp;4.17 shall apply for a period three (3)&nbsp;years after the date hereof, or any such shorter periods as specified in any regulatory enforcement action or otherwise required by the applicable
regulatory authority. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONDITIONS PRECEDENT TO CLOSING </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Conditions Precedent to the Obligations of the Purchaser to Purchase Securities</U>. The obligation of the Purchaser to acquire Common
Shares, Preferred Shares and Warrant at the Closing is subject to the fulfillment to the Purchaser&#146;s satisfaction, on or prior to the Closing Date, of each of the following conditions, any of which may be waived by the Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. The representations and warranties of the Company contained herein shall be true and correct in all
material respects (except for those representations and warranties which are qualified as to materiality or with references to Material Adverse Effect, in which case such representations and warranties shall be true and correct in all respects) as
of the date when made and as of the Closing Date, as though made on and as of such date, except for such representations and warranties that speak as of a specific date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Performance</U>. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and
conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No
Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of
any of the transactions contemplated by the Transaction Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>No Threatened Orders</U>. No bank regulatory authority shall
have threatened orally or in writing or otherwise informed the Company or any of its Subsidiaries that it is contemplating any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cease-and-desist</FONT></FONT> or other order or
enforcement action, except to the extent that such action would not result in a Material Adverse Effect, and neither the Company nor any of its Subsidiaries shall have been threatened orally or in writing or otherwise informed by any bank regulatory
authority that it intends to assess a civil money penalty against the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Consents</U>. The
Purchaser and the Company shall have obtained in a timely fashion all consents, permits, approvals, registrations and waivers necessary for consummation of the purchase and sale of the Securities (including all Required Approvals and Regulatory
Approvals), all of which shall be and remain so long as necessary in full force and effect (and, with respect to the Regulatory Approvals, which shall not contain any Materially Burdensome Regulatory Condition). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Reserved</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)
<U>Adverse Changes</U>. Since the date of execution of this Agreement, no event or series of events shall have occurred that has had or would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Listing</U>. The Common Shares shall have been authorized for listing on the NYSE American market, subject to official notice of
issuance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>No Suspensions of Trading in Common Stock</U>. The Common Stock shall not have been
suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date,
either (i)&nbsp;in writing by the Commission or the Principal Trading Market or (ii)&nbsp;by falling below the minimum listing maintenance requirements of the Principal Trading Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Company Deliverables</U>. The Company shall have delivered the Company Deliverables in accordance with
<U>Section</U><U></U><U>&nbsp;2.2(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Compliance Certificate</U>. The Company shall have delivered to the Purchaser a
certificate, dated as of the Closing Date and signed by its Chief Executive Officer or its Chief Financial Officer, dated as of the Closing Date, certifying to the fulfillment of the conditions specified in <U>Sections 5.1(a), (b)</U> and
<U>(d)</U>&nbsp;and to the current capitalization of the Company as of the Closing Date in the form attached hereto as <U>Exhibit G</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Termination</U>. This Agreement shall not have been terminated as to the Purchaser in accordance with
<U>Section</U><U></U><U>&nbsp;6.19</U> herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Required Regulatory Capital</U>. The Bank shall have regulatory capital in an
amount equal or greater to the Required Regulatory Capital, as measured as of the month end immediately preceding the Closing Date and as calculated on Schedule RCR, as adjusted (i)&nbsp;on a pro forma basis after taking into account the
Subscription Amount hereunder for which all conditions precedent under <U>Section</U><U></U><U>&nbsp;5.2</U> have been satisfied (and assuming that 100% of the net proceeds are contributed to the Bank) and (ii)&nbsp;to accrue for all expenses and <FONT
STYLE="white-space:nowrap">one-time</FONT> charges reasonably expected to occur in connection with the transactions contemplated by this Agreement to the extent not already reflected in the Company&#146;s or the Bank&#146;s financial statements.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Conditions Precedent to the Obligations of the Company to sell Securities</U>. The Company&#146;s obligation to sell and issue the
Common Shares, Preferred Shares and Warrant at the Closing to the Purchaser is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any of which may be waived by the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. The representations and warranties made by the Purchaser in <U>Section</U><U></U><U>&nbsp;3.2</U>
hereof shall be true and correct in all material respects (except for those representations and warranties which are qualified as to materiality, in which case such representations and warranties shall be true and correct in all respects) as of the
date when made, and as of the Closing Date as though made on and as of such date, except for representations and warranties that speak as of a specific date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Performance</U>. The Purchaser shall have performed, satisfied and complied in all material respects with all covenants, agreements and
conditions required by the Transaction Documents to be performed, satisfied or complied with by the Purchaser at or prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Consents</U>. The Purchaser and the Company shall have obtained in a timely fashion all consents, permits, approvals, registrations and
waivers necessary for consummation of the purchase and sale of the Securities (including all Required Approvals and Regulatory Approvals), all of which shall be and remain so long as necessary in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Purchasers Deliverables</U>. The Purchaser shall have delivered its Purchaser
Deliverables in accordance with <U>Section</U><U></U><U>&nbsp;2.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Listing</U>. The Common Shares shall have been
authorized for listing on the NYSE American market, subject to official notice of issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Termination</U>. This Agreement shall
not have been terminated as to the Purchaser in accordance with <U>Section</U><U></U><U>&nbsp;6.19</U> herein. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MISCELLANEOUS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>Fees and
Expenses</U>. The Company and the Purchaser shall each pay the fees and expenses of their respective advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party in connection with the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied in connection with the sale and issuance of the Securities to the Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of
the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules. At or after the Closing, and without further consideration, the Company and the Purchaser will execute and deliver to the other such further documents as may be reasonably requested in order to give practical
effect to the intention of the parties under the Transaction Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <U>Confidential Supervisory Information</U>. The parties
acknowledge and agree that no party shall disclose confidential supervisory information (including information identified in 12 C.F.R. Part 4, 12 C.F.R. Part 261 Subpart C and Va. Code &#167; <FONT STYLE="white-space:nowrap">6.2-904(A))</FONT> of a
governmental authority in connection herewith to the extent prohibited by applicable law. To the extent legally permissible, appropriate substitute disclosures or actions shall be made or taken under circumstances in which the limitations of the
preceding sentence apply. However, the inability of any party to disclose confidential supervisory information shall not relieve any party from liability for any inaccurate representations or warranties or any other misstatements or omissions in
connection with this Agreement and the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 <U>Notices</U>. Any and all notices or other communications
or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a)&nbsp;the date of transmission, if such notice or communication is delivered via facsimile or <FONT
STYLE="white-space:nowrap">e-mail</FONT> (provided the sender receives a machine-generated confirmation of successful facsimile transmission or <FONT STYLE="white-space:nowrap">e-mail</FONT> notification or confirmation of receipt of an <FONT
STYLE="white-space:nowrap">e-mail</FONT> transmission) at the facsimile number or <FONT STYLE="white-space:nowrap">e-mail</FONT> address specified in this <U>Section</U><U></U><U>&nbsp;6.4</U> prior to 5:00 P.M., New York City time, on a Trading
Day, (b)&nbsp;the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or <FONT STYLE="white-space:nowrap">e-mail</FONT> at the facsimile number or <FONT STYLE="white-space:nowrap">e-mail</FONT>
address specified in this <U>Section</U><U></U><U>&nbsp;6.4</U> on a day that is not a Trading Day or later than 5:00 P.M., New York City time, on any Trading Day, (c)&nbsp;the Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service with next day delivery specified, or (d)&nbsp;upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to the Company:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Blue Ridge Bankshares, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1807 Seminole Trail</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Charlottesville, Virginia 22901</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Telephone No.: (804) <FONT STYLE="white-space:nowrap">518-2680</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Facsimile No.: (540) <FONT STYLE="white-space:nowrap">743-5536</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attention: G. William Beale</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">E-mail:</FONT> William.Beale@mybrb.bank</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">With a copy to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Williams Mullen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">200 South 10th Street, Suite 1600</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Richmond, Virginia 23219</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Telephone No.: (804) <FONT STYLE="white-space:nowrap">420-6000</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Facsimile No.: (804) <FONT STYLE="white-space:nowrap">420-6507</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attention: Scott H. Richter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.30em; font-size:10pt; font-family:Times New Roman">Lee G. Lester</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">E-mail:</FONT> srichter@williamsmullen.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:3.20em; font-size:10pt; font-family:Times New Roman">llester@williamsmullen.com</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to a Purchaser:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">To the address set forth under the Purchaser&#146;s name on the signature page hereof;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or such other address as may be designated in writing hereafter, in the same manner, by such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5 <U>Amendments; Waivers; No Additional Consideration</U>. No provision of this Agreement may be waived, modified, supplemented or amended
except in a written instrument signed, in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought. No waiver of any default with respect to any
provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission
of either party to exercise any right hereunder in any manner impair the exercise of any such right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6 <U>Construction</U>. The
headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties
to express their mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring
any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.7 <U>Successors and
Assigns</U>. The provisions of this Agreement shall inure to the benefit of and be binding upon the parties and their successors and permitted assigns. This Agreement, or any rights or obligations hereunder, may not be assigned by the Company
without the prior written consent of the Purchaser. The Purchaser may assign its rights hereunder in whole or in part to any Person to whom the Purchaser assigns or transfers any Securities in compliance with the Transaction Documents and applicable
law, provided such transferee shall agree in writing to be bound, with respect to the transferred Securities, by the terms and conditions of this Agreement that apply to the &#147;Purchaser&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.8 <U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors and
permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except (i)&nbsp;the Placement Agent is an intended third party beneficiary of <U>Article III</U> hereof and (ii)&nbsp;each Purchaser
Indemnified Party is an intended third party beneficiary of Section&nbsp;4.8. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.9 <U>Governing Law</U>. All questions concerning the
construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.
Each party agrees that all Proceedings concerning the interpretations, enforcement and defense of the transactions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective Affiliates, employees or agents) shall be commenced exclusively in the
New York Courts. Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such New York
Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. <B>EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL
RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.10 <U>Survival</U>. Subject to applicable statute of limitations, the representations, warranties, agreements and covenants contained herein
shall survive the Closing and the delivery of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.11 <U>Execution</U>. This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, or by <FONT STYLE="white-space:nowrap">e-mail</FONT> delivery of a &#147;.pdf&#148; format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.12 <U>Severability</U>. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and
upon so agreeing, shall incorporate such substitute provision in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.13 <U>Rescission and Withdrawal Right</U>.
Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents, whenever the Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does
not timely perform its related obligations within the periods therein provided, then the Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole
or in part without prejudice to its future actions and rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.14 <U>Replacement of Securities</U>. If any certificate or instrument
evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate or
instrument, but only upon receipt of evidence reasonably satisfactory to the Company and the Transfer Agent of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate affidavit of that fact and an
agreement to indemnify and hold harmless the Company and the Transfer Agent for any losses in connection therewith or, if required by the Transfer Agent, a bond in such form and amount as is required by the Transfer Agent. The applicants for a new
certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement Securities. If a replacement certificate or instrument evidencing any Securities is requested due to
a mutilation thereof, the Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.15 <U>Remedies</U>. In addition to being entitled to exercise all rights provided herein
or granted by law, including recovery of damages, each of the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss
incurred by reason of any breach of obligations described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection with any action for a temporary restraining order)
the defense that a remedy at law would be adequate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.16 <U>Payment Set Aside</U>. To the extent that the Company makes a payment or
payments to the Purchaser pursuant to any Transaction Document or the Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently
invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full
force and effect as if such payment had not been made or such enforcement or setoff had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.17 <U>Adjustments in Share
Numbers and Prices</U>. In the event of any stock split, subdivision, dividend or distribution payable in shares of Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly
shares of Common Stock), combination or other similar recapitalization or event occurring after the date hereof and prior to the Closing, each reference in any Transaction Document to a number of shares or a price per share shall be deemed to be
amended to appropriately account for such event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.18 <U>Legal Advice</U>. The Purchaser has been represented by its own separate legal
counsel in its review and negotiation of the Transaction Documents. The Purchaser acknowledges that Troutman Pepper, counsel to the Placement Agent, has rendered legal advice to the Placement Agent and not to the Purchaser in connection with the
transactions contemplated hereby, and that the Purchaser has relied for such matters on the advice of its own counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.19
<U>Termination</U>. This Agreement may be terminated and the sale and purchase of the Shares and the Warrant abandoned at any time prior to the Closing by either the Company or the Purchaser upon written notice to the other, if the Closing has not
been consummated on or prior to 5:00 P.M., New York City time, on the Outside Date; <I>provided, however</I>, that the right to terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;6.19</U> shall not be available to any Person whose
failure to comply with its obligations under this Agreement has been the cause of or resulted in the failure of the Closing to occur on or before such time. This Agreement may also be terminated by the Purchaser in the event that the Company or any
of its Subsidiaries becomes subject to a regulatory enforcement action that has or would reasonably be expected to have a Material Adverse Effect. Nothing in this <U>Section</U><U></U><U>&nbsp;6.19</U> shall be deemed to release any party from any
liability for any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents or to impair the right of any party to compel specific performance by any other party of its obligations under this Agreement or
the other Transaction Documents. Upon a termination in accordance with this <U>Section</U><U></U><U>&nbsp;6.19</U>, the Company and the Purchaser shall not have any further obligation or liability (including arising from such termination) to the
other. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be
duly executed by their respective authorized signatories as of the date first indicated above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">BLUE RIDGE BANKSHARES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. William Beale</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: G. William Beale</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NAME OF PURCHASER:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Richard T.
Spurzem</P></TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Aggregate Purchase Price (Subscription Amount): <U>$11,598,488.20</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Common Shares to be Acquired (at Common Stock Purchase Price ($2.39)):</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>290,000</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Number of Series B Preferred Shares to be Acquired (at Preferred Stock Purchase Price ($9,566.13)):<BR><U>1,140</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Series C Preferred Shares to be Acquired (at Preferred Stock Purchase Price ($9,566.13)):<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>0</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Underlying Preferred Shares Subject to Warrant:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>607</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tax ID No.: ____________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address for Notice:</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Telephone No.: ____________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Facsimile No.: ____________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">E-mail</FONT> Address: ____________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention: _______________________</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Delivery Instructions:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(if different than above)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">c/o _______________________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Street: _______________________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">City/State/Zip: ______________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention: __________________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone No.: ____________________________</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBITS</U>: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Form of Warrant (Series B) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Form of Registration Rights Agreement </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="white-space:nowrap">C-1:</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Accredited Investor Questionnaire </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="white-space:nowrap">C-2:</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Stock Certificate Questionnaire </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">D:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Form of Opinion of Company Counsel </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">E:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Form of Irrevocable Transfer Agent Instructions </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">F:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Form of Secretary&#146;s Certificate </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">G:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Form of Officer&#146;s Certificate </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULES</U>: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.1(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#8201;Subsidiaries </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.1(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#8201;Filings, Consents and Approvals </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.1(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#8201;Issuance of Securities </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.1(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#8201;Capitalization </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.1(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#8201;Compliance </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.1(y)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#8201;Registration Rights </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT A </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF WARRANT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEITHER THESE SECURITIES NOR THE
SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED OR ASSIGNED (I)&nbsp;IN THE ABSENCE OF (A)&nbsp;AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B)&nbsp;AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II)&nbsp;UNLESS SOLD PURSUANT TO RULE 144 UNDER
THE SECURITIES ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BLUE RIDGE BANKSHARES, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT TO PURCHASE SERIES B PREFERRED STOCK </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"><B>Warrant No. [&#149;]</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Original Issue Date: June [-], 2024</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Blue Ridge Bankshares, Inc., a Virginia corporation (the &#147;<I>Company</I>&#148;), hereby certifies that,
for value received, Richard T. Spurzem or his permitted registered assigns (the &#147;<I>Holder</I>&#148;), is entitled to purchase from the Company up to a total of 607 shares of Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series
B, par value $50.00 per share (the &#147;<I>Series B Preferred Stock</I>&#148;), of the Company (each such share, a &#147;<I>Warrant Share</I>&#148; and all such shares, the &#147;<I>Warrant Shares</I>&#148;) at an exercise price equal to $10,000.00
per share (as adjusted from time to time as provided in <U>Section</U><U></U><U>&nbsp;9</U> herein, the &#147;<I>Exercise Price</I>&#148;), at any time and from time to time on or after the date hereof (the &#147;<I>Original Issue Date</I>&#148;)
and through and including 5:30 P.M., New York City time, on June [-], 2029 (the &#147;<I>Expiration Date</I>&#148;), and subject to the following terms and conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Warrant (this &#147;<I>Warrant</I>&#148;) is issued pursuant to that certain Securities Purchase Agreement, dated June&nbsp;7, 2024 by and
between the Company and the Holder (the &#147;<I>Purchase Agreement</I>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. In addition to the terms defined
elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Registration of Warrants</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &#147;<I>Warrant Register</I>&#148;), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any registered assignee to which this Warrant is permissibly assigned hereunder) from time to time. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Registration of Transfers</U>. Subject to the restrictions on transfer set forth in
<U>Section</U><U></U><U>&nbsp;4.1</U> of the Purchase Agreement and compliance with all applicable securities laws, the Company shall register the transfer of all or any portion of this Warrant in the Warrant Register, upon surrender of this
Warrant, with the Form of Assignment attached as <U>Schedule 2</U> hereto duly completed and signed, to the Company&#146;s transfer agent or to the Company at its address specified in the Purchase Agreement and (x)&nbsp;delivery, at the request of
the Company, of an opinion of counsel reasonably satisfactory to the Company to the effect that the transfer of such portion of this Warrant may be made pursuant to an available exemption from the registration requirements of the Securities Act and
all applicable state securities or blue sky laws and (y)&nbsp;delivery by the transferee of a written statement to the Company certifying that the transferee is an &#147;accredited investor&#148; as defined in Rule 501(a) under the Securities Act
and making the representations and certifications set forth in Sections 3.2(b)&#150;(g) of the Purchase Agreement, to the Company at its address specified in the Purchase Agreement. Upon any such registration or transfer, a new warrant to purchase
Series B Preferred Stock in substantially the form of this Warrant (any such new warrant, a &#147;<I>New Warrant</I>&#148;) evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing the
remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and
obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company shall prepare, issue and deliver at its own expense any New Warrant under this <U>Section 3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Exercise and Duration of Warrants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All or any part of this Warrant shall be exercisable by the registered Holder in any manner permitted by
<U>Section</U><U></U><U>&nbsp;10</U> of this Warrant at any time and from time to time on or after the Original Issue Date and through and including 5:30 P.M. New York City time, on the Expiration Date. At 5:30 P.M., New York City time, on the
Expiration Date, the portion of this Warrant not exercised prior thereto shall be and become void and of no value and this Warrant shall be terminated and no longer outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Holder may exercise this Warrant by delivering to the Company (i)&nbsp;an exercise notice, in the form attached as <U>Schedule 1</U>
hereto (the &#147;<I>Exercise Notice</I>&#148;), completed and duly signed, and (ii)&nbsp;payment of the Exercise Price for the number of Warrant Shares as to which this Warrant is being exercised (which may take the form of a &#147;cashless
exercise&#148; if so indicated in the Exercise Notice and if a &#147;cashless exercise&#148; may occur at such time pursuant to <U>Section</U><U></U><U>&nbsp;10</U> below), and the date on which the last of such items is delivered to the Company (as
determined in accordance with the notice provisions hereof) is an &#147;<I>Exercise Date</I>.&#148; The delivery by (or on behalf of) the Holder of the Exercise Notice and the applicable Exercise Price as provided above shall constitute the
Holder&#146;s certification to the Company that its representations contained in Sections 3.2(b)&#150;(g) of the Purchase Agreement are true and correct as of the Exercise Date as if remade in their entirety (or, in the case of any transferee Holder
that is not a party to the Purchase Agreement, such transferee Holder&#146;s certification to the Company that such representations are true and correct as to such assignee Holder as of the Exercise Date). The Holder shall not be required to deliver
the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the
remaining number of Warrant Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Delivery of Warrant Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Upon exercise of this Warrant, the Company shall promptly (but in no event later than three (3)&nbsp;Trading Days after the Exercise Date)
issue or cause to be issued and cause to be delivered to or upon the written order of the Holder and in such name or names as the Holder may designate (provided that, if the Registration Statement is not effective and the Holder directs the Company
to deliver a certificate for the Warrant Shares in a name other than that of the Holder or an Affiliate of the Holder, it shall deliver to the Company on the Exercise Date an opinion of counsel reasonably satisfactory to the Company to the effect
that the issuance of such Warrant Shares in such other name may be made pursuant to an available exemption from the registration requirements of the Securities Act and all applicable state securities or blue sky laws), (i) a certificate for the
Warrant Shares issuable upon such exercise, free of restrictive legends, or (ii)&nbsp;an electronic delivery of the Warrant Shares to the Holder&#146;s account at the Depository Trust Company (&#147;<I>DTC</I>&#148;) or a similar organization,
unless in the case of clause (i)&nbsp;and (ii) a registration statement covering the resale of the Warrant Shares and naming the Holder as a selling stockholder thereunder is not then effective or the Warrant Shares are not freely transferable
without volume and manner of sale restrictions pursuant to Rule 144 under the Securities Act, in which case such Holder shall receive a certificate for the Warrant Shares issuable upon such exercise with appropriate restrictive legends. The Holder,
or any Person permissibly so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date. If the Warrant Shares are to be issued free of all restrictive
legends, the Company shall, upon the written request of the Holder, use its reasonable best efforts to deliver, or cause to be delivered, Warrant Shares hereunder electronically through DTC or another established clearing corporation performing
similar functions, if available; provided, that, the Company may, but will not be required to, change its transfer agent if its current transfer agent cannot deliver Warrant Shares electronically through such a clearing corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) To the extent permitted by law, the Company&#146;s obligations to issue and deliver Warrant Shares in accordance with and subject to the
terms hereof (including the limitations set forth in <U>Section</U><U></U><U>&nbsp;11</U> below) are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any
provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any
obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise limit such obligation of the Company to the Holder in connection with the
issuance of Warrant Shares. Nothing herein shall limit the Holder&#146;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with
respect to the Company&#146;s failure to timely deliver certificates representing shares of Series B Preferred Stock upon exercise of the Warrant as required pursuant to the terms hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Charges, Taxes and Expenses</U>. Issuance and delivery of certificates for shares of Series B Preferred Stock upon exercise of this
Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company;
<I>provided, however</I>, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any certificates for Warrant Shares or the Warrants in a name other than that of the
Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Replacement of Warrant</U>. If this Warrant is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction (in such case) and, in each case, a customary and reasonable indemnity and surety bond, if requested by the Company. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable
regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company
as a condition precedent to the Company&#146;s obligation to issue the New Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Reservation of Warrant Shares</U>. The Company
covenants that it will at all times reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved Series B Preferred Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this
Warrant as herein provided, the number of Warrant Shares that are initially issuable and deliverable upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder
(taking into account the adjustments and restrictions of <U>Section</U><U></U><U>&nbsp;9</U>). The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in
accordance with the terms hereof, be duly and validly authorized, issued and fully paid and nonassessable. The Company will take all such action as may be reasonably necessary to assure that such shares of Series B Preferred Stock may be issued as
provided herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation system upon which the Series B Preferred Stock may be listed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Certain Adjustments</U>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to
adjustment from time to time as set forth in this <U>Section</U><U></U><U>&nbsp;9</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Stock Dividends and Splits</U>. If the
Company, at any time while this Warrant is outstanding, (i)&nbsp;pays a stock dividend on its Series B Preferred Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Series B Preferred Stock,
(ii)&nbsp;subdivides its outstanding shares of Series B Preferred Stock into a larger number of shares, (iii)&nbsp;combines its outstanding shares of Series B Preferred Stock into a smaller number of shares or (iv)&nbsp;issues by reclassification of
shares of Series B Preferred Stock any shares of capital of the Company, then in each such case the Exercise Price shall be multiplied by a fraction, the numerator of which shall be the number of shares of Series B Preferred Stock outstanding
immediately before such event and the denominator of which shall be the number of shares of Series B Preferred Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i)&nbsp;of this paragraph shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii)&nbsp;or (iii) of this paragraph shall become effective immediately after the
effective date of such subdivision or combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Pro Rata Distributions</U>. If the Company, at any time while this Warrant is
outstanding, distributes to all holders of Series B Preferred Stock for no consideration (i)&nbsp;evidences of its indebtedness, (ii)&nbsp;any security (other than a distribution of Series B Preferred Stock covered by the preceding paragraph) or
(iii)&nbsp;rights or warrants to subscribe for or purchase any security, or (iv)&nbsp;any other asset (in each case, &#147;<I>Distributed Property</I>&#148;), then, upon any exercise of this Warrant that occurs after the record date fixed for
determination of stockholders entitled to receive such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
distribution, the Holder shall be entitled to receive, in addition to the Warrant Shares otherwise issuable upon such exercise (if applicable), the Distributed Property that such Holder would
have been entitled to receive in respect of such number of Warrant Shares had the Holder been the record holder of such Warrant Shares immediately prior to such record date without regard to any limitation on exercise contained therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Fundamental Transactions</U>. If, at any time while this Warrant is outstanding (i)&nbsp;the Company effects any merger or
consolidation of the Company with or into another Person, in which the Company is not the survivor or the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly, at least 50% of the voting
securities of the surviving entity, (ii)&nbsp;the Company effects any sale of all or substantially all of its assets or a majority of its Series B Preferred Stock is acquired by a third party, in each case, in one or a series of related
transactions, (iii)&nbsp;any tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which all or substantially all of the holders of Series B Preferred Stock are permitted to tender or exchange their
shares for other securities, cash or property, or (iv)&nbsp;the Company effects any reclassification of the Series B Preferred Stock or any compulsory share exchange pursuant to which the Series B Preferred Stock is effectively converted into or
exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Series B Preferred Stock covered by <U>Section</U><U></U><U>&nbsp;9(a)</U> above or a conversion of the Series B Preferred Stock
covered by <U>Section</U><U></U><U>&nbsp;9(f)</U>) (in any such case, a &#147;<I>Fundamental Transaction</I>&#148;), then the Holder shall have the right thereafter to receive, upon exercise of this Warrant, the same amount and kind of securities,
cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise
in full of this Warrant without regard to any limitations on exercise contained herein (the &#147;<I>Alternate Consideration</I>&#148;). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to
apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Series B Preferred Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Series B Preferred Stock are given any choice as to the securities, cash or property to be received in a
Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall not effect any such Fundamental
Transaction unless prior to or simultaneously with the consummation thereof, any successor to the Company, surviving entity or the corporation purchasing or otherwise acquiring such assets or other appropriate corporation or Person shall assume the
obligation to deliver to the Holder, such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant. The provisions of this paragraph (c)&nbsp;shall
similarly apply to subsequent transactions analogous of a Fundamental Transaction type. Notwithstanding the foregoing, in the event of a Fundamental Transaction that, is (1)&nbsp;a transaction where the consideration paid to the holders of the
Series B Preferred Stock consists of cash, (2)&nbsp;a &#147;Rule <FONT STYLE="white-space:nowrap">13e-3</FONT> transaction&#148; as defined in Rule <FONT STYLE="white-space:nowrap">13e-3</FONT> under the Exchange Act, or (3)&nbsp;a Fundamental
Transaction involving a person or entity not traded on the New York Stock Exchange, the NYSE American exchange, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market, at the request of the Holder delivered before the
ninetieth (90<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after such Fundamental Transaction, the Company (or the successor entity to the Company) shall purchase this Warrant from the Holder by paying to the Holder, within five
(5)&nbsp;Trading Days after such request (or, if later, on the effective date of the Fundamental Transaction), cash in an amount equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of such Fundamental
Transaction. For purposes hereof, &#147;<I>Black Scholes Value</I>&#148; means the value of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Warrant based on the Black Scholes Option Pricing Model obtained from the &#147;OV&#148; function on Bloomberg determined as of the day immediately following the public announcement of the
applicable Fundamental Transaction and reflecting (i)&nbsp;a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of this Warrant as of such date of request and (ii)&nbsp;an expected volatility
equal to the greater of (A)&nbsp;sixty percent (60%) and (B)&nbsp;the one hundred (100)&nbsp;day volatility obtained from the HVT function on Bloomberg determined as of the Trading Day immediately prior to the announcement of the Fundamental
Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <U>Number of Warrant Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to paragraph (a)&nbsp;and (e) of this
<U>Section</U><U></U><U>&nbsp;9</U>, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for
the increased or decreased number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Subsequent Equity Sales</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except as provided in paragraph (e)(iii) of this <U>Section</U><U></U><U>&nbsp;9</U>, if and whenever the Company shall issue or sell, or
is, in accordance with any of paragraphs (e)(ii)(1) through (e)(ii)(7) of this <U>Section</U><U></U><U>&nbsp;9</U>, deemed to have issued or sold, any shares of Common Stock for no consideration or for a consideration per share less than the
Exercise Price per Warrant Share on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to Common Stock basis in effect immediately prior to the time of such issue or sale, then and in each such case (a &#147;<I>Trigger Issuance</I>&#148;) the
then-existing Exercise Price shall be reduced as of the close of business on the effective date of the Trigger Issuance, to a price determined as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">Adjusted Exercise Price</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">= <U>(A x B) + D</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">A+C</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">where </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;A&#148; equals the Common Stock Deemed Outstanding immediately preceding such Trigger Issuance; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;B&#148; equals the Exercise Price in effect immediately preceding such Trigger Issuance; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;C&#148; equals the aggregate number of shares of Common Stock issued or deemed issued hereunder in such Trigger Issuance; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;D&#148; equals the aggregate consideration, if any, received or deemed to be received by the Company upon such Trigger Issuance; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided, however</I>, that in no event shall the Exercise Price after giving effect to such Trigger Issuance be greater than the Exercise Price
immediately prior to such Trigger Issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this paragraph (e), &#147;<I>Common Stock Deemed Outstanding</I>&#148; shall mean, at any
given time, the sum of (I)&nbsp;the number of shares of Common Stock actually outstanding at such time, plus (II)&nbsp;the number of shares of Common Stock issuable upon exercise of Options (as defined in paragraph (e)(ii)(1) of this
<U>Section</U><U></U><U>&nbsp;9</U>) actually outstanding at such time, plus (III)&nbsp;the number of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares of Common Stock issuable upon conversion or exchange of Convertible Securities (as defined in paragraph (e)(ii)(1) of this <U>Section</U><U></U><U>&nbsp;9</U>) actually outstanding at such
time (treating as actually outstanding any Convertible Securities issuable upon exercise of Options actually outstanding at such time), in each case, regardless of whether the Options or Convertible Securities are actually exercisable at such time;
provided, that Common Stock Deemed Outstanding at any given time shall not include shares owned or held by or for the account of the Company or any of its wholly-owned subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) For purposes of this paragraph (e), the following paragraphs (e)(ii)(1) to (e)(ii)(7) shall also be applicable: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) <U>Issuance of Rights or Options</U>. In case at any time the Company shall in any manner grant (directly and not by assumption in a
merger or otherwise) any warrants or other rights to subscribe for or to purchase, or any options for the purchase of, Common Stock or any stock or security directly or indirectly convertible into or exchangeable for Common Stock (such warrants,
rights or options being called &#147;<I>Options</I>&#148; and such convertible or exchangeable stock or securities being called &#147;<I>Convertible Securities</I>&#148;), whether or not such Options or the right to convert or exchange any such
Convertible Securities are immediately exercisable, and the price per share for which Common Stock is issuable upon the exercise of such Options or upon the conversion or exchange of such Convertible Securities (determined by dividing (i)&nbsp;the
sum (which sum shall constitute the applicable consideration) of (x)&nbsp;the total amount, if any, received or receivable by the Company as consideration for the granting of such Options, plus (y)&nbsp;the aggregate amount of additional
consideration payable to the Company upon the exercise of all such Options, plus (z), in the case of such Options that relate to Convertible Securities, the aggregate amount of additional consideration, if any, payable upon the issue or sale of such
Convertible Securities and upon the conversion or exchange thereof, by (ii)&nbsp;the total maximum number of shares of Common Stock issuable upon the exercise of such Options or upon the conversion or exchange of all such Convertible Securities
issuable upon the exercise of such Options) shall be less than the Exercise Price per Warrant Share on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to Common Stock basis in effect immediately prior to the time of the granting of such
Options, then the total number of shares of Common Stock issuable upon the exercise of such Options or upon conversion or exchange of the total amount of such Convertible Securities issuable upon the exercise of such Options shall be deemed to have
been issued for such price per share as of the date of granting of such Options or the issuance of such Convertible Securities and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price. Except as otherwise
provided in paragraph (e)(ii)(3), no adjustment of the Exercise Price shall be made upon the actual issue of such Common Stock or of such Convertible Securities upon exercise of such Options or upon the actual issue of such Common Stock upon
conversion or exchange of such Convertible Securities. For the avoidance of doubt, the term &#147;Convertible Securities&#148; shall not include the Series B Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) <U>Issuance of Convertible Securities</U>. In case the Company shall in any manner issue (directly and not by assumption in a merger or
otherwise) or sell any Convertible Securities, whether or not the rights to exchange or convert any such Convertible Securities are immediately exercisable, and the price per share for which Common Stock is issuable upon such conversion or exchange
(determined by dividing (i)&nbsp;the sum (which sum shall constitute the applicable consideration) of (x)&nbsp;the total amount received or receivable by the Company as consideration for the issue or sale of such Convertible Securities, plus
(y)&nbsp;the aggregate amount of additional consideration, if any, payable to the Company upon the conversion or exchange thereof, by (ii)&nbsp;the total maximum number of shares of Common Stock issuable upon the conversion or exchange of all such
Convertible Securities) shall be less than the Exercise Price per Warrant Share </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to Common Stock basis in effect immediately prior to the time of such issue or sale, then the total maximum number of shares of Common
Stock issuable upon conversion or exchange of all such Convertible Securities shall be deemed to have been issued for such price per share as of the date of the issue or sale of such Convertible Securities and thereafter shall be deemed to be
outstanding for purposes of adjusting the Exercise Price, provided that (a)&nbsp;except as otherwise provided in paragraph (e)(ii)(3), no adjustment of the Exercise Price shall be made upon the actual issuance of such Common Stock upon conversion or
exchange of such Convertible Securities and (b)&nbsp;no further adjustment of the Exercise Price shall be made by reason of the issue or sale of Convertible Securities upon exercise of any Options to purchase any such Convertible Securities for
which adjustments of the Exercise Price have been made pursuant to the other provisions of paragraph (e). No adjustment pursuant to this Section&nbsp;9 shall be made if such adjustment would result in an increase of the Exercise Price then in
effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) <U>Change in Option Price or Conversion Rate</U>. Upon the happening of any of the following events, namely, if the purchase
price provided for in any Option referred to in paragraph (e)(ii)(1) of this <U>Section</U><U></U><U>&nbsp;9</U>, the additional consideration, if any, payable upon the conversion or exchange of any Convertible Securities referred to in paragraphs
(e)(ii)(1) or (e)(ii)(2), or the rate at which Convertible Securities referred to in paragraphs (e)(ii)(1) or (e)(ii)(2) are convertible into or exchangeable for Common Stock shall change at any time (including, but not limited to, changes under or
by reason of provisions designed to protect against dilution), the Exercise Price in effect at the time of such event shall forthwith be readjusted to the Exercise Price that would have been in effect at such time had such Options or Convertible
Securities still outstanding provided for such changed purchase price, additional consideration or conversion rate, as the case may be, at the time initially granted, issued or sold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(4) <U>Stock Dividends</U>. Subject to the provisions of this paragraph (e), in case the Company shall declare a dividend or make any other
distribution upon any stock of the Company (other than the Common Stock) payable in Common Stock, Options or Convertible Securities, then any Common Stock, Options or Convertible Securities, as the case may be, issuable in payment of such dividend
or distribution shall be deemed to have been issued or sold without consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(5) <U>Consideration for Stock</U>. In case any
shares of Common Stock, Options or Convertible Securities shall be issued or sold for cash, the consideration received therefor shall be deemed to be the gross amount received by the Company therefor. In case any shares of Common Stock, Options or
Convertible Securities shall be issued or sold for a consideration other than cash, the amount of the consideration other than cash received by the Company shall be deemed to be the fair value of such consideration as determined in good faith by the
Board of Directors of the Company. In case any Options shall be issued in connection with the issue and sale of other securities of the Company, together comprising one integral transaction in which no specific consideration is allocated to such
Options by the parties thereto, such Options shall be deemed to have been issued for such consideration as determined in good faith by the Board of Directors of the Company. If Common Stock, Options or Convertible Securities shall be issued or sold
by the Company and, in connection therewith, other Options or Convertible Securities (the &#147;<I>Additional Rights</I>&#148;) are issued, then the consideration received or deemed to be received by the Company shall be reduced by the fair market
value of the Additional Rights (as determined using the Black Scholes Option Pricing Model or another method mutually agreed to by the Company and the Holder). The Board of Directors of the Company shall respond promptly, in writing, to an inquiry
by the Holder as to the fair market value of the Additional Rights. In the event that the Board of Directors of the Company and the Holder are unable to agree upon the fair market value of the Additional Rights, the Company and the Holder shall
jointly select an appraiser who is experienced in such matters. The decision of such appraiser shall be final and conclusive, and the cost of such appraiser shall be borne evenly by the Company and the Holder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(6) <U>Record Date</U>. In case the Company shall take a record of the holders of its
Common Stock for the purpose of entitling them (i)&nbsp;to receive a dividend or other distribution payable in Common Stock, Options or Convertible Securities or (ii)&nbsp;to subscribe for or purchase Common Stock, Options or Convertible Securities,
then such record date shall be deemed to be the date of the issue or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of
such right of subscription or purchase, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Notwithstanding the foregoing, no adjustment will be made under this
paragraph&nbsp;(e) in respect of: (i)&nbsp;the issuance of securities upon the exercise or conversion of any Common Stock or Common Stock Equivalents issued by the Company prior to the date hereof, (ii)&nbsp;the grant of options, warrants, Common
Stock or other Common Stock Equivalents (but not including any amendments to such instruments) under any duly authorized Company stock option plan, restricted stock plan or other equity compensation plan, dividend reinvestment plan, or stock
purchase plan, whether now existing or hereafter approved by the Company and its stockholders in the future, and the issuance of Common Stock in respect thereof, (iii)&nbsp;the issuance of securities in connection with a Strategic Transaction,
(iv)&nbsp;the issuance of securities in a transaction described in paragraph (a)&nbsp;or (b) of this <U>Section</U><U></U><U>&nbsp;9</U>, (v) shares of Common Stock in an offering for cash for the account of the Company that is underwritten on a
firm commitment basis and is registered with the Securities and Exchange Commission under the Securities Act, or (vi)&nbsp;the issuance or sale (or deemed issuance or sale) of the Warrants, and the issuance of Common Stock in respect thereof
(collectively, &#147;<I>Excluded Issuances</I>&#148;). For purposes of this paragraph, a &#147;<I>Strategic Transaction</I>&#148; means a transaction or relationship in which (1)&nbsp;the Company issues shares of Common Stock to a Person that the
Board of Directors of the Company determined in good faith is, itself or through its Subsidiaries, an operating company in a business synergistic with the business of the Company (or a shareholder thereof) and (2)&nbsp;the Company expects to receive
benefits in addition to the investment of funds, but shall not include (x)&nbsp;a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to a Person whose primary business is investing in securities or
(y)&nbsp;issuances to lenders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv)<U>Trading Market Limitation</U>. Upon any adjustment to the Exercise Price pursuant to paragraph
(e)(i) above, the number of Warrant Shares purchasable hereunder shall be adjusted by multiplying such number by a fraction, the numerator of which shall be the Exercise Price in effect immediately prior to such adjustment and the denominator of
which shall be the Exercise Price in effect immediately thereafter. This provision shall not restrict the number of shares of Series B Preferred Stock that a Holder may receive or beneficially own in order to determine the amount of securities or
other consideration that such Holder may receive in the event of a transaction contemplated by <U>Section</U><U></U><U>&nbsp;9</U> of this Warrant. Notwithstanding any other provisions in this <U>Section</U><U></U><U>&nbsp;9</U> to the contrary, if
a reduction in the Exercise Price pursuant to paragraph (e)(i) of this <U>Section</U><U></U><U>&nbsp;9</U> would require the Company to obtain stockholder approval of the transactions contemplated by the Purchase Agreement pursuant to the applicable
rules of the Company&#146;s Principal Trading Market and such stockholder approval has not been obtained, (i)&nbsp;the Exercise Price shall be reduced to the maximum extent that would not require stockholder approval under such Rule, and
(ii)&nbsp;the Company shall use its commercially reasonable efforts to obtain such stockholder approval as soon as reasonably practicable, including by calling a special meeting of stockholders to vote on such Exercise Price adjustment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Conversion of Series B Preferred Stock</U>. In the event that all (but not less than
all) outstanding shares of Series B Preferred Stock (other than with respect to any Holder that are prohibited from conversion as a result of the Ownership Limit (as defined below)) are converted, automatically or by action of the holders thereof,
into Common Stock pursuant to the provisions of the Company&#146;s Articles of Incorporation as then in effect, then from and after the date on which such outstanding shares of Series B Preferred Stock have been so converted, this Warrant shall be
exercisable, subject to Section&nbsp;11, for such number of shares of Common Stock into which the Warrant Shares would have been converted had the Warrant Shares been outstanding on the date of such conversion as provided in the Company&#146;s
Articles of Amendment as then in effect, and the Exercise Price shall equal the Exercise Price in effect as of immediately prior to such conversion divided by the number of shares of Common Stock into which one Warrant Share would have been
converted on such date, all subject to further adjustment thereafter from time to time in accordance with the provisions of this Warrant. Within a reasonable period thereafter, the Company shall furnish to the Holder a like Warrant reflecting the
foregoing and corresponding adjustments in substitution for this Warrant, but only upon receipt of this original Warrant or, if this Warrant is mutilated, lost, stolen, or destroyed, a customary and reasonable indemnity and surety bond, if requested
by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Calculations</U>. All calculations under this <U>Section</U><U></U><U>&nbsp;9</U> shall be made to the nearest
cent or the nearest share, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Notice of Adjustments</U>. Upon the occurrence of each adjustment pursuant to this
<U>Section</U><U></U><U>&nbsp;9</U>, the Company at its expense will, at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such
adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments
and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company&#146;s transfer agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Notice of Corporate Events</U>. If, while this Warrant is outstanding, the Company (i)&nbsp;declares a dividend or any other
distribution of cash, securities or other property in respect of its Series B Preferred Stock, including, without limitation, any granting of rights or warrants to subscribe for or purchase any capital stock of the Company or any subsidiary,
(ii)&nbsp;authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction or (iii)&nbsp;authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company,
then, except if such notice and the contents thereof shall be deemed to constitute material <FONT STYLE="white-space:nowrap">non-public</FONT> information, the Company shall deliver to the Holder a notice of such transaction at least ten
(10)&nbsp;Trading Days prior to the applicable record or effective date on which a Person would need to hold Series B Preferred Stock in order to participate in or vote with respect to such transaction; <I>provided, </I>that no notice shall be
required if information is disseminated in a press release or document furnished or filed with the Commission; <I>and provided, further</I>, that the failure to deliver such notice or any defect therein shall not affect the validity of the corporate
action required to be described in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or any of its subsidiaries, the
Company shall simultaneously file such notice with the Commission (as defined in the Purchase Agreement) pursuant to a Current Report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Payment of Exercise Price</U>. The Holder shall pay the Exercise Price in immediately
available funds; <I>provided, however</I>, that if, on any Exercise Date there is not an effective Registration Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then the Holder may, in
its sole discretion, satisfy its obligation to pay the Exercise Price through a &#147;cashless exercise&#148;, in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">X = Y <FONT STYLE="white-space:nowrap">[(A-B)/A]</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;X&#148; equals
the number of Warrant Shares to be issued to the Holder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;Y&#148; equals the total number of Warrant Shares with respect to which
this Warrant is being exercised; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;A&#148; equals the average of the Closing Sale Prices of the shares of Series B Preferred Stock
(as determined below) for the five (5)&nbsp;consecutive Trading Days ending on the date immediately preceding the Exercise Date; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;B&#148; equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Warrant, &#147;<I>Closing Sale Price</I>&#148; means, for any security as of any date, the last trade price for such
security on the Principal Trading Market for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended hours basis and does not designate the last trade price, then the last
trade price of such security prior to 4:00 P.M., New York City time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets, or, if no last trade price is reported for such security by Bloomberg Financial Markets,
the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the &#147;pink sheets&#148; by Pink Sheets LLC. If the Closing Sale Price cannot be calculated for a security on a particular date
on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of
such security, then the Board of Directors of the Company shall use its good faith judgment to determine the fair market value. The Board of Directors&#146; determination shall be binding upon all parties absent demonstrable error. All such
determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a
&#147;cashless exercise&#148; transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Purchase
Agreement (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.
<U>Limitations on Exercise</U>. Notwithstanding anything to the contrary contained herein, the number of Warrant Shares (or shares of Common Stock into which this Warrant becomes exercisable pursuant to Section&nbsp;9(f)) that may be acquired by the
Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to ensure that the issuance of such Warrant Shares (or shares of Common Stock into which this Warrant becomes exercisable pursuant to
Section&nbsp;9(f)) upon exercise (or other issuance), would not (i)&nbsp;cause </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or result in such Holder and its Affiliates, collectively, being deemed to own, control or have the power to vote or dispose of securities which would represent more than 9.99% of the voting
securities of any class or series of the Company&#146;s capital stock outstanding at such time (excluding for the purpose of this calculation any reduction in ownership resulting from sales, transfers or other dispositions by such Holder of voting
securities of the Corporation), (ii) otherwise cause such Holder or any of its Affiliates to be required to file a notice or application for approval under the BHC Act, the CIBC Act or any similar state or federal statute or (iii)&nbsp;require such
Holder or any of its Affiliates to obtain the prior approval of any bank regulator (collectively, the &#147;<I>Ownership Limit</I>&#148;); provided, further, that any Warrant Shares that would otherwise be issued to the Holder upon exercise of this
Warrant, but cannot be issued to such Holder at the time of exercise as a result of the Ownership Limit, shall thereafter be issued to such Holder on the first date on which such issuance would not cause or result in a violation of the Ownership
Limit, and, provided further, that such restriction on exercise as provided in this <U>Section</U><U></U><U>&nbsp;11</U> shall not apply to (x)&nbsp;a Holder that has obtained all consents, permits, approvals, registrations and waivers of any
governmental authority which are necessary or advisable for such Holder to exceed the Ownership Limit or (y)&nbsp;any bank holding company controlling the Company as of the date hereof. This provision shall not restrict the number of shares of
Series B Preferred Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in
<U>Section</U><U></U><U>&nbsp;9</U> of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>No Fractional Shares</U>. No fractional Warrant Shares will be issued in
connection with any exercise of this Warrant. In lieu of any fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole number and the Company shall pay the Holder in cash
the fair market value (based on the Closing Sale Price) for any such fractional shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Notices</U>. Any and all notices or other
communications or deliveries required or permitted to be provided hereunder (including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest of (i)&nbsp;the date of transmission, if
such notice or communication is delivered via facsimile or <FONT STYLE="white-space:nowrap">e-mail</FONT> (provided the sender receives a machine-generated confirmation of successful facsimile transmission or
<FONT STYLE="white-space:nowrap">e-mail</FONT> notification or confirmation of receipt of an <FONT STYLE="white-space:nowrap">e-mail</FONT> transmission) at the facsimile number or <FONT STYLE="white-space:nowrap">e-mail</FONT> address specified in
the Purchase Agreement prior to 5:00 P.M., New York City time, on a Trading Day, (ii)&nbsp;the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or
<FONT STYLE="white-space:nowrap">e-mail</FONT> at the facsimile number or <FONT STYLE="white-space:nowrap">e-mail</FONT> address specified in the Purchase Agreement on a day that is not a Trading Day or later than 5:00 P.M., New York City time, on
any Trading Day, (iii)&nbsp;the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service specifying next business day delivery, or (iv)&nbsp;upon actual receipt by the Person to whom such notice is
required to be given, if by hand delivery. The address, facsimile number and <FONT STYLE="white-space:nowrap">e-mail</FONT> address of a Person for such notices or communications shall be as set forth in the Purchase Agreement unless changed by such
Person by two (2)&nbsp;Trading Days&#146; prior notice to the other Persons in accordance with this <U>Section</U><U></U><U>&nbsp;13</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Warrant Agent</U>. The Company shall serve as warrant agent under this Warrant. Upon thirty (30)&nbsp;days&#146; notice to the Holder,
the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any
corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant
agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&#146;s last address as shown on the Warrant Register. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>No Rights as a Stockholder</U>. The Holder, solely in such Person&#146;s capacity as a holder of this Warrant, shall not be entitled to
vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&#146;s capacity as the Holder of this
Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance
or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In
addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are
asserted by the Company or by creditors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Authorized Shares</U>. (i)&nbsp;The Company covenants that during the
period the Warrant is outstanding, it will reserve from its authorized and unissued Series B Preferred Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon
the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Series B Preferred Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon
exercise of the purchase rights represented by this Warrant, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in
respect of any transfer occurring contemporaneously with such issue). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Except and to the extent as waived or consented to by the
Holder, the Company shall not by any action, including, without limitation, amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be
necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (a)&nbsp;not increase the par value of any Warrant Shares above the amount
payable therefor upon such exercise immediately prior to such increase in par value, (b)&nbsp;take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares
upon the exercise of this Warrant, and (c)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to
perform its obligations under this Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Before taking any action which would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be required from any public regulatory body or bodies having jurisdiction
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Successors and Assigns</U>. Subject to the restrictions on transfer set forth in this Warrant and in Section&nbsp;4.1 of
the Purchase Agreement, and compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may not be assigned by the Company without the written consent of the Holder except to a successor in the event of a
Fundamental Transaction. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to
any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Amendment and Waiver</U>. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company may take
any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Acceptance</U>. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions
contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Governing Law; Jurisdiction</U>. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND
INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY
SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR
DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE
JURISDICTION OF ANY SUCH COURT. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR
CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THE PURCHASE AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE
THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit
or affect any of the provisions hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Severability</U>. In case any one or more of the provisions of this Warrant shall be
invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the Company and the Holder will attempt in good faith to agree
upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its
authorized officer as of the date first indicated above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BLUE RIDGE BANKSHARES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">G. William Beale</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SCHEDULE 1 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF EXERCISE NOTICE </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[To be
executed by the Holder to purchase shares of Series B Preferred Stock under the Warrant] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) The undersigned is the Holder of Warrant No. __________ (the &#147;<I>Warrant</I>&#148;) issued by Blue Ridge Bankshares, Inc., a Virginia corporation (the
&#147;<I>Company</I>&#148;). Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth in the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2)
The undersigned hereby exercises its right to purchase __________ Warrant Shares pursuant to the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) The Holder intends that payment of the
Exercise Price shall be made as (check one): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Cash Exercise </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Cashless Exercise&#148; under <U>Section</U><U></U><U>&nbsp;10</U> of the Warrant </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) If the Holder has elected a Cash Exercise, the Holder shall pay the sum of $___________ in immediately available funds to the Company in accordance with
the terms of the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(5) Pursuant to this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in accordance with the
terms of the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(6) By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the
exercise evidenced hereby the Holder will not beneficially own in excess of the number of shares of Series B Preferred Stock (as determined in accordance with Section&nbsp;13(d) of the Securities Exchange Act of 1934) permitted to be owned under
<U>Section</U><U></U><U>&nbsp;11</U> of the Warrant to which this notice relates. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dated:____________________</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name of Holder: ___________________________</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:__________________________________</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: _______________________________</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title: _______________________________</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Signature must conform in all respects to name of Holder as specified on the face of the Warrant) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SCHEDULE 2 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF ASSIGNMENT </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[To be
completed and executed by the Holder only upon transfer of the Warrant] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
<U>&#8195;&#8195;&#8195;&#8195;&#8195;</U> <U></U><U></U><U></U><U></U>(the &#147;<I>Transferee</I>&#148;) the right represented by the within Warrant to purchase <U>&#8195;&#8195;&#8195;&#8195;&#8195;</U> <U></U><U></U><U></U><U></U>shares of
Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B of Blue Ridge Bankshares, Inc. (the &#147;<I>Company</I>&#148;) to which the within Warrant relates and appoints <U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>
<U></U><U></U><U></U><U></U>attorney to transfer said right on the books of the Company with full power of substitution in the premises. In connection therewith, the undersigned represents, warrants, covenants and agrees to and with the Company
that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the offer and sale of the Warrant contemplated hereby is being made in compliance with Section&nbsp;4(1) of the
Securities Act of 1933, as amended (the &#147;<I>Securities Act</I>&#148;) or another valid exemption from the registration requirements of Section&nbsp;5 of the Securities Act and in compliance with all applicable securities laws of the states of
the United States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the undersigned has not offered to sell the Warrant by any form of general solicitation or general advertising,
including, but not limited to, any advertisement, article, notice or other communication published in any newspaper, magazine or similar media or broadcast over television or radio, and any seminar or meeting whose attendees have been invited by any
general solicitation or general advertising; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the undersigned has read the Transferee&#146;s investment letter included herewith, and to its actual
knowledge, the statements made therein are true and correct; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the undersigned understands that the Company may condition the transfer of the Warrant contemplated hereby upon
the delivery to the Company by the undersigned or the Transferee, as the case may be, of a written opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel in comparable transactions) to the effect
that such transfer may be made without registration under the Securities Act and under applicable securities laws of the states of the United States. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(Signature must conform in all respects to name of holder as specified on the face of the Warrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Address of Transferee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">In the presence of:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT B </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">FORM OF REGISTRATION RIGHTS AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This Registration Rights Agreement (this &#147;<I>Agreement</I>&#148;) is made and entered into as of June [-], 2024, by and between Blue
Ridge Bankshares, Inc., a Virginia corporation (the &#147;<I>Company</I>&#148;), and Richard T. Spurzem (the &#147;<I>Purchaser</I>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This Agreement is made pursuant to the Securities Purchase Agreement, dated as of June&nbsp;7, 2024, between the Company and the Purchaser
(the &#147;<I>Purchase Agreement</I>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and
for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the
meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Advice</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Affiliate</I>&#148; means, with respect to any Person, any other Person which directly or indirectly controls, is controlled by, or
is under common control with, such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Agreement</I>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Business Day</I>&#148; means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general
transaction of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Closing Date</I>&#148; has the meaning set forth in the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Commission</I>&#148; means the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Common Stock</I>&#148; means the common stock of the Company, no par value, and any securities into which such common stock may
hereinafter be reclassified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Company</I>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Convertible Preferred Stock</I>&#148; means the Series B and Series C. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Cutback Shares</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Effective Date</I>&#148; means the date that the Registration Statement filed pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> is
first declared effective by the Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Effectiveness Deadline</I>&#148; means, with respect to the Initial Registration
Statement or the New Registration Statement, the sixtieth (60<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day following the Filing Deadline (or, in the event the Commission reviews and has written comments to the Initial
Registration Statement or the New Registration Statement, the ninetieth (90<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day following the Filing Deadline); <I>provided, however</I>, that if the Company is notified by the
Commission that the Initial Registration Statement or the New Registration Statement will not be reviewed or is no longer subject to further review and comments, the Effectiveness Deadline as to such Registration Statement shall be the fifth (5<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above; <I>provided, further</I>, that if the Effectiveness Deadline falls on a
Saturday, Sunday or other day that the Commission is closed for business, the Effectiveness Deadline shall be extended to the next Business Day on which the Commission is open for business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Effectiveness Period</I>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Event</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(c)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Event Date</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Exchange Act</I>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>FINRA</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Filing Deadline</I>&#148; means, with respect to the Initial Registration Statement required to be filed pursuant to
<U>Section</U><U></U><U>&nbsp;2(a)</U>, the earliest of (a)&nbsp;the thirtieth (30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day following the Stockholder Approvals (as defined in the Purchase Agreement), (b) the thirtieth (30<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) calendar day following the Partial Conversion (as defined in the articles of amendment designating the Series B), or (c)&nbsp;October&nbsp;15, 2025; <I>provided, however</I>, that if the Filing
Deadline falls on a Saturday, Sunday or other day that the Commission is closed for business, the Filing Deadline shall be extended to the next business day on which the Commission is open for business. For the avoidance of doubt, the Filing
Deadline shall only apply to the Registrable Securities then existing in the form of Common Stock, and the Filing Deadline with respect to the remaining, unconverted (or unexchanged) Underlying Preferred Shares shall be thirty (30)&nbsp;calendar
days from the time such remaining, unconverted (or unexchanged) Underlying Preferred Shares are converted (or exchanged) into shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Holder</I>&#148; or &#147;<I>Holders</I>&#148; means the holder or holders, as the case may be, from time to time of Registrable
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Indemnified Party</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Indemnifying Party</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Initial Registration Statement</I>&#148; means the initial Registration Statement filed pursuant to
<U>Section</U><U></U><U>&nbsp;2(a)</U> of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>&#147;Liquidated Damages&#148; </I>has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>&#147;Losses</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(a)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>New Registration Statement</I>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Person</I>&#148; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture,
limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Principal Market</I>&#148; means the Trading Market on which the Common Stock is primarily listed on and quoted for trading, which,
as of the Closing Date, shall be the NYSE American. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Proceeding</I>&#148; means an action, claim, suit, investigation or proceeding
(including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Prospectus</I>&#148; means the prospectus included in a Registration Statement (including, without limitation, a prospectus that
includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with
respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including <FONT STYLE="white-space:nowrap">post-effective</FONT>
amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Purchase
Agreement</I>&#148; has the meaning set forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Purchaser</I>&#148; has the meaning set forth in the Preamble.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Registrable Securities</I>&#148; means all of (i)&nbsp;the Shares, (ii)&nbsp;the Warrant Shares, (iii)&nbsp;the Underlying
Preferred Shares and (iv)&nbsp;any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing,<I> provided</I>, that the Holder has completed and delivered to
the Company a Selling Stockholder Questionnaire; and<I> provided, further</I>, that with respect to a particular Holder, such Holder&#146;s Shares, Warrant Shares and Underlying Preferred Shares shall cease to be Registrable Securities upon the
earliest to occur of the following: (A)&nbsp;a sale pursuant to a Registration Statement or Rule 144 under the Securities Act (in which case, only such security sold by the Holder shall cease to be a Registrable Security); (B) becoming eligible for
resale by the Holder under Rule 144 without the requirement for the Company to be in compliance with the current public information required thereunder and without volume or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions, pursuant to a written opinion letter to such effect by counsel to the Company, addressed, delivered and acceptable to the Transfer Agent; or
(C)&nbsp;such securities cease to be outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Registration Statements</I>&#148; means any one or more registration
statements of the Company filed under the Securities Act that covers the resale of any of the Registrable Securities pursuant to the provisions of this Agreement (including without limitation the Initial Registration Statement, the New Registration
Statement and any Remainder Registration Statements), amendments and supplements to such Registration Statements, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated by reference
in such Registration Statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Remainder Registration Statement</I>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Required Investors</I>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Rule 144</I>&#148; means Rule 144 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Rule 415</I>&#148; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Rule 424</I>&#148; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Securities Act</I>&#148; means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Selling Stockholder Questionnaire</I>&#148; means a questionnaire in the form
attached as <U>Annex B</U> hereto, or such other form of questionnaire as may reasonably be adopted by the Company from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Series B</I>&#148; means the Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, par value $50.00 per share, of
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Series C</I>&#148; means the Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series C, par value
$50.00 per share, of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Shares</I>&#148; means the shares of Common Stock issued or issuable to the Purchaser pursuant
to the Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Trading Day</I>&#148; means a day on which the Common Stock is listed or quoted and traded on its
Principal Market; <I>provided</I>, that in the event that the Common Stock is not listed or quoted on any Trading Market, then Trading Day shall mean a Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Trading Market</I>&#148; means whichever of the New York Stock Exchange, the NYSE American, the NASDAQ Global Select Market, the
NASDAQ Global Market or the NASDAQ Capital Market on which the Common Stock is listed or quoted for trading on the date in question. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Underlying Preferred Shares</I>&#148; means the shares of Common Stock issued upon conversion of the Series B. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Warrant</I>&#148; means the Warrant to Purchase Series B Preferred Stock issued pursuant to the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>Warrant Shares</I>&#148; means the shares of Common Stock issued upon exercise of the Warrant after the conversion of the Series B.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Registration</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) On or prior to each Filing Deadline, the Company shall prepare and file with the Commission a Registration Statement (or amendment to
currently effective Registration Statement) covering the resale of all of the Registrable Securities not then registered on an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415 or, if
Rule 415 is not available for offers and sales of the Registrable Securities, by such other means of distribution of Registrable Securities as the Required Investors may reasonably specify. The Initial Registration Statement shall be on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> (except if the Company is then ineligible to register for resale the Registrable Securities on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> in which case such registration shall be on such other form
available to register for resale the Registrable Securities as a secondary offering) subject to the provisions of <U>Section</U><U></U><U>&nbsp;2(e)</U> and shall contain (except if otherwise required pursuant to written comments received from the
Commission upon a review of such Registration Statement) the &#147;Plan of Distribution&#148; section substantially in the form attached hereto as <U>Annex A</U> (which may be modified to respond to comments, if any, provided by the Commission).
Notwithstanding the registration obligations set forth in this <U>Section</U><U></U><U>&nbsp;2</U>, in the event the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be
registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly (i)&nbsp;inform each of the Holders and use its commercially reasonable efforts to file amendments to the Initial Registration Statement
as required by the Commission and/or (ii)&nbsp;withdraw </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Initial Registration Statement and file a new registration statement (a &#147;<I>New Registration Statement</I>&#148;), in either case covering the maximum number of Registrable Securities
permitted to be registered by the Commission, on Form <FONT STYLE="white-space:nowrap">S-3</FONT> or such other form available to register for resale the Registrable Securities as a secondary offering; <I>provided, however</I>, that prior to filing
such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with Securities Act Rules
Compliance and Disclosure Interpretation Question 612.09. If the Commission requires a limitation of the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding
that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of
Registrable Securities to be registered on such Registration Statement will first be reduced by Registrable Securities not acquired pursuant to the Purchase Agreement (whether pursuant to registration rights or otherwise), second by Registrable
Securities represented by holders of Warrant Shares (applied, in the case that some Warrant Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Warrant Shares held by such Holders), third by
Registrable Securities represented by Underlying Preferred Shares (applied, in the case that some Underlying Preferred Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Underlying Preferred Shares
held by such Holders, subject to a determination by the Commission that certain Holders must be reduced first based on the number of Underlying Preferred Shares held by such Holders), and fourth by Registrable Securities represented by Shares
(applied, in the case that some Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Shares held by such Holders, subject to a determination by the Commission that certain Holders must be reduced
first based on the number of Shares held by such Holders). In the event the Company amends the Initial Registration Statement or files a New Registration Statement, as the case may be, under clauses (i)&nbsp;or (ii) above, the Company will use its
commercially reasonable efforts to file with the Commission, as promptly as commercially reasonable efforts allow (and as further allowed by the Commission), one or more registration statements on Form <FONT STYLE="white-space:nowrap">S-3</FONT> or
such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended, or the New Registration Statement (the &#147;<I>Remainder Registration
Statements</I>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company shall use its commercially reasonable efforts to cause each Registration Statement to be declared
effective by the Commission as soon as practicable and, with respect to the Initial Registration Statement, no later than the Effectiveness Deadline (including filing with the Commission a request for acceleration of effectiveness in accordance with
Rule 461 promulgated under the Securities Act), and shall use its commercially reasonable efforts to keep each Registration Statement continuously effective under the Securities Act until the earlier of (i)&nbsp;such time as all of the Registrable
Securities covered by such Registration Statement have been publicly sold by the Holders and (ii)&nbsp;the date on which all Shares, Warrant Shares and Underlying Preferred Shares cease to be Registrable Securities (the &#147;<I>Effectiveness
Period</I>&#148;). The Company shall request effectiveness of a Registration Statement as of 5:00 P.M. New York City time on a Trading Day. The Company shall notify the Holders via email of the effectiveness of a Registration Statement within 24
hours of any Registration Statement becoming or being declared effective. The Company shall file a final Prospectus with the Commission as required by Rule 424(b) and shall provide the Holders with copies of the final Prospectus to be used in
connection with the sale or other disposition of the securities covered thereby. The Company shall promptly inform each Holder in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule
172 and, as a result thereof, the Holder is required to deliver a Prospectus in connection with any disposition of Registrable Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If: (i)&nbsp;the Initial Registration Statement is not filed with the Commission on or
prior to the Filing Deadline, (ii)&nbsp;the Initial Registration Statement is not declared effective by the Commission (or otherwise does not become effective) for any reason on or prior to the Effectiveness Deadline, (iii)&nbsp;after its Effective
Date, (A)&nbsp;such Registration Statement ceases for any reason (including without limitation by reason of a stop order, or the Company&#146;s failure to update the Registration Statement), to remain continuously effective as to all Registrable
Securities included in such Registration Statement or (B)&nbsp;the Holders are not permitted to utilize the Prospectus therein to resell such Registrable Securities for more than an aggregate of thirty (30)&nbsp;consecutive calendar days or forty
(40)&nbsp;calendar days (which need not be consecutive days) during any twelve (12)&nbsp;month period, or (iv)&nbsp;after the Filing Deadline, and only in the event a Registration Statement is not effective or available to sell all Registrable
Securities, the Company fails to satisfy the current public information requirement pursuant to Rule 144(c)(1) as a result of which the Holders who are not affiliates are unable to sell Registrable Securities without restriction under Rule 144 (or
any successor thereto), (any such failure or breach in clauses (i)&nbsp;through (iv) above being referred to as an &#147;<I>Event</I>,&#148; and, for purposes of clauses (i), (ii) or (iv), the date on which such Event occurs, or for purposes of
clause (iii), the date on which such thirty (30)&nbsp;or forty (40)&nbsp;calendar day period is exceeded, being referred to as an &#147;<I>Event Date</I>&#148;), then, in addition to any other rights the Holders may have hereunder or under
applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the earlier of (1)&nbsp;the applicable Event is cured or (2)&nbsp;the Registrable
Securities are eligible for resale pursuant to Rule&nbsp;144 without manner of sale or volume restrictions, the Company shall pay to each Holder an amount in cash, as liquidated damages and not as a penalty (&#147;<I>Liquidated Damages</I>&#148;),
equal to one percent (1.0%) of the aggregate purchase price paid by such Holder pursuant to the Purchase Agreement for any unregistered Registrable Securities then held by such Holder. The parties agree that (1)&nbsp;the Company will not be liable
for Liquidated Damages under this Agreement with respect to the Warrant or Warrant Shares (prior to their issuance), (2) the Company will not be liable for Liquidated Damages under this Agreement with respect to any Convertible Preferred Stock or
Underlying Preferred Shares (prior to their issuance), (3) notwithstanding anything to the contrary herein or in the Purchase Agreement, no Liquidated Damages shall be payable with respect to any period after the expiration of the Effectiveness
Period, and in no event shall, the aggregate amount of Liquidated Damages (excluding Liquidated Damages payable in respect of an Event described in Section&nbsp;2(c)(iv) herein) payable to a Holder exceed, in the aggregate, six percent (6%) of the
aggregate purchase price paid by such Holder pursuant to the Purchase Agreement (and shall in no event exceed twelve percent (12%) of the aggregate purchase price paid by such Holder if there is an event described in Section&nbsp;2(c)(iv) herein),
and (4)&nbsp;in no event shall the Company be liable in any thirty (30)&nbsp;day period for Liquidated Damages under this Agreement in excess of one percent (1.0%) of the aggregate purchase price paid by the Holders pursuant to the Purchase
Agreement. If the Company fails to pay any Liquidated Damages pursuant to this <U>Section</U><U></U><U>&nbsp;2(c)</U> in full within five (5)&nbsp;Business Days after the date payable, the Company will pay interest thereon at a rate of one and <FONT
STYLE="white-space:nowrap">one-half</FONT> percent (1.5%) per month (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such Liquidated Damages are due until such amounts, plus
all such interest thereon, are paid in full. The Liquidated Damages pursuant to the terms hereof shall apply on a daily <FONT STYLE="white-space:nowrap">pro-rata</FONT> basis for any portion of a month prior to the cure of an Event, except in the
case of the first Event Date. The Company shall not be liable for Liquidated Damages under this Agreement as to any Registrable Securities which are not permitted by the Commission to be included in a Registration Statement (&#147;<I>Cutback
Shares</I>&#148;) from the time that it is determined that such Cutback Shares are not permitted to be registered until such time as the provisions of this Agreement as to the Remainder Registration Statements required to be filed hereunder are due
to be filed and declared effective, applying similar timing requirements as those contained in <U>Section</U><U></U><U>&nbsp;2(a)</U>, as appropriately extended, as if such Remainder Registration Statement was an Initial Registration Statement, in
which case the provisions of this <U>Section</U><U></U><U>&nbsp;2(c)</U> shall once again apply, if applicable. In such case, the Liquidated Damages shall be calculated to only apply to the percentage of Registrable Securities which are permitted by
the Commission to be included in such Remainder Registration Statement.<B> </B>With respect to a Holder, the Effectiveness Deadline for a Registration Statement shall be extended without default or Liquidated Damages hereunder in the event that the
Company&#146;s failure to obtain the effectiveness of the Registration Statement on a timely basis results from&nbsp;the failure of any Holder to timely provide the Company with information requested by the Company and necessary to complete the
Registration Statement in accordance with the requirements of the Securities Act (in which case the Effectiveness Deadline would be extended with respect to Registrable Securities held by such Holder). </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each Holder agrees to furnish to the Company a completed Selling Stockholder
Questionnaire not more than five (5)&nbsp;Trading Days following the date of this Agreement. At least ten (10)&nbsp;Trading Days prior to the first anticipated filing date of a Registration Statement for any registration under this Agreement, the
Company will notify each Holder of the information the Company requires from that Holder other than the information contained in the Selling Stockholder Questionnaire, if any, which shall be completed and delivered to the Company promptly upon
request and, in any event, within three (3)&nbsp;Trading Days prior to the applicable anticipated filing date. Each Holder further agrees that it shall not be entitled to be named as a selling securityholder in the Registration Statement or use the
Prospectus for offers and resales of Registrable Securities at any time, unless such Holder has returned to the Company a completed and signed Selling Stockholder Questionnaire and a response to any requests for further information as described in
the previous sentence. If a Holder of Registrable Securities returns a Selling Stockholder Questionnaire or a request for further information, in either case, after its respective deadline, the Company shall use its commercially reasonable efforts
to take such actions as are required to name such Holder as a selling security holder in the Registration Statement or any <FONT STYLE="white-space:nowrap">pre-effective</FONT> or post-effective amendment thereto and to include (to the extent not
theretofore included) in the Registration Statement the Registrable Securities identified in such late Selling Stockholder Questionnaire or request for further information. Each Holder acknowledges and agrees that the information in the Selling
Stockholder Questionnaire or request for further information as described in this <U>Section</U><U></U><U>&nbsp;2(d)</U> will be used by the Company in the preparation of the Registration Statement and hereby consents to the inclusion of such
information in the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) In the event that Form <FONT STYLE="white-space:nowrap">S-3</FONT> is not available for
the registration of the resale of Registrable Securities hereunder, the Company shall register the resale of the Registrable Securities on any other available form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Registration Procedures</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with the Company&#146;s registration obligations hereunder, the Company shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Not less than five (5)&nbsp;Trading Days prior to the filing of each Registration Statement or any amendment or supplement thereto (except
for Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and any similar or successor
reports), (i) furnish to each Holder copies of such Registration Statement or amendment or supplement thereto, as proposed to be filed, which documents will be subject to the review and reasonable comment of such Holder (it being acknowledged and
agreed that if a Holder does not object to or comment on the aforementioned documents within such five (5)&nbsp;Trading Day period, then the Holder shall be deemed to have consented to and approved the use of such documents) and (ii)&nbsp;use
commercially reasonable efforts to cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary to conduct a reasonable investigation within the meaning of the Securities
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) Prepare and file with the Commission such amendments (including <FONT STYLE="white-space:nowrap">post-effective</FONT>
amendments) and supplements, to each Registration Statement and the Prospectus used in connection therewith as may be necessary to keep such Registration Statement continuously effective as to the applicable Registrable Securities for the
Effectiveness Period; (ii)&nbsp;cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424; (iii)
respond as promptly as reasonably practicable to any comments received from the Commission with respect to each Registration Statement or any amendment thereto and, as promptly as reasonably possible, provide the Holders true and complete copies of
all correspondence from and to the Commission relating to such Registration Statement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that pertains to the Holders as &#147;Selling Stockholders&#148; but not any comments that would result in the disclosure to the Holders of material and
<FONT STYLE="white-space:nowrap">non-public</FONT> information concerning the Company; and (iv)&nbsp;comply with the provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a
Registration Statement until such time as all of such Registrable Securities shall have been disposed of (subject to the terms of this Agreement) in accordance with the intended methods of disposition by the Holders thereof as set forth in such
Registration Statement as so amended or in such Prospectus as so supplemented; <I>provided, however</I>, that each Holder shall be responsible for the delivery of the Prospectus to the Persons to whom such Holder sells any of the Shares, the Warrant
Shares or the Underlying Preferred Shares (including in accordance with Rule 172 under the Securities Act), and each Holder agrees to dispose of Registrable Securities in compliance with the &#147;Plan of Distribution&#148; described in the
Registration Statement and otherwise in compliance with applicable federal and state securities laws. In the case of amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including pursuant
to this <U>Section</U><U></U><U>&nbsp;3(b)</U>) by reason of the Company filing a report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Form <FONT STYLE="white-space:nowrap">8-K</FONT> or
any analogous report under the Exchange Act, the Company shall have incorporated such report by reference into such Registration Statement, if applicable, or shall file such amendments or supplements with the Commission on the same day on which the
Exchange Act report which created the requirement for the Company to amend or supplement such Registration Statement was filed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
Notify the Holders (which notice shall, pursuant to clauses (iii)&nbsp;through (vi) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably practicable (and,
in the case of (i)(A) below, not less than one (1)&nbsp;Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing no later than one (1)&nbsp;Trading Day following the day: (i)(A) when a Prospectus or any
Prospectus supplement or <FONT STYLE="white-space:nowrap">post-effective</FONT> amendment to a Registration Statement is proposed to be filed; (B)&nbsp;when the Commission notifies the Company whether there will be a &#147;review&#148; of such
Registration Statement and whenever the Commission comments in writing on any Registration Statement (in which case the Company shall provide to each of the Holders true and complete copies of all comments that pertain to the Holders as a
&#147;Selling Stockholder&#148; or to the &#147;Plan of Distribution&#148; and all written responses thereto, but not information that the Company believes would constitute material and <FONT STYLE="white-space:nowrap">non-public</FONT>
information); and (C)&nbsp;with respect to each Registration Statement or any <FONT STYLE="white-space:nowrap">post-effective</FONT> amendment, when the same has become effective; (ii)&nbsp;of any request by the Commission or any other federal or
state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information that pertains to the Holders as &#147;Selling Stockholders&#148; or the &#147;Plan of Distribution&#148;; (iii) of the
issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for
that purpose; (iv)&nbsp;of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or
threatening of any Proceeding for such purpose; (v)&nbsp;of the occurrence of any event or passage of time that makes the financial statements included or incorporated by reference in a Registration Statement ineligible for inclusion or
incorporation by reference therein or any statement made in such Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to
such Registration Statement, Prospectus or other documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under which they were made), not misleading and (vi)&nbsp;of the
occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued
availability of a Registration Statement or Prospectus; <I>provided</I> that, any and all such information shall remain confidential </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to each Holder until such information otherwise becomes public, unless disclosure by a Holder is required by law; and <I>provided</I>, <I>further</I>, that notwithstanding each Holder&#146;s
agreement to keep such information confidential, each such Holder makes no acknowledgement that any such information is material, <FONT STYLE="white-space:nowrap">non-public</FONT> information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Use commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i)&nbsp;any order suspending the
effectiveness of a Registration Statement, or (ii)&nbsp;any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, as soon as practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If requested by a Holder, furnish to such Holder, without charge, at least one conformed copy of each Registration Statement and each
amendment thereto and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission; <I>provided</I>, that the Company shall
have no obligation to provide any document pursuant to this clause that is available on the Commission&#146;s EDGAR system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Prior to
any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holder in connection with the registration or qualification (or exemption from the registration or
qualification) of such Registrable Securities for the resale by the Holder under the securities or &#147;Blue Sky&#148; laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or
qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each
Registration Statement; <I>provided</I>, that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to taxation in any jurisdiction where it is not then so
subject or file a general consent to service of process in any jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) If requested by a Holder, cooperate with such Holder to
facilitate the timely preparation and delivery of certificates or book entry statements, as applicable, representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates or book entry
statements shall be free, to the extent permitted by the Purchase Agreement and under law, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may
reasonably request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Following the occurrence of any event contemplated by <U>Section</U><U></U><U>&nbsp;3(c)</U>, as promptly as
reasonably practicable (taking into account the Company&#146;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event), prepare a supplement or amendment, including a <FONT
STYLE="white-space:nowrap">post-effective</FONT> amendment, to the affected Registration Statements or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required
document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
(in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under which they were made), not misleading. If the Company notifies the Holders in accordance with clauses (iii)&nbsp;through (vi) of
<U>Section</U><U></U><U>&nbsp;3(c)</U> above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use its commercially reasonable
efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. For the avoidance of doubt, the Company&#146;s rights under <U>Section</U><U></U><U>&nbsp;3(c)</U> above shall include the ability to suspend the use of
any Prospectus arising from the filing of a post-effective amendment to a Registration Statement to update the Prospectus therein to include the information contained in the Company&#146;s Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K,</FONT> which suspensions may extend for the amount of time reasonably required to respond to any comments of the staff of the Commission on such amendment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company may require each selling Holder to furnish to the Company a certified
statement as to (i)&nbsp;the number of shares of Common Stock beneficially owned by such Holder and any Affiliate thereof, (ii)&nbsp;any Financial Industry Regulatory Authority (&#147;<I>FINRA</I>&#148;) affiliations, (iii)&nbsp;any natural persons
who have the power to vote or dispose of the common stock and (iv)&nbsp;any other information as may be requested by the Commission, FINRA or any state securities commission. During any periods that the Company is unable to meet its obligations
hereunder with respect to the registration of Registrable Securities because any Holder fails to furnish such information within three (3)&nbsp;Trading Days of the Company&#146;s request, any Liquidated Damages that are accruing at such time as to
such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended as to such Holder only, until such time as the Holder furnishes such information to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company shall cooperate with any registered broker through which a Holder proposes to resell its Registrable Securities in effecting a
filing with FINRA pursuant to FINRA Rule 5110 as requested by any such Holder and the Company shall pay the filing fee required for the first such filing within two (2)&nbsp;Business Days of the request therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Registration Expenses</U>. All fees and expenses incident to the Company&#146;s performance of or compliance with its obligations under
this Agreement (excluding any underwriting discounts, selling commissions, fees of underwriters, selling brokers, dealer managers or similar securities industry professionals and all legal fees and expenses of legal counsel for any Holder) shall be
borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i)&nbsp;all registration and filing fees
(including, without limitation, fees and expenses (A)&nbsp;with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, (B)&nbsp;with respect to compliance with applicable state securities
or Blue Sky laws (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities and determination of the eligibility of the Registrable
Securities for investment under the laws of such jurisdictions as requested by the Holders) and (C)&nbsp;if not previously paid by the Company in connection with <U>Section</U><U></U><U>&nbsp;3(j)</U> above, with respect to any filing that may be
required to be made by any broker through which a Holder intends to make sales of Registrable Securities with FINRA pursuant to the FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage commission in connection with
such sale, (ii)&nbsp;printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities and of printing prospectuses if the printing of prospectuses is reasonably requested by the Required Investors),
(iii) messenger, telephone and delivery expenses, (iv)&nbsp;fees and disbursements of counsel for the Company, (v)&nbsp;Securities Act liability insurance, if the Company so desires such insurance, and (vi)&nbsp;fees and expenses of all other
Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of
the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in
connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any underwriting discounts, selling commissions, fees of underwriters, selling brokers,
dealer managers or similar securities industry professionals or, except to the extent provided for in the Transaction Documents or provided for above in this <U>Section</U><U></U><U>&nbsp;4</U>, any legal fees or other costs of the Holders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Indemnification</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify, defend and hold
harmless each Holder, the officers, directors, agents, partners, members, managers, stockholders, Affiliates and employees of each of them, each Person who controls any such Holder (within the meaning of Section&nbsp;15 of the Securities Act or
Section&nbsp;20 of the Exchange Act) and the officers, directors, partners, members, managers, stockholders, agents and employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all
losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and investigation and reasonable attorneys&#146; fees) and expenses (collectively, &#147;<I>Losses</I>&#148;), as incurred, that arise out of
or are based upon (i)&nbsp;any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or preliminary prospectus or supplement thereto, in light of the circumstances under
which they were made) not misleading, or (ii)&nbsp;any violation or alleged violation by the Company of the Securities Act, Exchange Act or any state securities law or any rule or regulation thereunder, in connection with the performance of its
obligations under this Agreement, except to the extent, but only to the extent, that (A)&nbsp;such untrue statements, alleged untrue statements, omissions or alleged omissions are based solely upon information regarding such Holder furnished in
writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder&#146;s proposed method of distribution of Registrable Securities and was reviewed and approved in writing
by such Holder expressly for use in the Registration Statement, such Prospectus or preliminary prospectus or in any amendment or supplement thereto (it being understood that each Holder has approved <U>Annex A</U> hereto for this purpose), or
(B)&nbsp;in the case of an occurrence of an event of the type specified in <U>Section</U><U></U><U>&nbsp;3(c)(iii)</U>-<U>(vi)</U>, related to the use by a Holder of an outdated or defective Prospectus after the Company has notified such Holder in
writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated and defined in <U>Section</U><U></U><U>&nbsp;6(d)</U> below, to the extent that following the receipt of the Advice the
misstatement or omission giving rise to such Loss would have been corrected, or (C)&nbsp;to the extent that any such Losses arise out of the Holder&#146;s (or any other indemnified Person&#146;s) failure to send or give a copy of the Prospectus or
supplement (as then amended or supplemented), if required, pursuant to Rule 172 under the Securities Act (or any successor rule) to the Persons asserting an untrue statement or alleged untrue statement or omission or alleged omission at or prior to
the written confirmation of the sale of Registrable Securities to such Person if such statement or omission was corrected in such Prospectus or Supplement. Such indemnity shall remain in full force and effect regardless of any investigation made by
or on behalf of an Indemnified Party (as defined in <U>Section</U><U></U><U>&nbsp;5(c)</U>) and shall survive the transfer of the Registrable Securities by the Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Indemnification by Holders</U>. Each Holder shall, notwithstanding any termination of this Agreement, severally and not jointly,
indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors,
officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, that arise out of or are based solely upon (i)&nbsp;any untrue or alleged untrue statement of a
material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission to state a material fact required to
be stated therein or necessary to make the statements therein (in the case of any Prospectus, or any preliminary prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (A)&nbsp;to the extent, but
only to the extent, that such untrue statements or omissions are based upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or (B)&nbsp;to the extent, but only to the extent, that such
information relates to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Holder or such Holder&#146;s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such Holder expressly for use in a Registration Statement
(it being understood that the Holder has approved <U>Annex A</U> hereto for this purpose), such Prospectus or such preliminary prospectus or in any amendment or supplement thereto or (C)&nbsp;in the case of an occurrence of an event of the type
specified in <U>Section</U><U></U><U>&nbsp;3(c)(iii)</U>-<U>(vi)</U>, to the extent, but only to the extent, related to the use by such Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that the
Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated in <U>Section</U><U></U><U>&nbsp;6(d)</U> below, but only if and to the extent that following the receipt of the Advice the misstatement or
omission giving rise to such Loss would have been corrected, or (ii)&nbsp;Holder&#146;s failure to deliver or cause to be delivered the Prospectus or any amendment or supplement thereto made available by the Company in compliance with
<U>Section</U><U></U><U>&nbsp;6(c)</U>. In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise
to such indemnification obligation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted
against any Person entitled to indemnity hereunder (an &#147;<I>Indemnified Party</I>&#148;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the &#147;<I>Indemnifying Party</I>&#148;) in writing, and the
Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable fees and expenses incurred in connection with defense
thereof; <I>provided</I>, that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that such failure shall
have materially and adversely prejudiced the Indemnifying Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">An Indemnified Party shall have the right to employ separate counsel in
any such Proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1)&nbsp;the Indemnifying Party has agreed in writing to pay such fees and
expenses; (2)&nbsp;the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3)&nbsp;the named parties to any such
Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have reasonably determined, based upon the written advice of its counsel, that a conflict of interest
exists if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the
Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and such counsel shall be at the expense of the Indemnifying Party); <I>provided</I>, that the Indemnifying Party shall not be liable for the fees and
expenses of more than one separate firm of attorneys at any time for all Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be
unreasonably withheld, delayed or conditioned. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, which consent shall not be unreasonably withheld, delayed or conditioned, effect any settlement of any pending
Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to the terms of this Agreement, all documented fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this <U>Section</U><U></U><U>&nbsp;5(c)</U>) shall be paid to the Indemnified Party, as incurred, within twenty
(20)&nbsp;Trading Days of written notice thereof to the Indemnifying Party; <I>provided</I>, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which
such Indemnified Party is finally judicially determined to not be entitled to indemnification hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Contribution</U>. If a claim for indemnification under
<U>Section</U><U></U><U>&nbsp;5(a)</U> or <U>5(b)</U> is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall
contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions,
statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified
Party, and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include,
subject to the limitations set forth in this Agreement, any reasonable attorneys&#146; or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees
or expenses if the indemnification provided for in this <U>Section</U><U></U><U>&nbsp;5</U> was available to such party in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The parties hereto agree that it would not be just and equitable if contribution pursuant to this <U>Section</U><U></U><U>&nbsp;5(d)</U> were
determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this
<U>Section</U><U></U><U>&nbsp;5(d)</U>, (A) no Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such Holder from the sale of the Registrable Securities
subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission and (B)&nbsp;no contribution will be made under
circumstances where the maker of such contribution would not have been required to indemnify the Indemnified Party under the fault standards set forth in this Section&nbsp;5. No Person guilty of fraudulent misrepresentation (within the meaning of
Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
indemnity and contribution agreements contained in this <U>Section</U><U></U><U>&nbsp;5</U> are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties and are not in diminution or limitation of the
indemnification provisions under the Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their obligations under this Agreement, each Holder or
the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement. The Company
and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for
specific performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Piggyback on Registrations; Prohibition on Filing Other Registration
Statements</U>. Except to the extent contemplated by the Purchase Agreement or the disclosure schedules thereto, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of
the Company in a Registration Statement other than the Registrable Securities and the Company shall not prior to the Effective Date enter into any agreement providing any such right to any of its security holders. Except to the extent contemplated
by the Purchase Agreement or the disclosure schedules thereto, the Company shall not file with the Commission a registration statement relating to an offering for its own account under the Securities Act of any of its equity securities other than a
registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> or, in connection with an acquisition, on Form <FONT STYLE="white-space:nowrap">S-4</FONT> until the earlier of (i)&nbsp;the date that is thirty (30)&nbsp;days after the
Initial Registration Statement or New Registration Statement, as the case may be, is declared effective or (ii)&nbsp;the date that all Registrable Securities held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> are eligible for resale
without volume or manner of sale restrictions under Rule 144 and without the requirement for the Company to be in compliance with the current public information requirements under Rule 144. For the avoidance of doubt, the Company shall not be
prohibited from preparing and filing with the Commission a registration statement relating to an offering of Common Stock by existing stockholders of the Company under the Securities Act pursuant to the terms of registration rights held by such
stockholder or from filing amendments to registration statements filed prior to the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Compliance</U>. Each
Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to the
Registration Statement and shall sell the Registrable Securities only in accordance with a method of distribution described in the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the
Company of the occurrence of any event of the kind described in <U>Section</U><U></U><U>&nbsp;3(c)(iii)</U>-<U>(vi)</U>, such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is
advised in writing (the &#147;<I>Advice</I>&#148;) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its commercially reasonable efforts to ensure that the use
of the Prospectus may be resumed as promptly as is practicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>No Inconsistent Agreements</U>. Neither the Company nor any of its
Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date hereof, enter into any agreement with respect to its securities that conflicts with the provisions hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified
or supplemented, or waived unless the same shall be in writing and signed by the Company and Holders of a majority of the then outstanding Registrable Securities (the &#147;<I>Required Investors</I>&#148;), provided that any party may give a waiver
as to itself. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided
hereunder shall be delivered as set forth in the Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Successors and Assigns</U>. This Agreement shall inure to the
benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. The Company may not assign its rights (except by merger,
consolidation, share exchange or similar business combination transaction or in connection with another entity acquiring all or substantially all of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company&#146;s assets) or obligations hereunder without the prior written consent of the Required Investors. Each Holder may assign its respective rights hereunder in the manner and to the
Persons as permitted under the Purchase Agreement; provided in each case that (i)&nbsp;the Holder agrees in writing with the transferee or assignee to assign such rights and related obligations under this Agreement, and for the transferee or
assignee to assume such obligations, and a copy of such agreement is furnished to the Company within a reasonable time after such assignment, (ii)&nbsp;the Company is, within a reasonable time after such transfer or assignment, furnished with
written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being transferred or assigned, (iii)&nbsp;at or before the time the Company received the written notice
contemplated by clause (ii)&nbsp;of this sentence, the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein and (iv)&nbsp;the transferee is an &#147;accredited investor,&#148; as that term
is defined in Rule&nbsp;501 of Regulation&nbsp;D. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Execution and Counterparts</U>. This Agreement may be executed in two or more
counterparts, each of which when so executed shall be deemed to be an original and, all of which taken together shall constitute one and the same Agreement. Counterparts may be delivered via facsimile, <FONT STYLE="white-space:nowrap">e-mail</FONT>
(including pdf or any electronic signature covered by the U.S. ESIGN Act of 2000 or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Governing Law; WAIVER OF JURY TRIAL</U>. All questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be determined in accordance with Section&nbsp;6.9 of the Purchase Agreement. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL
RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)
<U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set
forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their good faith reasonable efforts to find and employ an alternative means to achieve the same or
substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties hereto that they would have executed the remaining terms, provisions,
covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)
<U>Headings</U>. The headings in this Agreement are for convenience only and shall not limit or otherwise affect the meaning hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)
<U>Entire Agreement</U>. This Agreement and the Purchase Agreement (and the other Transaction Documents) constitute the entire agreement among the parties hereto with respect to the subject matter hereof and supersede all prior and contemporaneous
arrangements or undertakings with respect thereto. There are no restrictions, promises, warranties or undertakings, other than as set forth or referred to herein and in the Purchase Agreement (and the other Transaction Documents). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BLUE RIDGE BANKSHARES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURCHASER</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Richard T. Spurzem</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ADDRESS FOR NOTICE</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">c/o:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Street:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">City/State/Zip:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tel:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fax:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>ANNEX A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PLAN OF DISTRIBUTION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are
registering the shares of Common Stock issued to the selling stockholders and issuable upon exercise of the warrants issued to the selling stockholders to permit the resale of these shares of Common Stock by the holders of the shares of Common Stock
and warrants from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling stockholders of the shares of Common Stock. We will bear all fees and expenses incident to our obligation to
register the shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders may sell all or a portion of the shares of Common Stock beneficially owned
by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents. If the shares of Common Stock are sold through underwriters or broker-dealers, the selling stockholders will be responsible for
underwriting discounts or commissions or agent&#146;s commissions. The shares of Common Stock may be sold on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale, in the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or in transactions otherwise than on these exchanges or systems or in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market and in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of
sale, or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions. The selling stockholders may use any one or more of the following methods when selling shares: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a
portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">settlement of short sales entered into after the effective date of the registration statement of which this
prospectus is a part; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated
price per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether such options are listed on an
options exchange or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the
Securities Act, as permitted by that rule, or Section&nbsp;4(a)(1) under the Securities Act, if available, rather than under this prospectus, provided that they meet the criteria and conform to the requirements of those provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Broker-dealers</FONT> engaged by the selling stockholders
may arrange for other <FONT STYLE="white-space:nowrap">broker-dealers</FONT> to participate in sales. If the selling stockholders effect such transactions by selling shares of Common Stock to or through underwriters, broker-dealers or agents, such
underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the selling stockholders or commissions from purchasers of the shares of Common Stock for whom they may act as agent or to whom
they may sell as principal. Such commissions will be in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction will not be in excess of a customary brokerage commission in
compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
connection with sales of the shares of Common Stock or otherwise, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the shares of Common Stock
in the course of hedging in positions they assume. The selling stockholders may also sell shares of Common Stock short and if such short sale shall take place after the date that this Registration Statement is declared effective by the Commission,
the selling stockholders may deliver shares of Common Stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The selling stockholders may also loan or pledge shares of Common
Stock to broker-dealers that in turn may sell such shares, to the extent permitted by applicable law. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of
one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this
prospectus (as supplemented or amended to reflect such transaction). Notwithstanding the foregoing, the selling stockholders have been advised that they may not use shares registered on this registration statement to cover short sales of our Common
Stock made prior to the date the registration statement, of which this prospectus forms a part, has been declared effective by the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the warrants or shares of Common Stock
owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of Common Stock from time to time pursuant to this prospectus or any amendment to this prospectus under
Rule 424(b)(3) or other applicable provision of the Securities Act of 1933, as amended, amending, if necessary, the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this
prospectus. The selling stockholders also may transfer and donate the shares of Common Stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of
this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders and any broker-dealer or agents participating in the distribution of the shares of Common Stock
may be deemed to be &#147;underwriters&#148; within the meaning of Section&nbsp;2(a)(11) of the Securities Act in connection with such sales. In such event, any commissions paid, or any discounts or concessions allowed to, any such broker-dealer or
agent and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Selling stockholders who are &#147;underwriters&#148; within the meaning of Section&nbsp;2(a)(11)
of the Securities Act will be subject to the applicable prospectus delivery requirements of the Securities Act including Rule 172 thereunder and may be subject to certain statutory liabilities of, including but not limited to, Sections 11, 12 and 17
of the Securities Act and <FONT STYLE="white-space:nowrap">Rule&nbsp;10b-5</FONT> under the Securities Exchange Act of 1934, as amended, or the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each selling stockholder has informed the Company that it is not a registered broker-dealer and does not have any written or oral agreement or
understanding, directly or indirectly, with any person to distribute shares of Common Stock. Upon the Company being notified in writing by a selling stockholder that any material arrangement has been entered into with a broker-dealer for the sale of
common stock through a block trade, special offering, exchange distribution or secondary distribution or a purchase by a broker or dealer, a supplement to this prospectus will be filed, if required, pursuant to Rule 424(b) under the Securities Act,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
disclosing (i)&nbsp;the name of each such selling stockholder and of the participating broker-dealer(s), (ii) the number of shares involved, (iii)&nbsp;the price at which such shares of Common
Stock were sold, (iv)&nbsp;the commissions paid or discounts or concessions allowed to such broker-dealer(s), where applicable, (v)&nbsp;that such broker-dealer(s) did not conduct any investigation to verify the information set out or incorporated
by reference in this prospectus, and (vi)&nbsp;other facts material to the transaction. In no event shall any broker-dealer receive fees, commissions and markups, which, in the aggregate, would exceed eight percent (8.0%). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the securities laws of some states, the shares of Common Stock may be sold in such states only through registered or licensed brokers or
dealers. In addition, in some states the shares of Common Stock may not be sold unless such shares have been registered or qualified for sale in such state or an exemption from registration or qualification is available and is complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that any selling stockholder will sell any or all of the shares of Common Stock registered pursuant to the
registration statement, of which this prospectus forms a part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each selling stockholder and any other person participating in such
distribution will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including, without limitation, to the extent applicable, Regulation M of the Exchange Act, which may limit the timing of purchases
and sales of shares of Common Stock by the selling stockholder and any other participating person. To the extent applicable, Regulation M may also restrict the ability of any person engaged in the distribution of the shares of Common Stock to engage
in market-making activities with respect to the shares of Common Stock. All of the foregoing may affect the marketability of the shares of Common Stock and the ability of any person or entity to engage in market-making activities with respect to the
shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay all expenses of the registration of the shares of Common Stock pursuant to the registration rights
agreement, including, without limitation, Securities and Exchange Commission filing fees and expenses of compliance with state securities or &#147;blue sky&#148; laws; <I>provided</I>, <I>however</I>, that each selling stockholder will pay all
underwriting discounts and selling commissions, if any and any related legal expenses incurred by it. We will indemnify the selling stockholders against certain liabilities, including some liabilities under the Securities Act, in accordance with the
registration rights agreement, or the selling stockholders will be entitled to contribution. We may be indemnified by the selling stockholders against civil liabilities, including liabilities under the Securities Act, that may arise from any written
information furnished to us by the selling stockholders specifically for use in this prospectus, in accordance with the related registration rights agreement, or we may be entitled to contribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>ANNEX B </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SELLING STOCKHOLDER NOTICE AND QUESTIONNAIRE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned holder of shares of the common stock, no par value, of Blue Ridge Bankshares, Inc., a Virginia corporation (the
&#147;<I>Company</I>&#148;), issued pursuant to a certain Securities Purchase Agreement by and between the Company and the Purchaser named therein, dated as of June&nbsp;7, 2024 (the &#147;<I>Agreement</I>&#148;), understands that the Company
intends to file with the Securities and Exchange Commission a registration statement (the &#147;<I>Resale Registration Statemen</I>t&#148;) for the registration and the resale of the Registrable Securities in accordance with the terms of a
Registration Rights Agreement, in the form attached to the Agreement (the &#147;<I>Registration Rights Agreement</I>&#148;). All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to sell or otherwise dispose of any Registrable Securities pursuant to the Resale Registration Statement, a holder of
Registrable Securities generally will be required to be named as a selling stockholder in the related prospectus or a supplement thereto (as so supplemented, the &#147;<I>Prospectus</I>&#148;), deliver the Prospectus to purchasers of Registrable
Securities (including pursuant to Rule 172 under the Securities Act) and be bound by the provisions of the Agreement and the Registration Rights Agreement (including certain indemnification provisions). Holders must complete and deliver this Selling
Stockholder Notice and Questionnaire (this &#147;<I>Questionnaire</I>&#148;) in order to be named as selling stockholders in the Prospectus. <B>Holders of Registrable Securities who do not complete, execute and return this Questionnaire within five
(5)</B><B></B><B>&nbsp;Trading Days following the date of the Registration Rights Agreement (1)</B><B></B><B>&nbsp;will not be named as selling stockholders in the Resale Registration Statement or the Prospectus and (2)</B><B></B><B>&nbsp;may not
use the Prospectus for resales of Registrable Securities.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain legal consequences arise from being named as a selling stockholder
in the Resale Registration Statement and the Prospectus. Holders of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not named as a selling stockholder in the Resale
Registration Statement and the Prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned holder (the &#147;<I>Selling Stockholder</I>&#148;) of Registrable Securities hereby gives notice to the Company of its
intention to sell or otherwise dispose of Registrable Securities owned by it and listed below in Item (3), unless otherwise specified in Item (3), pursuant to the Resale Registration Statement. The undersigned, by signing and returning this
Questionnaire, understands and agrees that it will be bound by the terms and conditions of this Questionnaire, the Agreement and the Registration Rights Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate and
complete: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUESTIONNAIRE </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Name. </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Full Legal Name of Selling Stockholder: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Full Legal Name of Registered Holder (if not the same as (a)&nbsp;above) through which Registrable Securities
listed in Item 3 below are held: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Address for Notices to Selling Stockholder: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone:</P></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contact Person:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail</FONT> address of Contact
Person:________________________________________________</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Beneficial Ownership of Registrable Securities: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Type and Number of Registrable Securities beneficially owned and issued pursuant to the Agreement:
</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Number of shares of Common Stock to be registered pursuant to this Questionnaire: </P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Broker-Dealer Status: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Are you a broker-dealer? </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;No&#8194;&#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If &#147;yes&#148; to Section&nbsp;4(a), did you receive your Registrable Securities as compensation for
investment banking services to the Company? </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;No&#8194;&#9744; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Note:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If no, the Commission&#146;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Are you an affiliate of a broker-dealer? For purposes of this Questionnaire, an &#147;affiliate&#148; of a
specified person or entity means a person or entity that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, the person or entity specified. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;No&#8194;&#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Note:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If yes, provide a narrative explanation below:</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the
ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;No&#8194;&#9744; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Note:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If no, the Commission&#146;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Note:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If yes, provide a narrative explanation below:</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Beneficial Ownership of Other Securities of the Company Owned by the Selling Stockholder. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Except as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company other
than the Registrable Securities listed above in Item 3.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Type and amount of other securities beneficially owned: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Relationships with the Company: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">State any exceptions here: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Plan of Distribution: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>The undersigned has reviewed the form of Plan of Distribution attached as Annex A to the Registration Rights Agreement, and hereby confirms
that, except as set forth below, the information contained therein regarding the undersigned and its plan of distribution is correct and complete.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">State any exceptions here: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Potential Nature of Beneficial Holding: </B>The purpose of this question is to identify the ultimate natural person(s)
or publicly held entity that will exercise(s) sole or shared voting or dispositive power over the Registrable Securities. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Is the undersigned required to file, or is it a wholly-owned subsidiary of a company that is required to file,
periodic and other reports (for example, Forms <FONT STYLE="white-space:nowrap">10-K,</FONT> <FONT STYLE="white-space:nowrap">10-Q,</FONT> <FONT STYLE="white-space:nowrap">8-K)</FONT> with the Commission pursuant to section 13(a) or 15(d) of the
Exchange Act? </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;No&#8194;&#9744; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">State whether the undersigned is a subsidiary of an investment company, registered under the Investment Company
Act of 1940: </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;No&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a subsidiary, please identify the publicly-held parent entity: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you answered &#147;Yes&#148; to questions 8(a) and 8(b), you may skip question 8(c) and 8(d). </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Please identify the controlling person(s) of the undersigned (the &#147;<I>Controlling Entity</I>&#148;). If
the Controlling Entity is not a natural person or a publicly held entity, please identify each controlling person(s) of such Controlling Entity. This process should be repeated until you reach natural persons or a publicly held entity that will
exercise sole or shared voting or dispositive power over the Registrable Securities: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Please provide contact information for all controlling persons and Controlling Entities identified in question
8(c), including (i)&nbsp;name of controlling person or Controlling Entity (including contact person for Controlling Entities), (ii) mailing address, <FONT STYLE="white-space:nowrap">(iii)&nbsp;e-mail</FONT> address, and (iv)&nbsp;telephone number.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*********** </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof and to furnish any supplementary information reasonably requested by the Company. All
notices hereunder shall be made in writing, by hand delivery, confirmed email transmission, first-class mail or air courier guaranteeing overnight delivery, postage prepaid and return receipt collected at the address set forth below. In the absence
of any such notification, the Company shall be entitled to continue to rely on the accuracy of the information in this Questionnaire. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By signing below,
the undersigned consents to the disclosure of the information contained in this Questionnaire and the inclusion of such information in the Resale Registration Statement and the Prospectus. The undersigned understands that such information will be
relied upon by the Company in connection with the preparation or amendment of any such Registration Statement and Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By signing below, the
undersigned acknowledges that it understands its obligation to comply, and agrees that it will comply, with the provisions of the Exchange Act and the rules and regulations thereunder, particularly Regulation M in connection with any offering of
Registrable Securities pursuant to the Resale Registration Statement. The undersigned also acknowledges that it understands that the answers to this Questionnaire are furnished for use in connection with Registration Statements filed pursuant to the
Registration Rights Agreement and any amendments or supplements thereto filed with the Commission pursuant to the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned hereby
acknowledges and is advised of the following Interpretation A.65 of the July 1997 SEC Manual of Publicly Available Telephone Interpretations regarding short selling: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;An issuer filed a Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration statement for a secondary offering of common stock which is not yet
effective. One of the selling shareholders wanted to do a short sale of common stock &#147;against the box&#148; and cover the short sale with registered shares after the effective date. The issuer was advised that the short sale could not be made
before the registration statement becomes effective, because the shares underlying the short sale are deemed to be sold at the time such sale is made. There would, therefore, be a violation of Section&nbsp;5 if the shares were effectively sold prior
to the effective date.&#148; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By returning this Questionnaire, the undersigned will be deemed to be aware of the foregoing interpretation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page Follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Questionnaire
to be executed and delivered either in person or by its duly authorized agent. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Dated:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">Beneficial Owner: _________________________________________________</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PLEASE EMAIL A COPY OF THE COMPLETED AND EXECUTED QUESTIONNAIRE, AND RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[Name] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[Name of Placement
Agent] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[Address] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[Address] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Tel: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>INSTRUCTION SHEET </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(to be read in conjunction with the entire Securities Purchase Agreement and Registration Rights Agreement) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Complete the following items in the Securities Purchase Agreement and/or Registration Rights Agreement: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Provide the information regarding the Purchaser requested on the signature page. The Securities Purchase
Agreement and the Registration Rights </P></TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Agreement must be executed by an individual authorized to bind the Purchaser. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Exhibit <FONT STYLE="white-space:nowrap">C-1</FONT></U> &#150; Accredited Investor Questionnaire:
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Provide the information requested by the Accredited Investor Questionnaire </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Exhibit <FONT STYLE="white-space:nowrap">C-2</FONT></U> Stock Certificate Questionnaire:
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Provide the information requested by the Stock Certificate Questionnaire </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Annex B</U> to the Registration Rights Agreement &#151; Selling Securityholder Notice and Questionnaire
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Provide the information requested by the Selling Securityholder Notice and Questionnaire </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Return the signed Securities Purchase Agreement and Registration Rights Agreement to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[Name] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[Name of Placement
Agent] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[Address] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[Address] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Tel: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Fax: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT <FONT STYLE="white-space:nowrap">C-1</FONT> </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">ACCREDITED INVESTOR QUESTIONNAIRE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(ALL INFORMATION WILL BE TREATED CONFIDENTIALLY) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To: Blue Ridge Bankshares, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Investor Questionnaire
(&#147;<I>Questionnaire</I>&#148;) must be completed by each potential investor in connection with the offer and sale of (i)&nbsp;shares of the common stock, no par value per share, and (ii)&nbsp;shares of the Mandatorily Convertible Cumulative
Perpetual Preferred Stock, Series B, par value $50.00 per share (the &#147;<I>Preferred Stock</I>&#148;) and (iii)&nbsp;shares of Preferred Stock that may be issued upon exercise of a certain warrant (collectively, the
&#147;<I>Securities</I>&#148;), of Blue Ridge Bankshares, Inc., a Virginia corporation (the &#147;<I>Corporation</I>&#148;). The Securities are being offered and sold by the Corporation without registration under the Securities Act of 1933, as
amended (the &#147;<I>Act</I>&#148;), and the securities laws of certain states, in reliance on the exemptions contained in Section&nbsp;4(a)(2) of the Act and on Regulation D promulgated thereunder and in reliance on similar exemptions under
applicable state laws. The Corporation must determine that a potential investor meets certain suitability requirements before offering or selling Securities to such investor. The purpose of this Questionnaire is to assure the Corporation that each
investor will meet the applicable suitability requirements. The information supplied by you will be used in determining whether you meet such criteria, and reliance upon the private offering exemptions from registration is based in part on the
information herein supplied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Questionnaire does not constitute an offer to sell or a solicitation of an offer to buy any security. Your answers will
be kept strictly confidential. However, by signing this Questionnaire, you will be authorizing the Corporation to provide a completed copy of this Questionnaire to such parties as the Corporation deems appropriate in order to ensure that the offer
and sale of the Securities will not result in a violation of the Act or the securities laws of any state and that you otherwise satisfy the suitability standards applicable to purchasers of the Securities. All potential investors must answer all
applicable questions and complete, date and sign this Questionnaire. Please print or type your responses and attach additional sheets of paper if necessary to complete your answers to any item. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left">PART&#8201;A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>BACKGROUND INFORMATION</U> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name of Beneficial Owner of the Securities:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Business Address:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">(Number and Street)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>

<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="5" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(City)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(State)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Zip Code)</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone Number: (___)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><I>If a corporation, partnership, limited liability company, trust or other entity:</I></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Type of entity:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">State of formation:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approximate Date of formation:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Were you formed for the purpose of investing in the securities being offered? </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes ____ No ____ </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>If an individua</U>l: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Residence Address:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">(Number and Street)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>

<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="5" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(City)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(State)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Zip Code)</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone Number: (___)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Age:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Citizenship:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Where registered to vote:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth in the space provided below the state(s), if any, in the United States in which you maintained your residence during
the past two years and the dates during which you resided in each state: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Are you a director or executive officer of the Corporation? </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes ____ No ____ </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Social Security or Taxpayer Identification No.</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left">PART&#8201;B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ACCREDITED INVESTOR QUESTIONNAIRE</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order for the Company to offer and sell the Securities in conformance with state and federal securities laws, the following information must
be obtained regarding your investor status. Please <U>initial each category</U><I> </I>applicable to you as a Purchaser of Securities of the Company. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">__ (1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A bank as defined in Section&nbsp;3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in Section&nbsp;3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary
capacity;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">__ (2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A broker or dealer registered pursuant to Section&nbsp;15 of the Securities Exchange Act of 1934;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">__ (3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An investment adviser registered pursuant to section 203 of the Investment Advisers Act of 1940 or registered pursuant to the laws of a state;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">__ (4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An investment adviser relying on the exemption from registering with the Securities and Exchange Commission under section 203(l) or (m)&nbsp;of the Investment Advisers Act of 1940;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">__ (5)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An insurance company as defined in Section&nbsp;2(13) of the Securities Act;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">__ (6)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section&nbsp;2(a)(48) of that Act;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">__ (7)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A Small Business Investment Company licensed by the U.S. Small Business Administration under Section&nbsp;301(c) or (d)&nbsp;of the Small Business Investment Act of 1958;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">__ (8)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A Rural Business Investment Company as defined in section 384A of the Consolidated Farm and Rural Development Act;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">__ (9)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of
$5,000,000;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">__ (10)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section&nbsp;3(21) of such act, which is either a bank,
savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are
accredited investors;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">__ (11)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A private business development company as defined in Section&nbsp;202(a)(22) of the Investment Advisers Act of 1940;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">__ (12)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An organization described in Section&nbsp;501(c)(3) of the Internal Revenue Code, a corporation, Massachusetts or similar business trust, partnership, or limited liability company, not formed for the specific purpose of acquiring
the Securities, with total assets in excess of $5,000,000;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">__ (13)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Securities, whose purchase is directed by a sophisticated person as described in Regulation D;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">__ (14)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An entity, of a type not listed above, not formed for the specific purpose of acquiring the Securities, owning investments in excess of $5,000,000;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">___(15)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A natural person whose individual net worth, or joint net worth with that person&#146;s spouse or spousal equivalent, at the time of his purchase exceeds $1,000,000;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">___(16)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A natural person who had an individual income in excess of $200,000 in each of the two most recent years, or joint income with that person&#146;s spouse or spousal equivalent in excess of $300,000, in each of those years, and has a
reasonable expectation of reaching the same income level in the current year;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">___(17)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A director, manager, executive officer, or general partner of the Company, or a director, manager, executive officer, or general partner of the manager of the Company;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">___(18)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A natural person holding in good standing one or more professional certifications or designations or credentials from an accredited educational institution that the Securities and Exchange Commission has designated as qualifying an
individual for accredited investor status. For purposes of this certification, the Securities and Exchange Commission has announced that the following professional licenses meet the attributes to qualify natural persons holding such licenses in good
standing as accredited investors: General Securities Representative license (Series 7), Private Securities Offerings Representative license (Series 82), and Investment Adviser Representative license (Series 65);</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">___(19)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A natural person who is &#147;knowledgeable employee,&#148; as defined in Rule <FONT STYLE="white-space:nowrap">3c-5(a)(4)</FONT> under the Investment Company Act of 1940, of the issuer of the securities being offered or sold where
the issuer would be an investment company, as defined in Section&nbsp;3 of such act, but for the exclusion provided by either Section&nbsp;3(c)(1) or Section&nbsp;3(c)(7) of such act;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">___(20)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A &#147;family office,&#148; as defined in Rule <FONT STYLE="white-space:nowrap">202(a)(11)(G)-1</FONT> under the Investment Advisers Act of 1940: (A) with assets under management in excess of $5,000,000, (B) that is not formed for
the specific purpose of acquiring the Securities, and (C)&nbsp;whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits
and risks of the prospective investment;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">___(21)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A &#147;family client,&#148; as defined in Rule <FONT STYLE="white-space:nowrap">202(a)(11)(G)-1</FONT> under the Investment Advisers Act of 1940, of a family office meeting the requirements in subsection (20)&nbsp;above and whose
prospective investment in the Company is directed by such family office pursuant to subsection (20)&nbsp;above;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">___(22)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An entity in which all of the equity owners qualify under any of the above subparagraphs. If the undersigned belongs to this investor category only, list the equity owners of the undersigned, and the investor category which each
such equity owner satisfies.</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FOR EXECUTION BY AN INDIVIDUAL: </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Print Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FOR EXECUTION BY AN ENTITY: </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entity Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Print Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADDITIONAL SIGNATURES (if required by partnership, corporation or trust document):
</B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entity Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Print Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entity Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Print Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT <FONT STYLE="white-space:nowrap">C-2</FONT> </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">STOCK CERTIFICATE QUESTIONNAIRE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to <U>Section</U><U></U><U>&nbsp;2.2(b)</U> of the Agreement, please provide us with the following information: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="24%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The exact name that the Securities are to be registered in (this is the name that will appear on the stock certificate(s)). You may use a nominee name if appropriate:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The relationship between the Purchaser of the Securities and the Registered Holder listed in response to Item 1 above:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The mailing address, telephone and telecopy number of the Registered Holder listed in response to Item 1 above:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Tax Identification Number (or, if an individual, the Social Security Number) of the Registered Holder listed in response to Item 1 above:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT D </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF OPINION OF COMPANY COUNSEL </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The Company validly exists as a corporation in good standing under the laws of the Commonwealth of Virginia. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The Company is a registered bank holding company under the Bank Holding Company Act of 1956, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The Bank is an insured depositary institution under the provisions of the Federal Deposit Insurance Act, and the Bank&#146;s deposit
accounts are insured up to applicable limits by the Federal Deposit Insurance Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The Company has (A)&nbsp;the corporate
power to execute and deliver the Transaction Documents and, to perform its obligations under those Transaction Documents including, without limitation, the issuance of the Shares, (B)&nbsp;taken all corporate action necessary to authorize the
execution, delivery and performance of the Transaction Documents and (C)&nbsp;executed and delivered the Transaction Documents (subject, with respect to subsections (A)&nbsp;and (B), to the need to obtain the Stockholder Approvals, file with the
VSCC the Articles Amendment, and receive from the VSCC a certificate of amendment issued with respect thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. Each of the Agreement,
the Warrant and Registration Rights Agreement has been duly authorized, executed and delivered by the Company and, assuming (except with respect to the Warrant) the due authorization, execution and delivery by the other parties thereto, constitutes
a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as the enforceability thereof may be limited by (A)&nbsp;bankruptcy, insolvency, fraudulent or voluntary conveyance, moratorium,
liquidation, reorganization or similar federal or state laws affecting the enforcement of creditors&#146; rights in general, (B)&nbsp;general principles of equity, whether applied by a court of law or equity, including the possible unavailability of
specific performance, appointment of a receiver or injunctive relief, (C)&nbsp;the exercise of discretionary powers by any court before which specific performance, injunctive relief or other equitable remedies may be sought, (D)&nbsp;other equitable
remedies and defenses, (E)&nbsp;procedural requirements of law applicable to the enforcement of creditors&#146; remedies, (F)&nbsp;principles of diligence, good faith, reasonableness, fair dealing, conscionability and materiality, (G)&nbsp;judicial
discretion inherent in the forum addressing enforceability, and (H)&nbsp;the effect of public policy on the enforceability of provisions relating to indemnification or contribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. The Company&#146;s execution and delivery of the Transaction Documents and consummation of the transactions contemplated thereby, including
without limitation the issuance of the Shares, (A)&nbsp;upon obtaining the Stockholder Approvals, filing with the VSCC the Articles Amendment, and receiving from the VSCC a certificate of amendment issued with respect thereto, will not result in a
violation of the Articles of Incorporation (as they are to be amended by the Articles Amendment) or Bylaws of the Company, (B)&nbsp;do not result in a breach of any of the terms or provisions of, constitute a default (or an event that, with notice
or lapse of time or both, would constitute a default) under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company under, any of the agreements and contracts identified on <U>Schedule
A</U> attached hereto, (C)&nbsp;do not violate any existing obligation of the Company under any court order or judgment of any governmental agency or court having jurisdiction over the Company that is identified on <U>Schedule B</U> attached hereto,
which exhibit lists all court orders or judgments that the Company has certified to us are applicable to it, or (D)&nbsp;do not result in a violation of any Applicable Law, except with respect to subsections (B)&nbsp;or (D), for such violations as
would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. Except as set forth in Section&nbsp;3.1(e) and 4.13 of the Agreement, no approval,
consent, authorization or order of, or filing with, any governmental authority having jurisdiction or authority over the Company is required by any Applicable Law in connection with the Company&#146;s execution and delivery of the Transaction
Documents and consummation of the transactions contemplated thereby, including without limitation the issuance of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. Assuming
the accuracy of the representations and warranties of, and compliance with the covenants and agreements by, each of the Purchaser and the Company set forth in the Agreement, it is not necessary in connection with the offer, sale and delivery of the
Shares to the Purchaser pursuant to the Agreement to register the Shares under the Securities Act, it being understood that we express no opinion as to any subsequent transfer, sale or conveyance of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. The issuance of the Common Shares has been duly authorized and the Common Shares, when issued and paid for in accordance with the terms of
the Agreement, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> free of any preemptive rights under the Company&#146;s Articles of Incorporation or Bylaws, under the VSCA or under any of the agreements
and contracts identified on <U>Schedule A</U> attached hereto (except as noted therein). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. The issuance of the Preferred Shares has
been duly authorized and the Preferred Shares, when issued and paid for in accordance with the terms of the Agreement, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> free of any preemptive rights under
the Company&#146;s Articles of Incorporation or Bylaws, under the VSCA or under any of the agreements and contracts identified on <U>Schedule A</U> attached hereto (except as noted therein). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. Subject to the need to obtain the Stockholder Approvals, file with the VSCC the Articles Amendment, and receive from the VSCC a
certificate of amendment issued with respect thereto, (A)&nbsp;the issuance of the Underlying Preferred Shares upon conversion of the Preferred Shares in accordance with their terms has been duly authorized on the part of the Company, (B)&nbsp;the
Underlying Preferred Shares have been duly reserved for issuance by all necessary corporate action on the part of the Company and (C)&nbsp;the Underlying Preferred Shares, when issued upon conversion of the Preferred Shares in accordance with the
terms of the Preferred Shares, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and free of any preemptive rights under the Company&#146;s Articles of Incorporation or Bylaws, under the VSCA or under any
of the agreements and contracts identified on <U>Schedule A</U> attached hereto (except as noted therein). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. The issuance of the
Warrant Shares upon exercise of the Warrant in accordance with their terms has been duly authorized on the part of the Company. The Warrant Shares have been duly reserved for issuance by all necessary corporate action on the part of the Company and,
when issued and paid for in accordance with the terms of the Warrant, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and free of any preemptive rights under the Company&#146;s Articles of Incorporation
or Bylaws, under the VSCA or under any of the agreements and contracts identified on <U>Schedule A</U> attached hereto (except as noted therein).</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. Subject to the need to obtain the Stockholder Approvals, file with the VSCC the Articles Amendment, and receive from the VSCC a
certificate of amendment issued with respect thereto, (A)&nbsp;the issuance of the Warrant Common Shares upon exercise of the Warrant or upon conversion of the Warrant Shares, in each case in accordance with their terms, has been duly authorized on
the part of the Company, (B)&nbsp;the Warrant Common Shares have been duly reserved for issuance by all necessary corporate action on the part of the Company and (C)&nbsp;the Warrant Common Shares, when issued upon exercise of the Warrant or upon
conversion of the Warrant Shares, in each case in accordance with their terms, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and free of any preemptive rights under the Company&#146;s Articles of
Incorporation or Bylaws, under the VSCA or under any of the agreements and contracts identified on <U>Schedule A</U> attached hereto (except as noted therein). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. The Company is not, and upon the issuance of the Shares pursuant to the Agreement will
not be, required to register as an &#147;investment company&#148; as such term is defined in the Investment Company Act of 1940, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT E </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF IRREVOCABLE TRANSFER AGENT INSTRUCTIONS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">As of _________, ____ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Computershare </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">250 Royall Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Canton, Massachusetts 02021 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: _________________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is made to that certain Securities Purchase Agreement, dated as of June&nbsp;7, 2024 (the &#147;<I>Agreement</I>&#148;), by and
between Blue Ridge Bankshares, Inc., a Virginia corporation (the &#147;<I>Company</I>&#148;), and Richard T. Spurzem (including his permitted transferees, the &#147;<I>Holder</I>&#148;), pursuant to which the Company is issuing to the Holder
(i)&nbsp;shares (the &#147;<I>Common Shares</I>&#148;) of Common Stock of the Company, no par value per share (the &#147;<I>Common Stock</I>&#148;), (ii) shares of Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B
(&#147;<I>Series B</I>&#148;), of the Company, par value $50.00 per share (the &#147;<I>Preferred Stock</I>&#148; and the shares of Common Stock into which such shares of Preferred Stock are converted, the &#147;<I>Underlying Preferred
Shares</I>&#148;) and (iii)&nbsp;warrant (the &#147;<I>Warrant</I>&#148;), which is exercisable into (Y)&nbsp;shares of Series B (&#147;<I>Warrant Preferred Shares</I>&#148;), or (Z)&nbsp;after the conversion of the Preferred Stock into Common Stock
pursuant to the provisions of the Company&#146;s Articles of Incorporation as then in effect, shares of Common Stock (&#147;<I>Common Preferred Shares</I>&#148; and together with the shares of Common Stock into which the Warrant Preferred Shares are
converted, the &#147;<I>Warrant Shares</I>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter shall serve as our irrevocable authorization and direction to you
(provided that you are the transfer agent of the Company at such time and the conditions set forth in this letter are satisfied), subject to any stop transfer instructions that we may issue to you from time to time, if any: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;to issue certificates representing shares of Common Stock upon transfer or resale of the Common Shares; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) after the conversion of the Preferred Stock into Common Stock pursuant to the provisions of the Company&#146;s Articles of Incorporation
as then in effect, to issue certificates representing shares of Common Stock upon transfer or resale of the Underlying Preferred Shares; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;to issue shares of Preferred Stock or, after the conversion of the Preferred Stock into Common Stock pursuant to the provisions of
the Company&#146;s Articles of Incorporation as then in effect, shares of Common Stock upon the exercise of the Warrant to or upon the order of the Holder from time to time upon delivery to you of a properly completed and duly executed Exercise
Notice, in the form attached hereto as <U>Annex</U><U></U><U>&nbsp;I</U>, which has been acknowledged by the Company as indicated by the signature of a duly authorized officer of the Company thereon together with indication of receipt of the
exercise price therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You acknowledge and agree that so long as you have received (a)&nbsp;written confirmation from the
Company&#146;s legal counsel that either (1)&nbsp;a registration statement covering resales of the Common Shares, the Underlying Preferred Shares and the Warrant Shares has been declared effective by the Securities and Exchange Commission (the
&#147;<I>Commission</I>&#148;) under the Securities Act of 1933, as amended (the &#147;<I>Securities Act</I>&#148;), or (2)&nbsp;the Common Shares, the Underlying Preferred Shares and the Warrant Shares have been sold in conformity with
Rule&nbsp;144 under the Securities Act (&#147;<I>Rule</I><I></I><I>&nbsp;144</I>&#148;) or are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144
as to such securities and without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions and (b)&nbsp;if applicable, a copy of such registration statement, then, unless otherwise
required by law, within three (3)&nbsp;Trading Days of your receipt of a notice of transfer or the Exercise Notice, you shall issue the certificates representing the Common Shares, the Underlying Preferred Shares and/or the Warrant Shares, as the
case may be, registered in the names of the Holder or transferees, as the case may be, and such certificates shall not bear any legend restricting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transfer of the Common Shares, the Underlying Preferred Shares or the Warrant Shares thereby and should not be subject to any stop-transfer restriction; <I>provided, however</I>, that if such
Common Shares, Underlying Preferred Shares and Warrant Shares are not registered for resale under the Securities Act or able to be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information
required under Rule 144 as to such securities and without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions, then the certificates for such Common Shares, Underlying Preferred
Shares and/or Warrant Shares shall bear the following legend: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON CONVERSION OF
THESE SECURITIES HAVE BEEN REGISTERED] [THESE SECURITIES HAVE NOT BEEN REGISTERED] UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED OR ASSIGNED (I)&nbsp;IN THE ABSENCE OF (A)&nbsp;AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B)&nbsp;AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II)&nbsp;UNLESS SOLD PURSUANT TO RULE 144 UNDER
THE SECURITIES ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Preferred Stock, the Warrant and, prior to the conversion of the Preferred Stock into Common Stock pursuant to the provisions of
the Company&#146;s Articles of Incorporation as then in effect, the Warrant Preferred Shares shall bear the foregoing legend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A form of
written confirmation from the Company&#146;s outside legal counsel that a registration statement covering resales of the Common Shares, Underlying Preferred Shares and the Warrant Shares has been declared effective by the Commission under the
Securities Act is attached hereto as <U>Annex</U><U></U><U>&nbsp;II</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please be advised that the Holder is relying upon this letter as an inducement
to enter into the Agreement and, accordingly, the Holder is a third party beneficiary to these instructions. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">BLUE RIDGE BANKSHARES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Annex I </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF EXERCISE NOTICE<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[To be executed by the Holder to purchase shares of Series B Preferred Stock under the Warrant] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) The undersigned is the Holder of
Warrant No. __________ (the &#147;<I>Warrant</I>&#148;) issued by Blue Ridge Bankshares, Inc., a Virginia corporation (the &#147;<I>Company</I>&#148;). Capitalized terms used herein and not otherwise defined herein have the respective meanings set
forth in the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) The undersigned hereby exercises its right to purchase __________ Warrant Shares pursuant to the Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) The Holder intends that payment of the Exercise Price shall be made as (check one): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Cash Exercise </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Cashless Exercise&#148; under <U>Section</U><U></U><U>&nbsp;10</U> of the Warrant </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) If the Holder has elected a Cash Exercise, the Holder shall pay the sum of $___________ in immediately available funds to the Company in accordance with
the terms of the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(5) Pursuant to this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in accordance with the
terms of the Warrant. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Dated:____________________</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name of Holder: ___________________________</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:__________________________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name: _______________________________</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title: _______________________________</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Signature must conform in all respects to name of Holder as specified on the face of the Warrant) </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the conversion of the Preferred Stock into Common Stock pursuant to the provisions of the Company&#146;s
Articles of Incorporation as then in effect, this Form of Exercise Notice and Acknowledgement will be updated to replace references to shares of Series B Preferred Stock with references to shares of Common Stock. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACKNOWLEDGEMENT </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby acknowledges this Exercise Notice and receipt of the appropriate exercise price and hereby directs Computershare to issue
the above indicated number of shares of Series B Preferred Stock in accordance with the Irrevocable Transfer Agent Instructions dated __________, ____, from the Company. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">BLUE RIDGE BANKSHARES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Annex II </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF NOTICE OF EFFECTIVENESS OF REGISTRATION STATEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Computershare </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">250 Royall Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Canton, Massachusetts 02021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: _________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Re: <U>Blue Ridge Bankshares, Inc.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies
and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are counsel to Blue Ridge Bankshares, Inc., a Virginia corporation (the &#147;<I>Company</I>&#148;), and have
represented the Company in connection with that certain Securities Purchase Agreement, dated as of June&nbsp;7, 2024, entered into by and between the Company and Richard T. Spurzem (the &#147;<I>Purchaser</I>&#148;) pursuant to which the Company
issued to the Purchaser (i)&nbsp;shares (the &#147;<I>Common Shares</I>&#148;) of Common Stock of the Company, no par value per share (the &#147;<I>Common Stock</I>&#148;), (ii) shares of Mandatorily Convertible Cumulative Perpetual Preferred Stock,
Series B (&#147;<I>Series B</I>&#148;), of the Company, par value $50.00 per share (the &#147;<I>Preferred Stock</I>&#148; and the shares of Common Stock into which such shares of Preferred Stock are converted, the &#147;<I>Underlying Preferred
Shares</I>&#148;) and (iii)&nbsp;warrant (the &#147;<I>Warrant</I>&#148;), which is exercisable into shares of Series B (&#147;<I>Warrant Preferred Shares</I>&#148;), or, after the conversion of the Preferred Stock into Common Stock pursuant to the
provisions of the Company&#146;s Articles of Incorporation as then in effect, shares of Common Stock (&#147;<I>Common Preferred Shares</I>&#148; and together with the shares of Common Stock into which the Warrant Preferred Shares are converted, the
&#147;<I>Warrant Shares</I>&#148;). Pursuant to that certain Registration Rights Agreement of even date, the Company agreed to register the resale of the Common Shares, the Underlying Preferred Shares and the Warrant Shares (collectively, the
&#147;<I>Registrable Securities</I>&#148;), under the Securities Act of 1933, as amended (the &#147;<I>Securities Act</I>&#148;). In connection with the Company&#146;s obligations under the Registration Rights Agreement, on
<U></U><U></U><U></U><U></U>, ____, ___ the Company filed a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-__</FONT> (File No.&nbsp;333-<U>&#8195;&#8195;&#8195; </U><U></U><U></U><U></U>) (the &#147;<I>Registration
Statement</I>&#148;) with the Securities and Exchange Commission (the &#147;<I>Commission</I>&#148;) relating to the Registrable Securities which names the Purchaser as a selling stockholder thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the foregoing, we advise you that a member of the Commission&#146;s staff has advised us by telephone that the Commission
has entered an order declaring the Registration Statement effective under the Securities Act at ____ [a.m.][p.m.] on __________, ____, and we have no knowledge, after telephonic inquiry of a member of the staff, that any stop order suspending its
effectiveness has been issued or that any proceedings for that purpose are pending before, or threatened by, the Commission and the Registrable Securities are available for resale under the Securities Act pursuant to the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter shall serve as our standing notice to you that _________________ may be freely transferred by the Purchaser pursuant to the
Registration Statement. You need not require further letters from us to effect any future legend-free issuance or reissuance of ___________________ to the Purchaser or the transferees of the Purchaser, as the case may be, as contemplated by the
Company&#146;s Irrevocable Transfer Agent Instructions dated __________, ____, provided at the time of such reissuance, the Company has not otherwise notified you that the Registration Statement is unavailable for the resale of
_____________________. This letter shall serve as our standing instructions with regard to this matter. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Very truly yours,</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT F </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF SECRETARY&#146;S CERTIFICATE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
undersigned hereby certifies that she is the duly elected, qualified and acting Secretary of Blue Ridge Bankshares, Inc., a Virginia corporation (the &#147;<I>Company</I>&#148;), and that as such she is authorized to execute and deliver this
certificate in the name and on behalf of the Company and in connection with the Securities Purchase Agreement, dated as of June&nbsp;7, 2024, by and between the Company and Richard T. Spurzem (the <I>&#147;Securities Purchase Agreement&#148;</I>),
and further certifies in her official capacity, in the name and on behalf of the Company, the items set forth below. Capitalized terms used but not otherwise defined herein shall have the meaning set forth in the Securities Purchase Agreement. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attached hereto as <U>Exhibit A</U> is a true, correct and complete copy of the resolutions duly adopted by the
Board of Directors of the Company at a meeting of the Board of Directors held on ___________. Such resolutions have not in any way been amended, modified, revoked or rescinded, have been in full force and effect since their adoption to and including
the date hereof and are now in full force and effect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attached hereto as <U>Exhibit B</U> is a true, correct and complete copy of the Articles of Incorporation of
the Company, together with any and all amendments thereto currently in effect, and, except as contemplated by the Stockholder Approvals, no action has been taken to further amend, modify or repeal such Articles of Incorporation, the same being in
full force and effect in the attached form as of the date hereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attached hereto as <U>Exhibit C</U> is a true, correct and complete copy of the Bylaws of the Company and any
and all amendments thereto currently in effect, and no action has been taken to further amend, modify or repeal such Bylaws, the same being in full force and effect in the attached form as of the date hereof. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each person listed below has been duly elected or appointed to the position(s) indicated opposite his or her
name and is duly authorized to sign the Securities Purchase Agreement and each of the Transaction Documents on behalf of the Company, and the signature appearing opposite such person&#146;s name below is such person&#146;s genuine signature.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Signature</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">[ &#8195;&#8195;&#8195;&#8195;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">[&#8195;&#8195;&#8195;&#8195; ]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned has hereunto set her hand as of this ____ day of ________, ___. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, [Insert Name], Chief Executive Officer, hereby certify that [Insert Name] is the duly elected, qualified
and acting Secretary of the Company and that the signature set forth above is her true signature. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Resolutions </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Articles of Incorporation </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Bylaws </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT G </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF OFFICER&#146;S CERTIFICATE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
undersigned, the Chief Executive Officer of Blue Ridge Bankshares, Inc., a Virginia corporation (the &#147;<I>Company</I>&#148;), pursuant to Section&nbsp;5.1(k) of the Securities Purchase Agreement, dated as of June&nbsp;7, 2024, by and between the
Company and Richard T. Spurzem (the &#147;<I>Securities Purchase Agreement</I>&#148;), hereby represents, warrants and certifies as follows (capitalized terms used but not otherwise defined herein shall have the meaning set forth in the Securities
Purchase Agreement): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The representations and warranties of the Company contained in the Securities Purchase Agreement are true and
correct in all material respects (except for those representations and warranties which are qualified as to materiality, in which case, such representations and warranties shall be true and correct in all respects) as of the date when made and as of
the date hereof, as though made on and as of such date, except for such representations and warranties that speak as of a specific date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of the date hereof, the number of shares and type of all authorized, issued and outstanding capital stock,
options and other securities of the Company (whether or not presently convertible into or exercisable or exchangeable for shares of capital stock of the Company) is set forth in <U>Schedule 3.1</U>(g) hereto. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company has performed, satisfied and complied in all material respects with all covenants, agreements and
conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the date hereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No bank regulatory authority has threatened orally or in writing or otherwise informed the Company or any of
its Subsidiaries that it is contemplating any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cease-and-desist</FONT></FONT> or other order or enforcement action, except to the extent that such action would not result in a Material
Adverse Effect, and neither the Company nor any of its Subsidiaries shall have been threatened orally or in writing or otherwise informed by any bank regulatory authority that it intends to assess a civil money penalty against the Company or any of
its Subsidiaries. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned has executed this certificate this ___ day of __________, _____. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">G-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 3.1(g) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Capitalization </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Common Stock </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Total Authorized:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Outstanding:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Subject to warrants, options, convertible securities, etc.:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Reserved for benefit plans and other issuances:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Remaining authorized but unissued:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Preferred Stock </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Total Authorized:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Outstanding:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Reserved for issuance:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Remaining authorized but unissued:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[&#8195;&#8195;&#8195;]</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">G-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SCHEDULES </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>These Disclosure Schedules set forth, among other things, items the disclosure of which is necessary or appropriate in response to an
express disclosure requirement in the Agreement or as an exception to one or more of the Company&#146;s representations, warranties, covenants or agreements in the Agreement; provided, that the mere inclusion of an item in these Disclosure Schedules
as an exception to a representation or warranty shall not be deemed an admission by the Company that such item represents a material exception or fact, event or circumstance or that such item is reasonably likely to result in a Material Adverse
Effect with respect the Company. All of the Company&#146;s representations, warranties, covenants and agreements contained in the Agreement are qualified by reference to the correspondingly numbered section of these Disclosure Schedules and none
thereof shall be deemed to be untrue or breached as a result of effects arising from actions taken in compliance with a written request or consent of the Purchaser. Information disclosed under one section of these Disclosure Schedules shall be
deemed to qualify (i)&nbsp;any subsections of the Agreement specifically referenced or cross-referenced and (ii)&nbsp;other subsections of the Agreement to the extent it is reasonably apparent (notwithstanding the absence of a specific cross
reference) from a reading of the disclosure that such disclosure applies to such other subsections and contains sufficient detail to enable a reasonable person to recognize the relevance of such disclosure to such other subsections. Capitalized
terms used but not defined herein shall have the meanings ascribed to such terms in the Agreement. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 3.1(a) </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Subsidiaries </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Blue Ridge Bank, National
Association </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BRB Financial Group, Inc. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 3.1(e) </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Filings,
Consents and Approvals </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amended and Restated Securities Purchase Agreement, dated April&nbsp;3, 2024, by and among the Company and each purchaser
identified on the signature pages thereto (the &#147;SPA&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Registration Rights Agreement, dated April&nbsp;3, 2024, by and among the Company and the
several purchasers signatory thereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Warrants, dated April&nbsp;3, 2024, issued by the Company in connection with the SPA </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Registration Rights Agreement, as contemplated by the Agreement, to be entered into by and between the Company and Richard T. Spurzem </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock Purchase Agreements and Registration Rights Agreements, dated December&nbsp;31, 2014 and March&nbsp;17, 2015, by and among the Company and the
purchasers signatory thereto </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 3.1(f) </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Issuance of Securities </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See Schedule 3.1(e) </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 3.1(g) </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Capitalization </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Common Stock </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Authorized:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,981,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subject to warrants, options, convertible securities, etc.:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reserved for benefit plans and other issuances:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,134,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remaining authorized but unissued:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,854,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Preferred Stock </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Authorized:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reserved for issuance:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remaining authorized but unissued:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">228,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See Schedule 3.1(e) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Schedule 3.1(m) </U></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Compliance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bank has one or more pillar failures in its BSA program, which are violations of law under Section&nbsp;8(s) of the Federal Deposit Insurance Act. The
Bank continues to take actions to remediate its BSA program, including corrections of pillar failures. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 3.1(y) </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Registration Rights </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See Schedule 3.1(e) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>brbs-20240607.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/11/2024 4:03:03 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:brbs="http://www.mybrb.bank/20240607"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.mybrb.bank/20240607"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="brbs-20240607_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="brbs-20240607_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>brbs-20240607_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/11/2024 4:03:03 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>brbs-20240607_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/11/2024 4:03:03 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="brbs-20240607.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140101756757328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 07, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000842717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  07,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BLUE RIDGE BANKSHARES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">VA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">54-1838100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1801 Bayberry Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Richmond<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(540)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">743-6521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, no par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BRBS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 3T;+6)E<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" !/1LM816_#-7\$  ##$0  &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 3T;+6)^@&_"Q @  X@P   T
M             ( !PPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !/1LM8
MEXJ[',     3 @  "P              @ &?#P  7W)E;',O+G)E;'-02P$"
M% ,4    " !/1LM8'#AEZC\!   \ @  #P              @ &($   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ 3T;+6"0>FZ*M    ^ $  !H
M         ( !]!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ 3T;+6&60>9(9 0  SP,  !,              ( !V1(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  (Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d828101d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>brbs-20240607.xsd</File>
    <File>brbs-20240607_lab.xml</File>
    <File>brbs-20240607_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d828101d8k.htm">d828101d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d828101d8k.htm": {
   "nsprefix": "brbs",
   "nsuri": "http://www.mybrb.bank/20240607",
   "dts": {
    "schema": {
     "local": [
      "brbs-20240607.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "brbs-20240607_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "brbs-20240607_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d828101d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-06-07_to_2024-06-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d828101d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-06-07_to_2024-06-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d828101d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.mybrb.bank//20240607/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-24-158758-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-158758-xbrl.zip
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M^=?09]&Q!P"$UA-5K8V#M@//=1$&8T<R_;>XKT'LK^)L%(^SA(Q%H![DO*6
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M;<=UMWVY^B%FFU/<W0RGO;UJMPU]_0502P,$%     @ 3T;+6%E(&-^I!@
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ME@R8:+=Q4=YQI;;T;Q?*=]'L=^RH/?\#4$L#!!0    ( $]&RU@FR/I6W 0
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M!SL'H*E6P.@+J(.#]6B#IQK_M<3J6Z1 ,([Y N%#P/X!T4-H.Q3E/,HSZ;P
M<.",9)3=MC2PFY"/S1*I[T^G3AA^"S1!;<BD]/[7DN/R9L NIC/7GXM@XP3)
MZE5VY3=3NA25GN',%+273NZ#UYQWK,Q+H+/1&?7>U[JK#_LVO3'-F\]SR,YL
M.Q!AJ/Y\@A"E\W3#=M"NG78.VAUVSN<@8\&<@7<71"_E<*WDG:]ISO\N'N@^
M@P<ZM=-!#$X6Z[0[;Y3_+BC?AX]?@EO_WGL&W;NUTQO'FDQ]S\Z3O5Z=!\W
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M[LR^>/1E.Z0??W5(?Y*=Z+* CLI5U0&(=? ;SO,7/^N8'D[JHFDXSXB%'AJ
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MB(52(K*V9[N\VGRH$A>A_GA9]O?(9(,.5CDB3!0@<824&90/=D= 0,ZV)]#
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M6=)8=G^*5=W-(8]/N<.:NNL\(O,/*<.^H!UK<Q\]%"2VY%S<E0G<?7%K7/+
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M:!D.#&FGEE5@;1FT,!>K2 FD<%5,5J2G<K"#E$*%@:9W$\[8!; Z9U(NBDW
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M-G&P(IR:(DC0:(BG3 V04L)""X^4]!#)%M>0H$'-?6C,!<H4=RD[CFUHZM3
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MWL7*W_[6Z:<VH_BD ;O^\?W'V++IP!9$:/^M)I0E;>IG$_K\N[R1BP<N1O1
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M[W+LJXIHH9(&!T8&ORMA$A:5)&6E'Q+ +IC(UR_&M+C[G_I\Z*5)N3/<!LX
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MDHR0SUUV-Z=*LQ>=4W%]QJV)$U$X37Z"%F1JW[@FH2"H:D=O*:7.J2/D%DM
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M-BV;MUUF$=VC(N8(O.6T$/*5&N3!V,0HN@RS"&65)FTC#$TSOY=2KY#@OWW
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M_,/'8(GN/=KOYPV22*:_$%NE Z/?Z,W#@"=TT5"J&CXY*^J&IXK9C2CRB61
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MEW?NT[Z_3N#VK9G->,G&RV<;4K",R*^'ILA("QWFLV!AD!B*34Q> 2&)VO2
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M7*_BZ]?H*MG%%I\]QIH//CO*SZD,C'Q+IGD4_Q)4 H;"0(,P(G6N:SR?"D.
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MJ]6FM8V)3R3'WJC^:%[!MT<WXCBNK_GR.^P6!PO*'"%YN;"!%G!/7Y5]:H4
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M(L=1,S1S5@4MCHT/D69']DTF$B:BW0^@XD/)%_5(+PT!#"0G-:I*AL29! S
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MO@2-!+>V>#ON)+,('OTLHJ9=>OC,G5%9HF=VGABH&M\=B5K(^G\&59P*V,!
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MFC(!,N684*$5T2\$0_/0 I)Q"=.<&Q&NMST_FQ9WUOXA79[T=:7L-[?_9I,
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M <?:)08+&^G.AOH'+*R#@SQSS4KJZ"*_2U^J+V4%N-HER B;EVXEIZ54/OB
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M%>[DT8 X)-^[4C]],RLTV^JV55U7PP29GTN;6LKU2A,%+@?3SFD?LNJI*.G
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M4VQ5F23W,1PZB'GK[3:O67FW:]:JKQ8":;\B-7,VET,VEFTY>B^Z<^HHM6R
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MC:_K6 @VCV,R;P:O%=Y[DPTF$&D$-I%IE];4+R@=H[S0%UG_18&,IGBK\3]
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M2(AZV:AZ5-<1$HXQ?N&82,.P>AC0KOAFDB-;9:B"G/2=@^HM4!_,MP7!O79
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M+(=VG8$%BXP+'MG .(46:F/BIV'D>VT_D0JO [?^2B\),A7"^6?C!'D/:Z0
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M!>]-A5&6NU^FL.]LX(/[G-!3:R,,5E/[WLT*&ZOD6_4Y1R*5U[<.12[153Q
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M*E=1CC>=O %L 3PR!;&A[&4-O;R>TBS*U,;R^<S Y(. AJ+_G_6L)8YRQS+
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MQZR+0#"KD6M4C(23 \H<B<9LL?<'&FV2DJ_HHO$C:]06**9*OZJJN).U5.B
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M1U>GL?:>3F29DE'P[ 2=3O51E.,TN2R4A4X(H1!(1UL>JI$BHS_Q%M&5WO"
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M)]Q]X%:.76":C_YB;31]Q\#!M[_4D)K(C%A@[K/O]*?XCZ'ZK17,>M#F,FE
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M#XE4BLXU@!Y/%Y !1ES(GA=OP2WX_*[L?E?6Z:S%[_<F?D;[]>)&T4(S MI
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M&V'?XP+50I$18[!@H# 5[%F=JE2G[M:2O0V)_B#IDPSTXGX$ ,Q\!REU@D3
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M\<E%%0F7.A0FY@P+2+F1"L&#JUZ>GSJTL'EZZF>YL'Z8][ZRPQQ.BK$3T83
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MX$K;BS9R["_M 8\/SZ1C;WZO0UDQ+K.T_1$*W 78X3,5S)W=!>5J?]$6)_N
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M6=X ]O0-Z(P Y)O?"4XE>'O1YH;:1O42K+"+ORE%9^',<_BIUG!%A-/$$0[
M!]#E\TKQY7HV:X&]I\ N)3>D"_M#Y6BG:L;J7TKU_2AN5\KI1\DF*]NKFJ3@
MV\)/XU]Y#U]+R#TE9"F1>$^E 2\AE_!=95F/T.^I@@3US!#H,$9YUH^Q%$3]
ML&N8/C&@@U5E1(VM_QL". 2$SR00$+FR89VX-Z$?H^ZT!8F&(&"&BI1KLK#Q
MM6"W%<&_E"I.^EC\$J7 *&'T,YAP%5$E4XK\0?T[6W6%X4!P9AG.,ZPH3;-)
MVHU[=D*V:-I924[3%H+E8SQ6/L-D3!PC/"5ORPJS9QA!- _A'=S<,%L(@ZF(
MIKT)?N+C*F9T%H_RN(#0.AYN?FK08L:@5^TP^,QQ(/&K3TS[,?7WKW>9H:8<
M^IGVTY<'[>\JE;RW3B5_QZGDYUPIOU!QB[J?EI(]K#"YE3HFUJNO:78[B'M7
M,9FJG, (B0++"T&?3=17IO(+[G5?'&!E4UO3#,Y:3A5JJP8)S8R-4X?TAC8[
M4(/=0CLO!2#YE[?9!"C#8G(K_%*OYF22FTA2-X<)6"A78##!2\DVPM[I#).7
MD>JV6SM8Z%/^^RLG5_4[--T>K'WD'ZW=961!^6C0%-DH7^1$<+9F9Z?=^JEM
MV3<KCT55\N9- &TCZ,!R;)9^2K[ L.RHBF!MZ[!-1E-2>#$X.C#S!>&0GO"(
M*]<XC)MG\ RT,\11*P5U'7^_(/$WR@<?#'ZR,D\@^YI ZC>-4NQNA<],)F.H
M[#FD3X(YX4.<;8+W0FO,)9%@Q<#'&(WU5(;J^>.">++RI/AJ.MNJ)_$[/)J+
M'K^E9$>=X]<=)!#C6^'QX\"V*V?@7VBQ<N@.D6?O4A=;@4*B^6(<'&49S\WF
M1MW!29W&4^\<54B\TY92^^:U+,\MR\M)_5)RQ )@0)DO:QT0&ZBY IXGXVT'
MFMGS3G^-)$=M[2C*HRLETM?*PSZAS_#+X+,S* ?XC=A1E!36*]<=P$&6 NLK
M)&8JWI^5GF@)4,N/HLD0OR8*I7P8$P$"BU^EF[GN[;^0,%<-K?T_'KX#?KM#
M1YB?2%O_X;L/G\Z"X[\?'WU!XNS#WX+.:7!RJAS:D_=?.A\!?04&/CO9W>^H
M?7QAKKI5>]6+_MY.X%&]<J.^9_4ZEH%QY3WJ0?&[]#<6^_7AW=-=DD>S(I:S
ME #[O\JM7,*OG]F*K_+7GY$_&-@\'QHX;]$3M+;'[F>/'3XO>^SX].+DXK>U
M+?:0MMBBF.:+VE*+$Q&M!L-N;F/LB2O_8_+UGX/V__%WCP_]O7E0\X3UGBRZ
M\X^/A]R\]@37GN#:$UQ[@FM/<+V?L_SZ(AD/GOQ63G/J[^_4?=]._='3=>IA
M:<"?[WP,SM4GG8LO9\?G02OIZ[PS)H:=UD[1'0HE2$0$W?O_V[ORWK:1+/^_
M 'T'HF=V(0.T._*1N-.9 +(L)YIV[*QD)Y-M- :T5++939$:4DRB_?3[CJIB
M\=!AZ[)C-C"31***=;QZY^^]%_2HT,/.:R22:<Z YU[6M_0%E+Z TA?P[&YM
MZ0LH?0&E+Z#T!92^@-(74/H"RO/\P7P!3S2O[[#,Z_N1E>[25"Y-Y=)4+F_M
M=F]M:2N7MG)I*S]F3;^TE9^3;57:RH_M1$I;^0G8RD?/P5;>V(Z^N7[;^M?[
M]DG[:GY^>7-W7^644X_=![1U-Z9:O^]4NU>7S=_ [.A<M<_:S<95*]U9>?-M
MYC\:">FPC[( "FT-[@[]P;=D?V^_=K-#O9]E]G'C-A242&];(VYG+$NM6'&4
M]-<K[)C\.K?29P5@6,HD>KFP4;9?/,#^%MOUU&<UME\L3_^*JOLXO;'E8T'.
MPK)Y(?7*OA'I=A!6C7/M(WH^^?4WU_,L9S023J@Z1T;CH/>7405/U**=G3WK
M2Q##%9Q86(74L?Q@Z/I"CH3-($9P 4:A"X^O4H;.WH\5:40_;FF)_=607"BX
M@CFBMH"RQM^$8%))-6(O*)2('W42,GP?>%@S0E;<!J(,130*L.(?4&Q[+(96
MG:M(E"3T:$CH8#4D-'1<CPI3]OMPZ)$-HML3HSLL-4J$ O_J!:.)Y<?#FX2<
M2MI9/^V8K__^& K>EN=7GE]Y?N7YE>=7GM_3UIT.5Z,[73G?K3:555=5R:T+
M5I-JJA6?V95"EBP/J"BE;F[(O]CYP36KI^X?W=^ME_[1]?A'3^=Y/5^NX?UG
MEYT/UN69=?FQ?8&U3N"OS<L/P)*^P)_7%]W6^>;]GO4]Z\JHW/D5#J?O32SQ
M'1A 1)T#4HE9N?8024%2S_D6&1T^AH'_33C>F!K.?')QUJZSM_D%[J<7Z.**
M#&<8=EC5C114$\MD42?X]7OY=:[Z]]%+JLKM# 7\H+^%Q1WPXFB6N#*?F\'"
MNOIB%$3NV DGJ=X:R<K(1<V]6.6AG8F^X![:]%.KK?O*-K"HN'+AX,M4'R+Y
M%NK6&L18218]CFH.\0B%AC,:>2"IL+@QM6Z,,/-O]ON:"<7QIA;SB/7LZ6&:
M8+#N<ZTAJ])2DR,Y.:R&&WS#W0QD-QSV7O2%YWZ5FWP%ZXD<KFU[*E,9R1EF
MXZ]&(L1  +6@#FZ *\K6*>J0L%)U\0BNW_-BI$GN@1C$8]Y;HTL)%I6GS53.
MN#LXFHAJ:\NU.'\)GRJ[ZA59\D6^P*K<2#MX?C&\((3-PV&J%=GX!U\C5SJA
M9<O%F*^<NOJD'+?<N+ZY<Z(_X]>U*+[Y4_14\T?43N!?Z3+"QH'1RTYV;*XO
M*V!E.'H VXU-R'ECT,-]QVI/ QW7P .Q5;CKZ?Y;L.Q/W6:3@SWAV.UY0#(-
MO/4<]:'2W+!G6!69&MW@@_0+QW2=4TEF]2NN^M_/+ .; HR#G<U3_=&>U3+Z
MDR4A+:ZX_MD)0XR.X4I96Y0"H>/>WL&QZ.?IOMR@2[@?@QS1Q--7+:-R9RVY
M@;IO=#D<V)LALMP:%H@?C7.';<QIA_[1CX5^F;P%FE+-%T[4^P)J@( 9R.B?
MEAN/6<B26PHLN<[RD(NYN[*9CEYIME66P+!>CWM2.+<.LMUT56SJ?A2$?;HC
MW!H;M@[DT#"R+;E0AV,R>BSN<$O3@_=AR.5&Z!:XL!1-Z2C(PG@T[DVH(WC@
M?14^_GT0.C$<!4TXM+X&'K!IO-FPT*]B@E.QL;F3,X:=BX=PW)[[G]CMRSV$
MMYI=@(TVO0/)O64#)2G_G<$ [Z"L,2Y7H7:+6Q %8<3BPPJ9=E"GX$9$!G?2
MG<1"X'7NR..63%RO&9NQ"NZ0CK)%%>L'"132>V F."WUL&:6+/>"*'+QB&+?
M^>K 4N06!X-J)>DKD# S&U^"/?G4*AQUU4-JHN[_&?M<#ST$"A,#.V%NW'Y#
MA#V76Q3TW0BV@#I>P0&0\"!AB,3!DV>M7-:I+IY-[H4X"R9F6C"1']9U[R-=
M2X*)@ABV&J9V*J>6^0&V_I._X+LRH%Y2\(.6_ 'PQ9[H4T>65.5XN=V&D)>W
M<][9R_?!*\[T*\RC[L.QW I:,FF< \?%]IM)BT*?(@?P,38><SP2AGA[>[B_
M\E!Q,4,@SA"L7Z*%VCOYLC^!(M FKE:24X&]Q7N6U+.'%<1#%:5  DI?2]E:
MXKUYW$3_./]1#!(=S@Y,U-Y$15,SUQH?2]0P#JPAF09HP(NAGYCX6,4<V#<U
M!=-:T495S9<IM4@I@%-X[%P%  \J'@YU?TGJB9D\'=%JL;$/M74C]G=C7N5J
M):_WS%9[%)^,1_A&$O^Z6<A4#0"?T ".!54 _,TJE ";P_'8_P2^B3VB2J=:
M^>H&7FK?]'3@WVW?M-9J+$TF!@Y VBI*"N:70OU_3B89:XXEG.;._2 [+^LF
M5-U%C2X )-MPP)2U84I9["XI!@X.4\/^?+Z%3>/'A$>0.AZ\R>T!B\+>[\Z(
M62EWS0TM(&]@"MPYJ6C0'5:FJ3EE,EM2XV&^ZFJY0[) Y)[B_+%_!TP3B.>6
MW@.,*![>L'5"%(0/(<@!#G9"33*YQTUZQ]3+S;X(2GW0]P#(OH=24/KTL$64
M3Q"DWIU P5VM- ALY(S'#GYD*?+0<D:>!A.&H+>1_4YMI[1=43@W0_: 8L(B
M#5CCK19V\/5M '?:QT^PKPWRY GS(_S5G4,$_V<<NA%P5'Z1,G_4JU0OGZEK
MM$X*EPBWG#LV?+]S;USNSAU)DT5/.3+G'"4P&-. D_>/=?^8K=2TR'+'1"-:
M0!90>.KBD1\@&>'<^:95N)F&B;I!_"Z;VG11*PH].GI=8.%$TCP%*?%(DG-?
M7E2G$Q^O-V%-1!(84!B<N"";!XX';\,'*0.Q50SLF+!:)*?VE'OQR3E'3TO7
MZ&K%^ZL];&0J+1!@94B8:*!D&\WMU6MBAUC7X5[]H  !Z0<,_P(9"O<7>3++
M1],V(Y65V<V KITA:NT"GL._'4^*N4UH/)!C/6Z4JCB5O[:X1)BE+SL0:6G_
M4$6G6EFMIE/@X)FAZ&S><7"\9S6DM<ZN K!QP4SHZ;T)C;:NQ-VPFQ2;[JY@
M=8#W"?; 34QC=K6!+N"HG31$)^Z0V4X]@9XI+Z4Z_Q0I9TC5U0WF$H?7%&J@
M[HVV%3F>*"* :H6W7QD_R7S,1E>IU^,'R@]M'*#AH37@<^2 =<>RE21W.QJC
M5<2P31(+:*/@[0M&H-DBG=)L: ]0 /TGII<BY25+8;-"^@&**&FC)L8O;&)D
M*9N#"6I_IOF7S)-/'B=7@:_4;/)3.BYU$BQRQQ@JZX")V: 6TL9! JL0"8\)
M$CQ& 4S#XOASD?=^X.^BM@CT!BS(5BC\ ;Q(*18C?.F(;7SVD214D>%+TY5_
MK<;;QJ_!'FG@-_E^7?IR<:?!!113JU OU2X[AZZ6XFFNOP6G9OU%,45]# 7<
M 10)"5%5*S.I*ON3AQ-6E@MMGZZ8U-=.6(L:/ ^CJ\U&3>M[5I<#$4M&%A;U
M*N0""Z!;/<BID(IE92_&-9Z>-T$AD[LC9/:2M @C0Y?)/5=,_FXH+\!4_BWU
M&O3(3W<\D*R=-4LR>)+Q4?,(OPIY,=5J41%$UXJ6^KD(V/3)I.-7<S8MS266
MVT&XI28'*7C5>AD)_G9+0JI:V3 SV:B0VB\44M6*BKF9]\\,)YAQN=5?.IY4
M9@X;N5WD]EE"MLHY/\D+05[.QR5=-R]<#WY,X:KN4MJ>F7FM\<B+A4;Z8MK4
M2QT-XAZFG\[F!O8L=L"ZX%PA/&4Q6Y"^A1,ID+MSMIA<5:O<XR?!?*J5IZ#:
M/TT']7[IH%ZI5#C, 3F!5IB+TP6?[A2=X83#6UJMH OP1MB)I]CTS3F$J\3+
M\^I7H^5]+[E4Q[^2TQRC.'CY<6I],7!]!M#C"]O)[W(@TL,7>1#ITZ3X@Y+B
MUX-6;VT3K=[N=%J?+IM45^*JT[CHGK4Z5N,=;*+5ONA>=:Z;6+:C^R GS$/F
M1^+MI[<-4I[_K?ZSZ:\/,=[NQ87P]L9C;%F"(>092UX%1;S=/WH!?YV@MM0=
M \L:SUC?2E[8!":)L+\/H'& A(XC,09Q_F+_Q7Y][8MMC,?^Z^1 U7]K/])S
M1^/>W@'I>R@8\F59%KAL2XFW#GIS$.Z&TF/H]"6.SAD3=L'A.*P*!ZGPDNE&
M[E/\T*%;\<_8%RP"7MD6'-XA%OP04H:]:;_5/WOS<_LM2[ =F\.C??2#<TV'
M$R\65L?MWS+F/Y):,&B,>R"Q=$Y'*C\D_1XIZU)O(02QB\B:OG4%AA[(YO\3
M0ZN6!#RQ-,D(Y*@[)E501JP$OCLU.J>JI08W!3U#1S*Q8%00),0.O^$AJI6:
M*RT*7F1^&8EI8;P/MUI]1V52LA:3'Z -@R8 ["0LR6*V43PZCI!:3,UU=RPY
M(1CY ^P<H73!?&B2K3(F'&LS'L:(' '-_Z,(1V(<.Y[I'<1Q;:">$"GG!-:J
MWZP^2[TUNX9D 7\_>K'WXL74=61>F0RJ8RC)6E*[YOKZM$B'2A[+#$FP'3;3
M" &3>GV1%U:%9<TS(P/2==6!RTAT9BW2\DMM#,_0C90E20 "FGOM2YIZ8.9J
M:ZU:=LR<XS:]^Z%5^U^5NS!0H>&9/N-D#\U=K5:R2F\^X6=A+RW#""G[BP&N
M]K2SK&7)>OIJF2R"6T9R:Y?-?"(Q3?.<[QS^3YGR>1I)&_3&QF_>ZWN%7,X#
M\<JW"20\N4J(@<>AY<*:O@8,4DE#9PA] $8*>TI@4R9!#)=:5AR3B #XC#&?
M"FPR0$/F-I^U *:X-%P04*DN*NQ?WV6T1@8_D4P:AX]@2A&:^4"Y4>*Q(\P!
M;%WR:LR%"&,)>%&8!<2FDU=$KD(ZX7 B2++PITQGGBPMCG^Y[_%H@8#00)JC
MX1",$DP+LILI%,M&J=H!QI\2YJ( U?#KTB',!ZP0I,M2+"9G5C^<PU0K!2QF
M;5L_(V#'7&D;AY$CN.EB$//\UWAR]X0#+"X<M)MFFB\6/?QA\IB""!JJ6IY'
M\.,:CR59">7I,#[;FS"V3.C4LY@2G&4R6DO.I5JY()RY;21_#'.>2E@LV.4-
MWQ??BVI#MO%?2E707G:G]Y<??/,$:-+Y=+>(@+P]9YQ\%[FWOC..0W;NYIWT
M [@+R<8D(&O,$?,S(E4.+JF#PATC)00HF9,/8A3"D#P$K'OSXA#K"1K;E.#]
M6%I$@>4%F'P7T>E2F$&&;D";<Y0N%Z+)0-&2@2L+;.K(3K62H6A/W#H$)/<C
MX?%KA$L;5ZLK#4QZ 26E4YZ;=/X!L2'_8,82%3)U>RZD0LG;7)15A6=$SW/P
M>;Y8J.)+$LF4UFM]!X/*O^4) /M0IEBUDM+'^!M3&YZ&-F37Y,&!Z9K,Z,CI
M'^2TV'TC1K.J;5'!I0AX@41JXBU%X"\2>[72B3UI^-8/#Z<O+M%2\0<X=?BK
M_$/_/&7HL;X#3.:6;"Y"[3N41(BOP%$L^$F2C8TO-?+DZ >IRTK).+2$ MAK
M'%(6FDPA,\K%)A[J](M9?@;2?DK3AIH2IGYRTLS<F-/<!^#.^B+<#0:[N LR
M)J5"4W!6X]#M)6C?VHVD!2X-*L'7-J5LCBB:1/,NOFM$+C[&HSP$N%+BXC?B
MUR:NV\/\"UPI,6_D&[4#^=*KT"&WPJDSH7LZ0?W:8(2.3#"B.VSH#'@22CA8
M2C8@]V%U76JN=[/4DX?1_L_RY=GP(PM:L&[0\\.)G7:FKBO%RIUAPI"DU*1^
MRH8?1689IT;"DZ)S2*V'%\L!$H>C?\ X!87.Y3'#,IYJS*)5II$LYSP%75%?
MF0>)P$):9T6$_9% @3H5"C.9\V;FKIZ"P7G HFJ_54:Q;=T%W\17=A;:+.M=
MYCJD%I@3GB>8,C-%L<!96OH>#A*#8[IXA:LD,\\H/=O+<O1U2Q*#?69>_$@E
M"<N!/,/5"70+G*-.TY!<-G.6S.N(S[$!H JV,\=[/4,KGN:$D!_A37Q=/[BO
M5OS[1:M]];[5L>#_NBVKVVI>=]I7[5;7NKBD#\V/VMWN-07IKC]>7EC-RXM/
MK4Z7RTQ5*[D!WC<^M:R35NO"ZK3>M;O 7%JG?UB_%S]W<7F5?_;ZXK25FT2C
M>84Q0U8=&_#O#RUX[-2JX7.L=:6?UCHC+*CQ\>-YFP.-W2OL"6 \>M[XW-W+
MONU#XXN<&[ST#*=EG<$XW<9YR[:ZE^>G-JQ<ABSQ2WQ'MPL,%6?4EOI!^X*&
M;9QT6Q=-'"A!<34NK!:,V[QJPR;PVCL-C';R_#Y@#/0L?Q+3=Z:3@*A@[,:G
M1ON<EMOZ5^O#1QKXK'/Y@38#IM7@>&N# JRTT.[UR3]A.M;5I4WCI^;4:?W/
M=;M#L^JJ0\_.H'%Q2B,WFY>=TP:N]S-0V-R=QPF=G%_#Y[]]X0_@;%N?VJ>X
M9:?6R1>8ZWGK7>,\7=N,:YIU6HWNY04,_@5.YJK=/8.)7':^P")H#:H$&DT-
M9IZ),>.>M=5975^<M[I=.EKKXW4'"/X"-\/J7,/,D7G1UA>M? _W#]<*Z[O
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MKQ@K$6'4GHI4F)"XD>MY#L*[7"_&HE>N3V5#3KH-!+3=AL[0-FKC?74#S]'
M&<_Y)A% J<*:Q]@ 44):SD2? I6G@MH)6FT_BD-:<@-;.U.-4)H7!MU</V9T
M"X*6$@03PE*&HL\PP>S<='=I555/32ZSL%P'ATW' "9;B0$4!?JV&($IB.V]
M^?GD\O0+?/C^ZL/YV_\'4$L! A0#%     @ 3T;+6/> 4;D_ P  1@L  !$
M             ( !     &)R8G,M,C R-# V,#<N>'-D4$L! A0#%     @
M3T;+6%E(&-^I!@  I$D  !4              ( !;@,  &)R8G,M,C R-# V
M,#=?;&%B+GAM;%!+ 0(4 Q0    ( $]&RU@FR/I6W 0  /LM   5
M      "  4H*  !B<F)S+3(P,C0P-C W7W!R92YX;6Q02P$"% ,4    " !/
M1LM8[=Y,^N$A  !(P@  #@              @ %9#P  9#@R.#$P,60X:RYH
M=&U02P$"% ,4    " !/1LM8H3BK^"N4 0 J0PD $0              @ %F
J,0  9#@R.#$P,61E>#$P,2YH=&U02P4&      4 !0!  0  P,4!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d828101d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="brbs-20240607.xsd" xlink:type="simple"/>
    <context id="duration_2024-06-07_to_2024-06-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000842717</identifier>
        </entity>
        <period>
            <startDate>2024-06-07</startDate>
            <endDate>2024-06-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-363">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-06-07_to_2024-06-07"
      id="Hidden_dei_EntityCentralIndexKey">0000842717</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-374">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-375">2024-06-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-376">BLUE RIDGE BANKSHARES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-377">VA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-378">001-39165</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-379">54-1838100</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-380">1801 Bayberry Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-381">Suite 101</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-382">Richmond</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-383">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-384">23226</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-385">(540)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-386">743-6521</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-387">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-388">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-389">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-390">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-391">Common stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-392">BRBS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-393">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-394">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2024-06-07_to_2024-06-07" id="ixv-395">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
